Anesthesia and Respiratory Devices - BCC 2018

Anesthesia and
Respiratory Devices:
Global Markets
June 2018
BCC Research Staff
Report Code: HLC167C

Table of Contents
Chapter 1: Introduction ......................................................................................... 2
Overview ....................................................................................................................................................... 2
Study Goals and Objectives........................................................................................................................... 3
Reasons for Doing This Study ........................................................................................................................ 3
Scope of Report............................................................................................................................................. 3
Information Sources...................................................................................................................................... 5
Secondary Research .................................................................................................................................. 5
Primary Research....................................................................................................................................... 6
Methodology................................................................................................................................................. 6
Geographic Breakdown................................................................................................................................. 7
Analyst’s Credentials ..................................................................................................................................... 9
Related BCC Research Reports...................................................................................................................... 9
Chapter 2: Summary and Highlights ..................................................................... 11

Chapter 3: Overview of Anesthesia and Respiratory Devices .............................. 15
Anesthesia Devices ..................................................................................................................................... 15
Respiratory Devices..................................................................................................................................... 15
Types of Anesthesia and Respiratory Devices ............................................................................................ 15
Airway and Anesthesia Devices ............................................................................................................... 15
Anesthesia Machines............................................................................................................................... 18
Pain Management Devices ...................................................................................................................... 18
Regional Anesthesia Disposables ............................................................................................................ 18
Respiratory Devices ................................................................................................................................. 20
Respiratory Disposables .......................................................................................................................... 23
Respiratory Measurement Devices ......................................................................................................... 24
Sleep Apnea Diagnostic Systems ............................................................................................................. 25
Chapter 4: Market Dynamics ............................................................................... 27

Market Drivers ............................................................................................................................................ 27
Increasing Prevalence of COPD ............................................................................................................... 27
High Prevalence of Obstructive Sleep Apnea (OSA) ................................................................................ 31
Air Pollution: Its Impact on Respiratory Health....................................................................................... 33
Growing Global Surgery Numbers ........................................................................................................... 34
Market Restraints ....................................................................................................................................... 36
Regulatory Constraints ............................................................................................................................ 36
Macroeconomic Factors .......................................................................................................................... 37
Chapter 5: Market Breakdown by Product Type .................................................. 40

Product Types in Anesthesia and Respiratory Devices ............................................................................... 40
Segmental Market Shares of Anesthesia and Respiratory Device Market ............................................. 42
Respiratory Devices ................................................................................................................................. 47
Respiratory Measurement Devices ......................................................................................................... 51
Respiratory Disposables .......................................................................................................................... 54
Airway and Anesthesia Devices ............................................................................................................... 57
Anesthesia Machines............................................................................................................................... 59
Regional Anesthesia Disposables ............................................................................................................ 61
Sleep Apnea Diagnostic Systems ............................................................................................................. 63
Pain Management Devices ...................................................................................................................... 65
Chapter 6: Market Breakdown by Region ............................................................ 68
Global Medical Device Industry Scenario ................................................................................................... 68
Global Anesthesia and Respiratory Devices Market ................................................................................... 68
North America............................................................................................................................................. 70
United States ........................................................................................................................................... 73
Canada ..................................................................................................................................................... 75
Mexico ..................................................................................................................................................... 77
Asia-Pacific .................................................................................................................................................. 80
Keys for Growth....................................................................................................................................... 81
China ........................................................................................................................................................ 83
India ......................................................................................................................................................... 85
Japan........................................................................................................................................................ 87
South Korea ............................................................................................................................................. 89
Australia .................................................................................................................................................. 91
Europe ......................................................................................................................................................... 93
Market Scenario ...................................................................................................................................... 93
Germany .................................................................................................................................................. 97
France ...................................................................................................................................................... 99
United Kingdom..................................................................................................................................... 101
Italy ........................................................................................................................................................ 102
Russia..................................................................................................................................................... 104
Rest of the World (ROW) .......................................................................................................................... 106
Market Scenario .................................................................................................................................... 106
Chapter 7: Patent Review/New Developments .................................................. 110

Significance of Patents .............................................................................................................................. 110
Patent Analysis .......................................................................................................................................... 111
Patent Review by Company ................................................................................................................ 111
Chapter 8: Pipeline Analysis ............................................................................... 124

Definition of Pipeline ................................................................................................................................ 124
Need for Novelty/Pipeline Products ...................................................................................................... 124
Pipeline Analysis........................................................................................................................................ 124
Chapter 9: Company Share Analysis ................................................................... 127

Industry Scenario ...................................................................................................................................... 127
Controlling Factors .................................................................................................................................... 127
Market Opportunities ............................................................................................................................... 128
Scope for Product Innovations .............................................................................................................. 128
Emerging Markets: A New Ray of Hope for Struggling Manufacturers ................................................ 128
Competitor Market Share ......................................................................................................................... 129
Chapter 10: Company Profiles ........................................................................... 133

About BCC Research ......................................................................................... 188
About BCC Research.................................................................................................................................. 189
BCC Membership ...................................................................................................................................... 189
BCC Custom Research ............................................................................................................................... 189
List of Tables
Summary Table A Global Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022
($ Millions) .................................................................................................................................................. 11
Summary Table B Global Market for Anesthesia and Respiratory Devices, by Region, Through 2022 ($
Millions) ...................................................................................................................................................... 12
Table 1 Prevalence of COPD, 1990 and 2010 .............................................................................................. 29
Table 2 Prevalence of OSA .......................................................................................................................... 32
Table 3 Respiratory Devices Recalled/Rejected by FDA ............................................................................. 37
Table 4 Global Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ..................... 40
Table 5 Global Market for Anesthesia and Respiratory Devices, by Product Type, 2016 ($ Millions) ....... 43
Table 6 Global Market for Anesthesia and Respiratory Devices, by Product Type, 2017 vs. 2022 (%) ...... 44
Table 7 Global Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 44
Table 8 Global Market for Respiratory Devices, by Region, 2016 ($ Millions) ........................................... 48
Table 9 Global Market for Respiratory Devices, by Sub-Types, 2016 ($ Millions) ...................................... 50
Table 10 Global Market for Respiratory Measurement Devices, By Region, 2016 ($ Millions) ................. 51
Table 11 Global Market for Respiratory Devices, by Sub-types, 2016 ($ Millions) .................................... 53
Table 12 Global Market for Respiratory Disposables, by Region, 2016 ($ Millions) .................................. 55
Table 13 Global Market for Respiratory Disposables, by Sub-types, 2016 ($ Millions) ............................. 56
Table 14 Global Market for Airway and Anesthesia Devices, by Region, 2016 ($ Millions) ....................... 57
Table 15 Global Market for Anesthesia Machines, by Region, 2016 ($ Millions) ....................................... 60
Table 16 Global Market for Anesthesia Disposables, by Region, 2016 ($ Millions) ................................... 62
Table 17 Global Market for Sleep Apnea Diagnostic Systems, by Region, 2016 ($ Millions) ..................... 64
Table 18 Global Market for Pain Management Devices, by Region, 2016 ($ Millions) .............................. 65
Table 19 Global Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................... 68
Table 20 Global Market for Anesthesia and Respiratory Devices, by Region, Through 2022 ($ Millions) . 69
Table 21 North America Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions)...... 71
Table 22 North America Market for Anesthesia and Respiratory Devices, by Country, Through 2022 ($
Millions) ...................................................................................................................................................... 71
Table 23 North America Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022
($ Millions) .................................................................................................................................................. 73
Table 24 U.S. Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ....................... 73
Table 25 U.S. Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 74
Table 26 Canada Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................. 76
Table 27 Canada Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 76
Table 28 Mexico Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions).................. 78
Table 29 Mexico Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 78
Table 30 Asia-Pacific Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ........... 80
Table 31 Asia-Pacific Market for Anesthesia and Respiratory Devices, by Country, Through 2022 ($
Millions) ...................................................................................................................................................... 80
Table 32 Asia-Pacific Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 82
Table 33 China Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) .................... 83
Table 34 China Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 84
Table 35 India Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) .................... 85
Table 36 India Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 86
Table 37 Japan Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................... 87
Table 38 Japan Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 87
Table 39 South Korea Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions).......... 89
Table 40 South Korea Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022
($ Millions) .................................................................................................................................................. 89
Table 41 Australia Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) .............. 91
Table 42 Australia Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 92
Table 43 Europe Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................. 93
Table 44 Europe Market for Anesthesia and Respiratory Devices, by Country, Through 2022 ($ Millions)
.................................................................................................................................................................... 94
Table 45 Europe Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 95
Table 46 Germany Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions).............. 97
Table 47 Germany Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) ...................................................................................................................................................... 97
Table 48 France Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions)................... 99
Table 49 France Market for Anesthesia and Respiratory Devices, by Product Type ($ Millions) .............. 99
Table 50 U.K. Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) .................... 101
Table 51 U.K. Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) .................................................................................................................................................... 101
Table 52 Italy Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions).................... 102
Table 53 Italy Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) .................................................................................................................................................... 103
Table 54 Russia Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................ 104
Table 55 Russia Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) .................................................................................................................................................... 104
Table 56 ROW Market for Anesthesia and Respiratory Devices, Through 2022 ($ Millions) ................... 106
Table 57 ROW Market for Anesthesia and Respiratory Devices, by Region, Through 2022 ($ Millions) . 107
Table 58 ROW Market for Anesthesia and Respiratory Devices, by Product Type, Through 2022 ($
Millions) .................................................................................................................................................... 108
Table 59 International Patent Offices ....................................................................................................... 110
Table 60 ResMed Patent Loss of Exclusivity Scenario............................................................................... 114
Table 61 Patents issued to Fisher and Paykel, 2016 ................................................................................. 114
Table 62 Patents issued to Fisher and Paykel, 2017 ................................................................................. 115
Table 63 Patents issued to Smiths Medical, 2016 .................................................................................... 117
Table 64 Patents issued to Smiths Medical, 2017 .................................................................................... 118
Table 65 Top 50 Medical Device Patents issued to Medtronic, 2016 ....................................................... 119
Table 66 Top 50 Medical Device Patents issued to Medtronic, 2017 ....................................................... 120
Table 67 Pipeline products of Key Players ................................................................................................ 125
Table 68 Global Market for Anesthesia and Respiratory Devices , by Company, 2016 ($ Millions) ........ 131
Table 69 B&D Company Revenue, 2014-2016 ($ Millions) ....................................................................... 141
Table 70 B&D Product Portfolio ................................................................................................................ 144
Table 71 GE Healthcare List of Subsidiaries ............................................................................................. 151
Table 72 Halyard Health Product Portfolio ............................................................................................... 158
Table 73 Invacare Corp Company Revenue, 2014-2016 ($ Millions) ........................................................ 159
Table 74 Invacare Corp Product Portfolio ................................................................................................ 161
Table 75 Medtronic Company Revenue, 2014-2016 ($ Millions) ............................................................ 162
Table 76 Medtronic Anesthesia and Respiratory Devices-Product Portfolio .......................................... 164
Table 77 Royal Philips-List of Subsidiaries ............................................................................................... 165
Table 78 Philips Health-Business Segments.............................................................................................. 167
Table 79 ResMed Net Revenue, 2014-2017 ($ Millions)......................................................................... 173
Table 80 ResMed’s Product Launches in Last Five Years .......................................................................... 174
Table 81 Teleflex, North America Anesthesia Segment Revenues, 2014-2016 ($ Millions) .................... 184
List of Figures
Summary Figure A Global Market for Anesthesia and Respiratory Devices, by Product Type, 2016-2022
($ Millions) .................................................................................................................................................. 12
Summary Figure B Global Market for Anesthesia and Respiratory Devices, by Region, 2016-2022 ($
Millions) ...................................................................................................................................................... 13
Figure 1 Global Surgery Volumes, 2004 and 2012 (Millions) ...................................................................... 35
Figure 2 Global Market for Anesthesia and Respiratory Devices, 2016-2022 ($ Millions) ......................... 41
Figure 3 Global Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ......... 42
Figure 4 Global Market for Anesthesia and Respiratory Devices, by Product Type, 2016-2022 ($ Millions)
.................................................................................................................................................................... 45
Figure 7 Global Market for Respiratory Devices, by Region, 2016-2022 ($ Millions) ................................. 49
Figure 8 Global Market Share for Respiratory Devices, by Sub-Types, 2016 (%) ....................................... 50
Figure 9 Global Market for Respiratory Measurement Devices, 2016-2022 ($ Millions) ........................... 52
Figure 10 Global Market Share for Respiratory Measurement Devices, by Sub-types, 2016 (%) .............. 53
Figure 11 Global Market for Respiratory Disposables, 2016–2022 ($ Millions) ......................................... 55
Figure 12 Global Market Share for Respiratory Disposables, by Sub-types, 2016 (%) ............................... 56
Figure 13 Global Market for Airway and Anesthesia Devices, 2016-2022 ($ Millions) .............................. 58
Figure 14 Global Market Share for Airway and Anesthesia Devices, by Sub-types, 2016 (%) .................... 59
Figure 15 Global Market for Anesthesia Machines, 2016- 2022 ($ Millions) ............................................. 60
Figure 16 Global Market Share for Anesthesia Machines, by Sub types, 2016 (%) ................................... 61
Figure 17 Global Market for Anesthesia Disposables, 2016-2022 ($ Millions) .......................................... 62
Figure 18 Global Market Share for Anesthesia Disposables, by Sub-types, 2016 (%) ................................ 63
Figure 19 Global Market for Sleep Apnea Diagnostic Systems, 2016-2022 ($ Millions) ............................ 64
Figure 20 Global Market Share for Sleep Apnea Diagnostic Systems, by Sub-types, 2016 (%) .................. 65
Figure 21 Global Market for Pain Management Devices, 2016-2022 ($ Millions)...................................... 66
Figure 22 Global Market for Anesthesia and Respiratory Devices, 2016-2022 ($ Millions) ....................... 69
Figure 23 Global Market for Anesthesia and Respiratory Devices, by Region, 2016-2022 ($ Millions) ..... 70
Figure 24 North America Market Share for Anesthesia and Respiratory Devices, by Country, 2016 (%) . 72
Figure 25 U.S. Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ........... 75
Figure 26 Canada Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ...... 77
Figure 27 Mexico Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ...... 79
Figure 28 Asia-Pacific Market Share for Anesthesia and Respiratory Devices, by Country, 2016 (%)........ 81
Figure 29 Asia-Pacific Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) 82
Figure 30 China Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ......... 84
Figure 31 India Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ......... 86
Figure 32 Japan Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ........ 88
Figure 33 South Korea Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%)
.................................................................................................................................................................... 90
Figure 34 Australia Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ... 92
Figure 35 Europe Market Share for Anesthesia and Respiratory Devices, by Country, 2016 (%) ............. 94
Figure 36 Europe Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ...... 96
Figure 37 Germany Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%).. 98
Figure 38 France Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ... 100
Figure 39 U.K Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016 (%) ......... 102
Figure 40 Italy Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ........ 103
Figure 41 Russia Market Share for Anesthesia and Respiratory Devices, by Product type, 2016 (%) ..... 105
Figure 42 ROW Market Share for Anesthesia and Respiratory Devices, by Country, 2016 (%)................ 107
Figure 43 Draegerwerk Patent Share, by Region, 2016 (%) ...................................................................... 112
Figure 44 ResmMed Number of Patents Issued, 2016 (%) ....................................................................... 112
Figure 45 ResMed Patent Activities, 2017 ................................................................................................ 113
Figure 46 Global Market Share for Anesthesia and Respiratory Devices, by Company, 2016 (%) .......... 129
Figure 47 Ambu A/S Company Financial Performance, 2012-2016 ($ Millions)....................................... 134
Figure 48 Ambu A/S Revenue Share, by Business Unit, 2016 (%)............................................................. 135
Figure 49 B. Braun Company Revenues, 2015 & 2016 ($ Millions) .......................................................... 137
Figure 50 B. Braun Revenue Share, by Region, 2016 (%) .......................................................................... 138
Figure 51 B. Braun Revenue Share, by Business Unit, 2016 (%) ............................................................... 139
Figure 52 B&D Revenue Share, by Business Segment, 2014-2016 ($ Millions) ....................................... 142
Figure 53 B&D Revenue, by Region, 2014-2016 ($ Millions) .................................................................... 143
Figure 54 Draegerwerk Annual Revenue, 2015 and 2016 ($ Millions) ..................................................... 145
Figure 55 Draegerwerk Revenue Share, by Region, 2016 (%) .................................................................. 146
Figure 56 Fisher & Paykel Annual Revenue, 2014-2017 ($ Millions) ....................................................... 148
Figure 57 Fisher and Paykel Revenue Share, by Region, 2017 (%) .......................................................... 149
Figure 58 GE Annual Revenue, 2012-2016 ($ Millions) ........................................................................... 152
Figure 59 GE Revenue Share, by Business Unit, 2016 (%) ....................................................................... 153
Figure 60 GE Healthcare Market Share, by Region, 2016 (%) .................................................................. 154
Figure 61 GE Healthcare Revenue Share, by Product Division, 2016 (%) ................................................ 155
Figure 62 Halyard Annual Revenue, 2014-2016 ($ Millions) .................................................................... 158
Figure 63 Invacare Corp Revenue Share, by Business Unit, 2014-2016 ($ Millions) ............................... 160
Figure 64 Invacare Corp Revenue Share, by Region, 2014-2016, ($ Millions) ......................................... 160
Figure 65 Medtronic Revenue, by Business Unit, 2014-2016 ($ Millions) ............................................... 163
Figure 66 Medtronic Revenue, by Region, 2014-2016 ($ Millions) ......................................................... 163
Figure 67 Philips Sales Revenue, 2015-2017 ($ Millions)......................................................................... 166
Figure 68 Philips Sales Revenue Shares, by Business Unit, 2016 (%) ....................................................... 166
Figure 69 Philips Sales Revenue Shares, by Business Unit, 2017 (%) ....................................................... 167
Figure 70 Philips Health Revenue Share, by Division, 2017 (%) ............................................................... 168
Figure 71 ResMed Inc, Annual Net Revenues, 2014-2017 ($ Millions) .................................................... 173
Figure 72 Smith Medical Revenue Share, by Sector, 2017 (%) ................................................................ 179
Figure 73 Teleflex Annual Revenue, 2014-2016 ($ Millions) ................................................................... 183
Figure 74 Teleflex Revenue Shares, by Region, 2016 (%) ........................................................................ 184
Chapter 1
Introduction
Chapter 1: Introduction
Overview
Anesthesia is a medically-induced temporary state of unconsciousness during which the recipient is
unaware of and insensitive to pain. Anesthetics are administered prior to and during surgical and dental
procedures. The use of anesthesia can suppress a patient’s central nervous system and alleviate anxiety
and inhibit long term memories of what can be very painful and traumatic procedures. The use of
anesthesia not only prevents and manages pain, it also enables less traumatic, faster operations with
fewer complications to the patient.
Anesthetic devices are used to safely deliver a measured quantity of medical gases that are mixed with a
specific concentration of anesthetic vapor during surgical procedures.
Artificial respiration or aided respiration is a mandatory healthcare practice for patients suffering from
severe respiratory diseases, critical conditions and traumatic injuries. Respiratory devices include those
devices which measure respiratory function as well as those which primarily eliminate mucus from
respiratory airways; this leads to the improvement of the pulmonary function.
There is a considerable increase in the number of operative conditions or surgeries globally resulting in a
significant opportunity for the anesthesia devices market to grow. Increases in air pollution along with
more diagnosed respiratory infections, allergies and diseases such as Chronic Obstructive Pulmonary
Disease (COPD) and Obstructive Sleep Apnea (OSA), are factors impacting the usage of respiratory
devices.
The anesthesia and respiratory devices market covers airway and anesthesia devices that are used in
conjunction with other anesthesia equipment. These devices provide support in administering the
anesthesia and managing the patient’s airflow:
• Anesthesia machines that contain and dispense the anesthetic vapor.
• Pain management devices are the devices that ensure the accurate delivery of anesthetic
vapors.
• Regional anesthesia disposables consisting of needles, catheters and kits used to perform
various type of anesthesia procedures such as epidural, peripheral and spinal anesthesia.
• Respiratory disposables consisting of the consumables like masks, cannula and valves those are
used to support respiratory devices or artificial respiration.
• Respiratory devices that facilitate breathing during respiratory failure and other respiratory
conditions.
© 2018 | BCC Research LLC HLC167C Anesthesia and Respiratory Devices: Global Markets | 2
• Respiratory measurement devices, which are the instruments or aids that measure a patient’s
respiratory performance; these devices include spirometers, capnographs and pulse oximeter
systems.
• Sleep apnea diagnostic systems, including fixed and portable polysomnography systems, which
are used to detect the presence of and measure the intensity of sleep apnea while sleep studies
are performed.
Study Goals and Objectives

The goals of this study are to quantify the market for various segments of the anesthesia and respiratory
devices market, to explore market dynamics such as drivers and restraints, to study the recent advances
available in the market, to identify the areas of growth within the anesthesia and respiratory devices
market, and to list the products in clinical development which are likely to soon be available.
Reasons for Doing This Study

Anesthesia and respiratory devices can resolve various environmental and lifestyle borne acute and
chronic respiratory disorders. Many consistent factors of these disorders promote the usage of these
devices and the anesthesia and respiratory device market is expected to experience substantial growth.
In addition, both anesthesia and respiratory support are required in the treatment and management of
critical care, operations and surgeries and trauma for pain management and life support functions. This
factor also contributes to the expected growth in this market.
Scope of Report
Market reports are the ideal guide for anyone wishing to understand a specific market better in terms of
revenues, technology innovations, distributors and competitors. This report provides both an overview
and country-level information for various categories, distribution shares and explores the competitive-
landscape in the market. This report details:
Comprehensive data related to the market revenue, company share and distribution share.
Corporate-level profiles of key companies in the anesthesia and respiratory devices market that operate
in the United States and other key countries, including a brief overview of each company, its business
activities and its hold or presence in the respective market. The selection of the companies is based on
their operational presence and sales performance.
A list of products under development by key companies in which these products are being clinically
investigated.
The market has been segmented based on device type and geographic area. By type, the market has
been segmented as anesthesia devices and consumables and respiratory devices and disposables. By
geography, the market has been segregated as North America including countries: the United States
(U.S.), Canada and Mexico; Europe including countries: Germany, the United Kingdom (U.K.), France and
Italy; Asia-Pacific including countries: China, India, Japan, Australia, New Zealand, South Korea, and
South Africa; Middle East which includes United Arab Emirates; South America including countries Brazil
and Argentina.
This market research report includes anesthesia and respiratory devices segregated as below in
categories based on their nature and usage.
Airway and Anesthesia devices:

• Airway management devices.
• Anesthesia Circuits.
• Anesthesia Masks.
• Breathing Filters.
• Laryngoscope Blades.
• Laryngoscope Handles.
Anesthesia Machines:
• Portable Anesthesia Delivery Machines.
• Stand Alone Anesthesia Delivery Machines.
• Anesthesia Workstations.
Pain Management Devices.
Regional Anesthesia Disposables:

• Epidural Anesthesia Disposables.
• Peripheral Anesthesia Disposables.
• Spinal Anesthesia Disposables.
Respiratory Devices:
• Humidifiers.
• Nebulizers.
• Oxygen Concentrators.
• Oxygen Conservers.
• Positive Airway Pressure Devices.
• Reusable Resuscitators.
• Ventilators.
Respiratory Disposables:
• Aerosol Masks.
• Cardio-Pulmonary Resuscitation (CPR) barriers.
• Nasal Cannula.
• Oxygen Masks.
• Patient Interface.
• Resuscitators.
Respiratory Measurement Devices:

• Capnographs.
• Spirometers.
• Pulse Oximeter Systems.
Sleep Apnea Diagnostic Systems:

• Fixed Polysomnography Systems.
• Portable Polysomnography Systems.
Information Sources
Secondary Research
The research process involves conducting exhaustive secondary research on internal and external
sources being carried out to source qualitative and quantitative information related to the market. The
first step in secondary research involves preparing the company profiles and product mapping for the
market nodes. The next step involves gathering data and information available in public domain for the
market nodes. The secondary research sources that are typically referred to include, but are not limited
to:
• Company websites, financial reports, broker reports, investor presentations and SEC filings.
• Industry trade journals, scientific journals and other technical literature.
• Relevant patent and regulatory databases.
• National government documents and statistical databases.
• Procedure registries.
• News articles, press releases and web-casts specific to the companies operating in the market.
Primary Research
Primary research typically involves e-mail interactions and telephone interviews. Primary interviews
help in validating the data and information from secondary sources and also in gathering data for
market nodes where secondary sources are not available. The participants who typically take part in
such a process include, but are not limited to:
• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers

and national sales managers.
• Outside experts: investment bankers, valuation experts, research analysts specializing in specific
medical equipment markets.
Methodology
BCC Research presents an analysis across the entire anesthesia and respiratory devices market based on
company-specific revenue as reported to the U.S. Securities and Exchange Commission (SEC) and/or
other governmental agencies, as well as company information such as conversations with company
officials, annual reports and product/financial news releases. Technological and demographic
information is gathered from industry sources, governmental sources and published news reports.
The market size estimations for the anesthesia and respiratory devices market is carried out through
bottom-up and top-down approaches. The bottom-up approach includes examining the historical
revenues of key players, studying the size of the applications, a value and supply-chain analysis and end-
user demand, which are then cross-validated by secondary and primary resources. Primary sources
include extensive first-hand interviews with doctors preferably pulmonologists and sleep specialists,
product managers, area and country sales managers and business heads involved in sales and business
development of anesthesia and respiratory devices. Secondary sources include various government and
business sources, medical journals, abstracts, and trade magazines. The top-down approach is an
accurate research process followed where the global market sizing is carried out through the secondary
research, validated by primary industry experts.
The research methodology used to calculate market size included the following details:
• Market revenues of key players were determined through primary and secondary research,
including a study of the annual reports of top market players, and interviews with key opinion
leaders and corporate heads such as chief executive officers (CEOs), directors, product heads,
business unit heads, etc.
• Revenues were added together to get market sizes of different devices types.
• For regional breakdown, various factors such as companies’ regional revenue mix, demographics
across regions, disease incidence, etc. Regional shares were verified through telephone
interviews.
• The forecast was based on analysis of market factors such as pricing, historic growth, expected
change in demographics in the future and experts’ views on future growth.
Geographic Breakdown
In this report, the geographic regions considered for market analysis include, and only include:
North America
• United States (U.S.).
• Mexico.
• Canada.
Europe (EU)
• United Kingdom (U.K.).
• France.
• Russia.
• Germany.
• Italy.
• Others.
Asia-Pacific
• China.
• India.
• Japan.
• South Korea.
• Others.
Rest of World (ROW)

• South America.
• Middle East and Africa (MEA).
Anesthesia and Respiratory Devices, by Type
Airway and Anesthesia Devices
Anesthesia Machines
Pain Management Devices
Regional Anesthesia Disposables
Anesthesia and Respiratory Devices,

BY TYPE
Respiratory Devices
Respiratory Disposables
Respiratory Measurement Devices
Sleep Apnea Diagnostic Systems
Analyst’s Credentials
Led by Research Head Karthik Arun, the BCC Research Staff is comprised of expert analysts skilled in
conducting primary research, secondary research and data analysis and who have decades of combined
experience covering a wide range of industries, including healthcare, advanced materials and emerging
technologies. Collectively, the team represents a diverse set of educational achievements with individual
graduate work completed in microbiology, electrical engineering, business administration and surgery,
among others.
Related BCC Research Reports

HLC081C Sleep Aids: Technologies and Global Markets
HLC177A Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets
Chapter 2
Summary and Highlights
Chapter 2: Summary and Highlights
The anesthesia and respiratory devices market is estimated at almost $21.1 billion in 2017, growing at a
compound annual growth rate (CAGR) of 4.8% to reach $26.7 billion in 2022.
Summary Table A
Global Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR%
Segment 2016 2017 2022
2017-2022
Respiratory Devices 7,456.3 7,852.4 9,996.4 4.9
Respiratory Measurement Devices 5,432.5 5,687.2 7,020.9 4.3
Respiratory Disposables 2,517.4 2,604.0 3,040.0 3.1
Airway and Anesthesia Devices 1,622.7 1,714.9 2,222.8 5.3
Anesthesia Machines 1,161.6 1,239.7 1,688.5 6.4
Regional Anesthesia Disposables 1,077.6 1,148.0 1,522.9 5.8
Pain Management Devices 319.4 347.5 513.5 8.1
Sleep Apnea Diagnostic Systems 464.1 500.5 711.9 7.3
Total 20,051.6 21,094.2 26,716.9 4.8
Source: BCC Research
Summary Figure A
2016-2022
($ Millions)
12,000.0
10,000.0
8,000.0
$ Millions
6,000.0
4,000.0
2,000.0
0.0
2016 2017 2022
Respiratory Devices Respiratory Measurement Devices

Respiratory Disposables Airway and Anesthesia Devices
Anesthesia Machines Regional Anesthesia Disposables
Pain Management Devices Sleep Apnoea Diagnostic Systems
Summary Table B
Global Market for Anesthesia and Respiratory Devices, by Region, Through 2022
($ Millions)
CAGR%
Region 2016 2017 2022
2017-2022
North America 9,424.3 9,896.7 12,423.4 4.7
Asia-Pacific 3,709.5 3,955.2 5,343.4 6.2
Europe 4,611.9 4,798.9 5,744.1 3.7
ROW 2,305.9 2,443.4 3,206.0 5.6
Total 20,051.6 21,094.2 26,716.9 4.8
Summary Figure B
Global Market for Anesthesia and Respiratory Devices, by Region, 2016-2022
($ Millions)
14,000.0
12,000.0
10,000.0
$ Millions
8,000.0
6,000.0
4,000.0
2,000.0
0.0
2016 2017 2022
North America Asia Pacific Europe ROW
Chapter 3
Overview of Anesthesia and
Respiratory Devices
Chapter 3: Overview of Anesthesia and
Respiratory Devices
Anesthesia Devices
Anesthesia device are those devices that assist anesthesiologists in accurately administering anesthetic
gases or vapors in a desired quantity and concentration. The adoption level of these devices is currently
higher in developed nations than in developing nations. There are various reasons for this difference
including the lack of regulations, a gap in available technology, doctors’ preferences towards
conventional procedures and economic constraints. However, because of some significant changes in
the healthcare policies in some Asian and Latin American countries, the usage of these devices is
expected to grow in the future.
Respiratory Devices
Respiratory devices are those devices that provide artificial respiration for a patient who is unable to
breathe regularly without assistance. Generally, artificial respiration is provided to patients who suffer
from chronic respiratory issues, are critically ill, are admitted in a neonatal care unit, or are placed in an
intensive care unit for enhanced respiratory support. These devices play a significant role is supporting a
patient’s recovery. These devices are generally of two types, hospital-based and home-based.
Types of Anesthesia and Respiratory Devices

Airway and anesthesia devices are typically single-use devices used in conjunction with anesthesia
equipment to administer anesthesia. These devices are of various types including anesthesia circuits,
airway management devices, anesthesia masks, reusable anesthesia masks, breathing filters,
laryngoscope blades and handles.
Airway Management Devices

Airway management devices include those devices which safely administer anesthesia to patients. They
are also used to open a pathway between patient’s lungs and an oxygen source. These devices are
classified as laryngeal masks, endotracheal tube and tracheostomy tubes.
Laryngeal Masks
A laryngeal mask is a device that is used to maintain an effective airway without tracheal intubation. It
consists of an inflatable silicon mask and a rubber connecting tube. It is inserted into the pharynx,
forming a low-pressure seal around the laryngeal inlet and permitting gentle positive pressure
ventilation.
Tracheostomy Tubes
Tracheostomy tubes are meant to support airflow and help the patient breath. The surgical procedure of
inserting a tracheostomy-tube into a patient’s windpipe is called tracheotomy. It is a 2-to-3-inch-long
curved tube designed to be directly placed into a patient’s windpipe through neck.
Endotracheal Tubes
An endotracheal tube is a breathing tube that is used temporarily to keep the airway open so breathing
can occur. This curved tube is inserted into the patient’s nose or mouth into his traches (windpipe). Tape
or a soft strap holds the tube in place. Size range from 3-10.5mm in internal diameter.
Anesthesia Circuits
An anesthesia circuit is an interface between an anesthesia machine and patient and is used to deliver
anesthesia to the patient. A typical circuit consists of a reservoir, rebreathing bags, flexible hoses,
absorbers, and a face piece.
Non-Breathing Circuits
Non-Breathing circuits provide patients access to environmental air as well as the anesthetic oxygen
mixture and allows exhalation into the environment. It is a simple anesthesia path which consists of a
mask worn by the patient.
Rebreathing Circuits
A rebreathing circuit promotes the recirculation of anesthetic gases. It consists of a carbon dioxide (CO2)
absorber, a reservoir and two uni-directional valves, one expiratory and one inspiratory tube.
Anesthesia Masks
An anesthesia mask includes a mask for providing anesthesia to the patient, a mask strap for holding the
mask against the patient’s mouth, and a jaw raising strap to raise the patient’s jaw and forward to avoid
airway obstruction.
Disposable Anesthesia Masks

Disposable anesthesia masks are single patient, one-time use masks; it reduces the time for cleaning,
sterilizing and disinfecting procedures. Disposable anesthesia masks reduce the risk of cross
contamination.
Reusable Anesthesia Masks

Reusable masks are same as disposable anesthesia masks but can be used multiple times with
sterilization after each use.
Breathing Filters
Breathing filters are single use disposable heat moisture exchange filters used in anesthesia and critical
care breathing circuits when it is very important to keep filtered and humidified anesthetic gases
inspired by the patients. This segment includes either bacterial filters, HME filters or a combination of
both.
Laryngoscope Blades
Laryngoscope blades are the distal components of a laryngoscope designed to provide illumination and
to displace the lower pharynx, larynx and upper trachea. It consists of a spatula to hold the tongue, a
curved or an angular flange to provide rigidity with an L-shaped or semi-circular groove for viewing
along its length and usually an illumination system using a conventional lamp or fiberoptic system.
Laryngoscope blades are available in various sizes for adult and pediatric use; they are also available as a
non-foldable integral part of plastic laryngoscopes. Some laryngoscopes are designed specifically for use
in a magnetic resonance imaging (MRI) environment. Disposable and reusable laryngoscope blades are
covered under this segment.
Disposable Laryngoscope Blades

These are single use blades that help to prevent cross infections. These are available in several sizes for
adult and pediatric use, and in several designs of a curved or angular flange. Usually a conventional lamp
or a fiberoptic system is provided for illumination, blades without illumination provision are also
available.
Reusable Laryngoscope Blades

These laryngoscope blades can be used multiple times with disinfection and sterilization after each use.
These are available in several sizes for adult and pediatric use, and in several designs of a curved or
angular flange. Usually a conventional lamp or a fiberoptic system is provided for illumination, blades
without an illumination provision are also available.
Laryngoscope Handles
Laryngoscope handles are designed to be handheld while also suppling power to the laryngoscope
blades. It usually consists of a hollow handle with a battery and battery charger. The handle and an
attached standard, conventional blade compose a working laryngoscope. Dedicated fiberoptic
laryngoscope handles are also available. MRI compatible laryngoscope blades are made of non-
magnetitic materials so that they can be safely used in MRI suites. Disposable and reusable laryngoscope
blades are tracked in this segment.
Disposable Laryngoscope Handles

These are single-use handles and because they disposed of after one use they prevent cross infection.
These typically contain a hollow handle with a battery and battery charger; however, simple handles
without the battery units are also available.
Reusable Disposables Laryngoscope Handles

As the name signifies, these laryngoscope handles can be used multiple times with disinfection and
sterilization after each use. Typically these contain a hollow handle with a battery and battery charger;
however, simple handles without the battery units are also available.
Anesthesia Machines
Anesthesia machines provide an accurate and continuous supply of medical gases (such as oxygen and
nitrous oxide), mixed with an accurate concentration of anesthetic vapor (such as isoflurane) that is
delivered to the patient at a safe pressure and flow. This category includes anesthesia workstations,
standalone anesthesia delivery machines and portable anesthesia delivery machines.
Anesthesia Workstations
An anesthesia workstation includes an anesthesia gas delivery system, flow management controls, a
breathing system, a standard circle absorber system, precision vaporizer, a ventilator (integrated with a
volume control and pressure controller), an anesthesia monitoring system, centralized monitoring and
networking system.
Portable Anesthesia Delivery Machines

Portable Anesthesia Delivery Machines are compact, comparatively less-complex in configuration and
are portable units typically encased in protective cases. They offer a gas delivery system and auxiliary
driving gas outlets for both oxygen and anesthetic gases. This includes limited features for patient
monitoring, vital signs, ventilation data, and gas and agent consumption measurements.
Stand Alone Anesthesia Delivery Machines

Standalone anesthesia delivery machines are devices used for delivery of anesthetic gases in Intensive
Care Units (ICU) and operation room settings. It includes the anesthetic gas delivery system, a standard
circle absorber system, vaporizers and an integrated monitoring system.

Pain management devices are used to provide patients with consistent, long-lasting pain relief by
delivering drugs intravenously, subcutaneously or epidurally to the patient. There are both reusable and
disposable external pain pumps which administer the anesthetic drugs via a subcutaneous or epidural
catheter that is tunneled into the patient.

Regional anesthesia disposables consist of needles, a catheter and kits used to perform various types of
anesthesia procedures such as epidural anesthesia, peripheral anesthesia and spinal anesthesia.
Epidural Anesthesia Disposables

Epidural anesthesia disposables are used for epidural anesthesia procedures performed in the lower
back (lumbar) region. Devices covered in this category are epidural catheters, epidural kits and epidural
needles.
Epidural Catheters
An epidural catheter is a thin nylon or teflon catheter that is guided to the epidural space via epidural
needle for the delivery of an anesthetic agent.
Epidural Kits
An epidural kit is a set of devices used during an epidural anesthesia procedure. A typical epidural kit will
include an epidural needle, an epidural catheter, a syringe, iodine solution, sodium chloride, gauze, etc.
Epidural Needles
Epidural needles are metal needles that act as a passage for an epidural catheter into the epidural space
beneath the vertebrae of the spinal column. Once the catheter is placed, the needle is removed and the
catheter remains in place and is used for the delivery of prescribed drugs.
Peripheral Anesthesia Disposables

Peripheral anesthesia is a technique which involves injecting medication directly around nerves of a
specific region to render the target area insensate. Peripheral anesthesia is a preferred technique for
many orthopaedic surgical procedures, in both inpatient and outpatient surgeries. Devices covered
under this category are peripheral catheters and peripheral needles
Peripheral Catheters
A peripheral catheter is a thin nylon or teflon catheter that is guided to the peripheral nerve space via a
peripheral needle for the delivery of an anesthetic agent.
Peripheral Needles
Peripheral needles are metal needles that act as a passage for a peripheral catheter into the peripheral
space. Once the catheter is placed, the needle is removed and catheter remains in place is used for the
delivery of prescribed drugs.
Spinal Anesthesia Disposables

Spinal anesthesia disposables are used for the administration of spinal anesthesia into cerebrospinal
fluid. The injection is usually made in the lumbar spine below the level where the spinal cord ends.
Spinal anesthesia disposables include spinal catheters and spinal needles.
Spinal Catheters
A spinal catheter is used during the continuous anesthesia procedure for repetitive supply of spinal
anesthesia into cerebrospinal fluid.
Spinal Kits
A spinal kit is a set of is a set of devices used during spinal anesthesia procedure. Each kit consists of
spinal syringe, introducer needle and drapes.
Spinal Needles
Spinal needles are used to inject anesthesia into spinal fluid during spinal anesthesia procedure. After
placing the spinal needle in desired position in cerebrospinal space, a spinal anesthesia-filled syringe is
attached to the hub of the spinal needle for the administration of anesthesia into cerebrospinal fluid.
Respiratory Devices
Respiratory devices are the devices that facilitate breathing during respiratory failure and other
respiratory disease conditions. There are many types of respiratory devices available in the market.
The following types are covered as a part of this report positive airway pressure (PAP) devices,
humidifiers, nebulizers, oxygen concentrators, oxygen conservers, reusable resuscitators and
ventilators.
Humidifiers
A respiratory gas humidifier ensures that patients on mechanical ventilation are supplied with optimally
conditioned respiratory gas. In active humidifying processes, moisture and heat is input to respiratory
gas by an electrically powered humidifier. The aggregation of water in the gas produced by an active
respiratory gas humidifier may be a suspension, or aerosol, which is produced by a nebulizer;
or particulate water, output from an evaporator or bubble humidifier.
Nebulizers
Nebulizers generate aerosols consisting of droplets of various sizes that are admixed to the inspired
respiratory gas. Types of nebulizers currently on the market include portable compressor nebulizers,
portable ultrasonic nebulizers, standalone compressor nebulizers and standalone ultrasonic nebulizers.
Portable Compressor Nebulizers

Portable compressor nebulizers provide a metered dose of medication to the user, as the liquid bottom
of the inhaler is rotated clockwise 180 degrees by hand, adding a build-up tension into a spring around
the flexible liquid container. It is small and portable in nature.
Portable Ultrasonic Nebulizers

The portable ultrasonic nebulizer consists of an electronic oscillator that generates a high
frequency ultrasonic wave, which causes the mechanical vibration of a piezoelectric element. This
vibrating element, which is in contact with a liquid reservoir, produces the vapor mist with its high
frequency vibration. As they create aerosols from ultrasonic vibration instead of using a heavy air
compressor, these types of nebulizers are preferred over conventional and heavy nebulizers.
Standalone Compressor Nebulizer

The standalone compressor nebulizer works with a similar principle to the portable compressor
nebulizer but these machines require traditional wall outlet for power supply. Standalone compressor
nebulizers are heavier than the portable compressor nebulizers and used in hospital or home settings.
Standalone Ultrasonic Nebulizers

The standalone ultrasonic nebulizer works with a similar principle to the portable ultrasonic nebulizer
but these machines are attached with a standalone aerosol generator to an integrated air supply that
delivers air in high volume at adjustable rates. These devices can be used at home or hospital.
Oxygen Concentrators
Oxygen concentrators are used to deliver oxygen to those who require it. Patients may require it if they
have a condition that causes or results in low levels of oxygen in their blood. Several parts make up a
concentrator, including a compressor, sieve bed filter and circuit boards. The working principle of an
oxygen concentrator is much like a window air conditioning unit: it takes in air, modifies it and delivers it
in a new form. An oxygen concentrator takes in air, purifies and delivers it for use by people requiring
medical oxygen because of low oxygen levels in their blood. Oxygen concentrators are of two types:
fixed oxygen concentrators and portable oxygen concentrators.
Fixed Oxygen Concentrators

Fixed oxygen concentrators are the oxygen concentrators which are wall mounted and require a
traditional wall outlet for power supply.
Portable Oxygen Concentrators

Portable oxygen concentrators are the oxygen concentrators which are mobile in nature and can be
easily moved when an installed battery for power supply is available. This unit doesn’t require a wall
outlet for power supply on a continuous basis. Portable oxygen concentrators are preferred these days
as they are light weight and easy to handle.
Oxygen Conservers
Oxygen conservers regulate the flow of oxygen from an oxygen tank. They deliver oxygen as the patient
inhales, resulting in greater efficiency and cost saving ratios. Oxygen conservers are most commonly
utilized with home oxygen delivery systems and come in a variety of sizes and configurations to fit
different oxygen tanks and cylinders.
Positive Airway Pressure Devices

Positive airway pressure (PAP) is a method of respiratory ventilation used primarily in the treatment of
sleep apnea. PAP ventilation can also be used during “the wearing off” period of a ventilated intensive
care patient, in exacerbations of COPD, pulmonary edema and other settings of respiratory failure. PAP
devices are of three types; automatic self adjusting positive airway pressure (APAP) devices, bi-level
positive airway pressure (BPAP) devices and continuous positive airway pressure (CPAP) devices.
Automatic Self Adjusting Positive Airway Pressure (APAP) Devices

Automatic self adjusting positive airway pressure (APAP) devices automatically tune the amount of
pressure delivered to the patient to the required level ensuring an unobstructed airway by measuring
the resistance of the patient’s breathing. It provides the patient a precise pressure required at a given
moment avoiding the compromise of fixed pressure. It consists of a flow generator which provides the
airflow, an interface (nasal pillow, nasal or full-face mask, or most commonly a lip seal mouthpiece) that
provides connection to the user’s airway, and a hose connecting the flow generator to the interface.
Bi-level Positive Airway Pressure (BPAP) Devices

Bi-level positive airway pressure (BPAP) devices or variable positive airway pressure (BPAP) devices
provide two levels of pressure: inspiratory positive airway pressure (IPAP) and a lower expiratory
positive airway pressure (EPAP) for easier exhalation that are used in spontaneous and timed modes. It
consists of an air flow generator, an interface (nasal pillow, nasal or full-face mask, or most commonly a
lip seal mouthpiece) that provides connection to the user’s airway and a hose connecting the flow
generator to the interface.
Continuous Positive Airway Pressure (CPAP) Devices
Continuous positive airway pressure (CPAP) machines are used for the treatment of sleep apnea and in
intensive care units as a form of ventilation. The machine delivers air at a titrated pressure determined
by the sleep physician. It consists of an airflow generator, an interface (nasal pillow, nasal or full-face
mask, or most commonly a lip seal mouthpiece) that provides connection to the user’s airway and a
hose connecting the flow generator to the interface.
Reusable Resuscitators
A reusable resuscitator is a device in which positive pressure is used to inflate the lungs of an
unconscious patient who is unable to breath, keeping them oxygenated and alive. It is operated through
a regulator which delivers gas through pressure. The regulator can be either automatic or manual.
These are manufactured from silicon and are latex free.
Ventilators
A medical ventilator is a device meant to provide mechanical ventilation to a patient. A positive
pressured ventilator consists of a compressible air reservoir or turbine, air and oxygen supplies, a set of
valves and tubes and a disposable or reusable patient circuit. Based on usage they are categorised as
critical care ventilators, neonatal/paediatric ventilators and transport ventilators.
Critical Care Ventilators

Critical care ventilators provide artificial respiratory support to critical patients in intensive care units
with a micro-process or controlled integrated facility for ventilation monitoring suitable for paediatric
and adult ventilation. It consists of a compressible air reservoir or turbine, air and oxygen supplies, a set
of valves and tubes and a disposable or reusable patient circuit.
Neonatal/Pediatric Ventilators
Neonatal/pediatric ventilators are the devices those provide artificial respiratory support to pediatric
and neonatal patients. They are specially designed for pediatric use. It consists of a compressible air
reservoir or turbine, air and oxygen supplies, a set of valves and tubes and a disposable or reusable
patient circuit.
Transport Ventilators
Transport ventilators are used to provide ventilation or artificial respiration to critical patients during
their transportation between various departments of a hospital or outside the hospital in mobile
medical transport applications. It consists of a compressible air reservoir or turbine, air and oxygen
supplies, a set of valves and tubes and a disposable or reusable patient circuit.
Respiratory disposables are single-use devices used in conjunction with respiratory support equipment.
Respiratory disposables are of various types including aerosol masks, cardio pulmonary resuscitation
(CPR) barriers, nasal cannula, oxygen masks, patient interface and resuscitators.
Aerosol Masks
An aerosol mask is an extended accessory of the nebulizer which assists in the direct breathing of
medication delivered as an aerosol to the patient. Aerosol masks cover the nose and mouth and are
made of plastic, silicon or rubber.
Cardio-Pulmonary Resuscitation (CPR) barriers

CPR barriers are the devices used when delivering mouth-to-mouth artificial respiration. These devices
ensure the unidirectional airflow, thus preventing transfer of any infection by avoiding direct contact
from the mouth of victim to the rescuer.
Nasal Cannula
A nasal cannula is a device used to deliver supplemental oxygen or airflow to a person in need of
respiratory assistance. This device consists of a plastic tube which fits behind the ears, and a set of two
prongs which are placed in the nostrils. Each cannula consists of an open recessed channel disposed
between a pair of bridges for retaining extension tube within the ear piece and a locking exit hole at its
distal end for helping to secure the extension tube to provide a fixed distance adjustment between the
nasal cannula and ears of the patient.
Oxygen Masks
An oxygen mask is a mask which is placed on the mouth and nose and through which oxygen is supplied
from an attached storage tank to the lungs. Oxygen masks may cover the nose and mouth (oral nasal
mask) or the entire face (full face mask). They may be made of plastic, silicone or rubber.
Patient Interface
A patient interface is a mask used together with a positive air pressure device or a home ventilator,
worn by a patient during the time the positive pressure or ventilation therapy is delivered. This includes
nasal mask, nasal pillows and full-face mask.
Resuscitators
A Resuscitator is a respiratory management device, which uses positive pressure to inflate the lungs of
an unconscious person who is not breathing, to keep the blood oxygenated and the patient alive.
Respiratory measurement devices are the devices which are used to measure pressure flow and volume
in a patient’s airway and lungs. The types of respiratory measurement devices are capnographs,
spirometers and pulse oximeter systems.
Capnographs
A capnography device provides the continuous analysis and recording of carbon dioxide concentrations
in respiratory gases. Capnographs are the monitors which measure the level of exhaled carbon dioxide
by measuring the absorption of infrared light. Capnographs consist of two components, monitors and
sensors. Capnographs are classified as bedside capnographs and handheld capnographs.
Bedside Capnographs
Bedside capnographs are stand alone in nature and incorporates side steam technology for applications
with both intubated and non-intubated patients.
Handheld Capnographs
A handheld capnograph is a full featured, highly portable unit with a choice of configurations delivering
capnography and is ideally suited for the use in hospitals.
Spirometers
Spirometers are the devices used for measuring the volume of air inspired and expired by the lungs of a
patient. By analyzing the movement of air into and out of the lungs, a spirometer measures ventilation
and produces the spirogram which helps to identify two different types of abnormal ventilation
patterns, obstructive and restrictive. The spirometers are of various types and are widely used by the
hospitals.
Pulse Oximeter Systems

Pulse oximeter systems are the devices which monitor a person's oxygen saturation (SO2) though a
reading of SpO2 (peripheral oxygen saturation) and SaO2 (arterial oxygen saturation) from arterial blood
gas analysis. Both are correlated for measuring oxygen saturation in clinical use. Based on usage, these
systems are of various types including finger pulse oximeters, handheld pulse oximeters, tabletop pulse
oximeters and wrist pulse oximeters.
Finger Pulse Oximeters

A finger pulse oximeter is used for monitoring a patient’s oxygenation and pulse rates when undergoing
surgical procedures particularly those involving anesthesia or conscious sedation.
Handheld Pulse Oximeters

A handheld pulse oximeter is a portable, light weight pulse oximeter for point-of-care checking of blood
oxygen saturation. It works on a battery and electronically displays results.
Tabletop Pulse Oximeters

A tabletop pulse oximeter is a bulky version of a portable system. It main features include audio and
visual alarms for oxygen saturation and pulse rate monitoring, a pulse tone with variable pitch and
digital signal processing for accurate reading.
Wrist Pulse Oximeters
Wrist pulse oximeters pass two wavelengths of light through the body part to a photo detector when
placed on the wrist. It measures the changing absorbance at each of the wavelengths, allowing it to
determine the absorbance due to the pulsing arterial blood alone, excluding venous blood, skin, bone,
muscle and fat.

Sleep apnea diagnostic systems are used for the diagnosis of obstructive sleep apnea (OSA). They can be
used in both home and hospital settings. There are two types, fixed polysomnography systems and
portable polysomnography systems.
Fixed Polysomnography Systems

These systems monitor many body functions including brain activity (EEG), eye movements (EOG),
muscle activity or skeletal muscle activation (EMG), heart rhythm (ECG), and breathing function or
respiratory effort during sleep.
Portable Polysomnography Systems

Portable polysomnography systems are devices which are mobile or light weight versions of the fixed
polysomnography systems. They simplify the task of performing a sleep study. They may or may not
come with a battery and as a part of recent technological advancements, novel products like wireless
polysomnography systems are also available in the market within this segment.
Chapter 4
Market Dynamics
Chapter 4: Market Dynamics
Market Drivers
Increasing Prevalence of COPD
Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by chronic obstruction of
lung airflow that interferes with normal breathing and is not fully reversible. COPD is a term that is used
to include chronic bronchitis, emphysema, or a combination of both conditions.
Chronic Bronchitis
Chronic bronchitis is a condition leading to swollen breathing tubes (airways) because of mucus (phlegm
or sputum) production. Airway obstruction occurs in chronic bronchitis because the inflammation and
the excessive production of mucus leads to the narrowing of the breathing tubes. In cases of
emphysema, the alveoli walls are damaged; the alveoli lose their stretchiness and ability to trap air and
result in difficulty in pushing all the air out of the lungs. Because the lungs do not empty efficiently, the
lungs contain more air than normal; this is called air trapping and causes hyperinflation in the lungs.
Having extra air in the lungs and the excess mucus on a consistent basis causes constriction or
obstruction and makes the interior of the airways smaller than normal.
Diagnosis- The diagnosis of chronic bronchitis is made based on symptoms of a cough that produces
mucus or phlegm on most days, for three months, and in some cases the cough is observed for two or
more years (even after various treatments for cough reduction).
Emphysema
Emphysema is a lung condition in which the walls of the air sacs (alveoli) are partially or completely
damaged. A healthy human lung consists of more than 300 million alveoli which are normally stretchy
and springy, like small balloons. Same as a balloon, it takes effort to blow up normal alveoli and it takes
no energy to empty normal alveoli. When alveoli are unhealthy and have lost the stretchy, springy
ability, it requires extra effort to breathe; this results in a person feeling short of breath. Airway
obstruction occurs in emphysema because the alveoli that normally support the airways open cannot do
so during inhalation or exhalation. Without their support, the breathing tubes collapse, causing
obstruction to the flow of air.
Causes for COPD

COPD can be caused by many factors:
• Smoking tobacco and marijuana is the most common cause for COPD.
• Environmental factors are another key cause for COPD. These factors include heavy exposure to
certain dusts in work environments, chemical and heavy metals exposures, and indoor or
outdoor air pollution can greatly contribute to COPD.
• Genetics or hereditary factors are another key reason leading to the development of COPD.
Symptoms of COPD
COPD is identified usually with symptoms including:
• Shortness of breath, especially with physical activity.
• An uncontrollable cough.
• Excessive mucus production.
• Wheezing.
• Chest tightness.
Diagnosis of COPD
Symptomatic patients are evaluated with a breathing test that measures airway obstruction called
spirometry.
In the majority of COPD cases, patients remain undiagnosed or wrongly diagnosed in clinical practice
because of several reasons:
• There is a myth that COPD is mainly a condition that predominately affects tobacco smokers,
this leads to the under-diagnosis of COPD in non-smokers who actually contribute almost half of
all COPD cases.
• Lack of utilizing spirometry as a diagnostic tool, because of a knowledge gap for physicians and
the non-availability of spirometers.
• There is difficulty in differentiating COPD from asthma. This confusion leads to under-diagnosis;
delays in treatment allows the state of the disease to progressively get worse.
Treatment
Upon diagnosis, physicians suggest that patients who smoke should cease smoking before and during
treatment. Medications are typically prescribed to widen the airways (bronchodilators), reduce swelling
in the airways (anti-inflammatory drugs, such as steroids), and/or treat infection (antibiotics). COPD can
also cause the oxygen level in the blood to drop below healthy levels; if this occurs, supplemental
oxygen will be prescribed. As a process of these prescribed medications and for effective drug delivery,
assisted medical delivery or medical devices are employed.
Respiratory medical devices play a significant role in the management and treatment of COPD.
Epidemiology of COPD
Mortality
In a global burden study performed in 2015, it was found that 3.2 million people died from COPD
worldwide, an increase of 11.6% when compared with 1990. COPD is an important contributor to the
burden of non-communicable diseases. COPD kills more people than HIV-AIDS, malaria and tuberculosis
combined in the South-East Asian region. Although much of the burden is either preventable or
treatable with affordable interventions, this disease has received less attention than other non-
communicable diseases.
Prevalence
The burden of COPD across the world is high. In 2015, the Centre for Global Health Research and the
World Health Organization (WHO) performed a systematic review to understand the COPD prevalence
trends across the globe. To understand the disease progression levels and growth rates, the outcomes
were compared between two years: 1990 and 2010.
The highest COPD prevalence estimated in this study was observed in the American region (as defined
by the WHO), with an estimated prevalence of 13.3% and 15.2% in 1990 and 2010, respectively. In the
WHO’s Western Pacific region, the number of COPD cases reported in 1990, was approximately 60
million and in 2010, almost 113 million cases were reported with COPD.
The COPD prevalence rates at a global and regional level were found as indicated in Table 1 below.
Table 1
Prevalence of COPD, 1990 and 2010
% increase in
Cases (in Prevalence Cases (in Prevalence
Region COPD (1990 vs
millions) in 1990 (%) in 1990 millions) in 2010 (%) in 2010
2010)
World 227.3 10.7 384.0 11.7 68.9
AFRO 14.1 9.8 28.5 11.4 102.1
AMRO 41.6 13.3 72.0 15.2 73.1
EMRO 13.4 11.8 29.3 13.4 118.7
EURO 54.2 11.8 66.4 13.7 22.5
SEARO 44.5 7.9 75.1 9.7 68.8
WPRO 59.5 9.2 112.7 11.1 89.4
Source: Journal of Global Health, 2015.
The World Health Organization (WHO) defines the regions listed in Table 1 as:
• AFRO- As per WHO, ARFO region resembles the African region countries including Algeria,
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cabo Verde, Central African
Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Equatorial
Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho,
Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria,
Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, South Africa, South Sudan,
Swaziland, Togo, Uganda, United Republic of Tanzania, Zambia and Zimbabwe.
• AMRO- As per WHO, AMRO stands for American region which constitutes countries including
Canada, Cuba, United States of America, Brazil, Chile, Colombia, Costa Rica, Jamaica, Mexico,
Panama, Paraguay, Uruguay, Venezuela, Bolivia, Ecuador, Guatemala, Haiti, Nicaragua and Peru.
• EMRO- As per WHO, EMRO stands for Eastern Mediterranean Region which consists countries
including Bahrain, Cyprus, Iran, Islamic Republic of, Jordan, Kuwait, Lebanon, Libyan Arab
Jamahiriya, Oman, Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United Arab Emirates,
Afghanistan, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan and Yemen.
• EURO- As per WHO, EURO stands for European region which consists of countries including
Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece,
Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San
Marino, Slovenia, Spain, Sweden, Switzerland, United Kingdom, Albania, Armenia, Bosnia and
Herzegovina, Bulgaria, Georgia, Kyrgyzstan, Poland, Romania, Slovakia, Tajikistan, The former
Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Uzbekistan, Yugoslavia, Belarus,
Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, Russian Federation and
Ukraine.
• SEARO- As per WHO, SEARO stands for South-East Asian Region which consists of countries
including India, Bangladesh, Bhutan, Democratic People’s Republic of Korea, Maldives,
Myanmar, Nepal, Indonesia, Sri Lanka and Thailand.
• WPRO- As per WHO, WPRO stands for Western Pacific Region which consists of countries
including Australia, Brunei Darussalam, Japan, New Zealand, Singapore, Cambodia, China, Fiji,
Kiribati, Lao People’s Democratic Republic, Malaysia, Marshall Islands, Micronesia, Federated
States of, Mongolia, Nauru, Niue, Palau, Papua New Guinea, Philippines, Republic of Korea,
Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu and Vietnam.
COPD Impact on Anesthesia and Respiratory Devices Market

COPD is a serious, progressive, expensive and difficult disease to treat. As of now, despite revolutions in
healthcare research, there is no cure found for this disease. Prevention is the only key to reduce the
growing burden of COPD. However, with the rising prevalence of COPD globally, the disease is
conditionally treated or suppressed with the prescription of various drugs used in the management of
respiratory health.
Inhalation route is the fastest and most effective method of delivering medications to the respiratory
system during treatment of COPD. As a part of treatment and management of COPD, inhalers and
nebulizers play the most dynamic role.
Usage of medical devices is not just restricted to treatment of COPD although they are necessary for
effective diagnosis, drug delivery, critical care management and respiratory support for individuals with
COPD. Because it is a chronic disease, COPD creates an abundant demand for the usage of respiratory
devices like Inhalers, nebulizers, spirometers, oximeters, breath filters and respiratory disposables.
The prevalence of COPD has never declined and is expected to continue the same pace of growth across
the globe. Unlike other diseases, COPD’s rise is dependent on urbanization, as most of the studies
proved that urban people are severely prone to COPD. In the respiratory devices segment, COPD has an
ultimate share and in most markets the percentage of shares is almost dependent on the COPD
prevalence rates. Hence, COPD is considered a key driving factor for the anesthesia and respiratory
devices market.
High Prevalence of Obstructive Sleep Apnea (OSA)
Obstructive sleep apnea is caused by a blockage of the airway, usually when the tongue collapses
against the soft palate and the soft palate collapses against the back of the throat during sleep, and the
airway is closed. This airway obstruction creates a real-time obstruction to the respiratory process that
leads to the disturbance of sleep and a low quality of sleep. The effects of OSA are not just restricted to
bad sleep quality but also to respiratory health, causing deoxygenation. Patients have a high risk of
developing cardiovascular disorders and chronic disorders like diabetes and obesity. Risk factors for OSA
include obesity, aging, gender, menopause and ethnicity.
Types of OSA
In central sleep apnea, the airway is not blocked but the brain fails to signal the muscles to breathe.
Complex sleep apnea, as the name implies, is a combination of the two conditions. With each apnea
event, the brain rouses the sleeper, usually only partially, to signal breathing to resume. In those
individuals with severe sleep apnea this can happen hundreds of times a night, often most intensely late
in the sleep cycle during rapid-eye-movement (REM) sleep. As a result, the patient’s sleep is extremely
fragmented and of poor quality. Meanwhile the disorder continuously reduces the oxygenation of the
blood, further stressing the sleeper’s physical system.
Symptoms
OSA is generally observed with frequent episodes of any of the below and sometimes multiple
symptoms together on a frequent basis:
• Loud or frequent snoring.

• Silent pauses in breathing.
• Choking or gasping sounds.
• Daytime sleepiness or fatigue.
• Unrefreshing sleep.
• Insomnia.
• Morning headaches.
• Nocturia (waking during the night to go to the bathroom).
• Difficulty concentrating.
• Memory loss.
• Decreased sexual desire.
Diagnosis
The only accurate diagnostic tool for determining the presence of OSA is a sleep study via
polysomnogram. This is conducted by a certified sleep specialist during a patient’s through-the-night
visit to a sleep laboratory that will include monitoring, among other things, blood oxygen levels,
respiration rate, brain-wave activity, leg movements, and most significantly, the apnea-hypopnea index,
which is the number of apnea and hypopnea (partial inhalation) incidents the sleeper experiences per
hour. Home based testing, known as limited channel testing (LCT), is also available for certain patients. A
patient’s utility of LCT must be evaluated by a clinician to verify eligibility.
Prevalence of OSA
According to the American Sleep Association’s sleep disorder statistics, it is estimated that 25 Million
adults in the United States (U.S.) have OSA. The prevalence of OSA has been strikingly high and is
estimated to be 27.5% in male and 15% in female population. This creates an alarming situation.
In 2008, a population-based epidemiological study was performed to determine the prevalence of OSA;
the study found that the global prevalence of OSA is 21.7% for adult men and 13.2% for adult women in
the general population.
The prevalence of the disease was found to be higher in specific population subsets, including
overweight or obese people, diabetic and hypo or hyperthyroid patients. The study depicted the fact
that OSA prevalence estimates across the globe including North America, Europe, Australia, and Asia are
not substantially different suggests that this disease is common; OSA is not restricted only to developed
countries but is also common in developing countries.
Table 2
Prevalence of OSA
Region Prevalence % Diagnosis Method/Technique

North America Male-17%, Female-5% Polysomnography
Europe Male-26%, Female-28% Polysomnography
MESAM (Portable monitoring and
Australia Male-25.9%, Female-11%
Oximetry)
Asia Male-18%, Female- 9.1% Polysomnography
Source- Expert Review of Respiratory Medicine, 2008
OSA and its Impact on the Respiratory Devices Market

The prevalence of OSA is found to be uniformly high across the globe. Especially in the biggest
healthcare markets, the North American and Asian-Pacific Regions the prevalence is considerably high.
As discussed earlier, usage of respiratory devices is mandatory for the management and treatment of
OSA. Given the widespread, under-recognized prevalence of this disorder by the governments of
burdened countries, the public and personal health care costs globally are likely to grow enormous.
After COPD, OSA contributes the highest share in the usage of respiratory devices. The demand for OSA
diagnostic systems has been increasing globally as polysomnography is the only technique approved and
employed for the accurate diagnosis and estimation of OSA.
For treatment and disease management, various respiratory devices are utilized like respiratory masks
including nasal pillows, nasal masks, full face masks and pediatric masks, as well as respiratory devices
including positive airway pressure devices (CPAP, Bilevel or BPAP and APAP), oxygen concentrators,
humidifiers and ventilators.
As there are no prevention techniques available to eradicate or arrest OSA, this area is expected to be a
boon for the respiratory device business and hence, the majority of the medical device manufacturers
are investing in the development of novel and advanced OSA devices.
Air Pollution: Its Impact on Respiratory Health

Air pollution is the extensive emission of injurious substances into the atmosphere. Air pollution is
considered a modern-day curse that is a by-product of urbanization and industrialization. Interestingly,
along with evolving history and transitions in line with economic, technological and political changes, air
pollution is equally progressing. Its impact is not just restricted to air quality depletion and ecosystem
imbalance. Hazardous emissions resulted from the air pollution are considered to have direct correlation
with human health and mortality.
Air pollution occurs both in both indoor (e.g. household) and outdoor environments. However, in terms
of risk index, outdoor pollution is more severe. Below are a few emissions which are considered serious
pollutants:
• Sulphur dioxide (SO2).

• Nitrogen oxides (NOx).
• Ozone (O3).
• Particulate matter (small suspended particles of varying sizes).
• Carbon monoxide (CO).
• Volatile organic compounds (VOCs).
The above pollutants are considered to have a range of undesirable impacts, including damage to
human health, ecosystems, food crops and built environments. An evidence-based attribution of the air
pollutants to specific health or environmental outcomes is complex as some pollutants act as pre-
cursors to others. For instance, SO2 and NOx will not have serious effects directly but when together
emitted or mixed together, these chemicals have a tendency of reacting in the atmosphere to form
strong particulate matter compounds. Such particulate matter compounds cause significant damage to
the environment. While the sources of each pollutant differ, most are results of fuel combustion and
uncontrolled or faulty industrial activities; pollutants are released as by-products of these processes.
Burden on Human Respiratory Health

In 2017, the WHO highlighted air pollution as the greatest environmental risk to human health. In 2016
it was estimated to be the cause of 6 million premature deaths worldwide. In 1990, deaths related to air
pollution was estimated at 3.4 million. Overall, most pollution-related deaths are in Asia; in 2016 South,
Southeast and East Asia alone accounted for nearly 3 million pollution-related deaths.
In 2011, the WHO concluded that exposure to indoor air pollution doubles the risk of COPD, pneumonia
and other acute lower respiratory infections, and may account for roughly 800,000 annual worldwide
deaths in children five years of age and younger. In various studies performed across the globe, it was
statistically found that air pollutants or harmful emissions tend to lead to acute lower respiratory
infections in children and COPD in adults at two to three times the rate when compared to
unpolluted/less polluted regions. Most importantly, with the extensive industrialization and a lack
government and pollution board guidelines, Asia has emerged as a hub for pollution and offers the
highest risk for chronic respiratory disorders.
Impact on Anesthesia and Respiratory Market

In the past few years, excessive air pollution levels and poor air quality have led to a dramatic increase in
the incidence of chronic respiratory disorders. This unparalleled growth has led pharmaceutical and
medical device manufacturers across the globe to explore the market as a part of serving humankind
with better respiratory health. Because respiratory health concerns are covered as a part of
reimbursement and group insurances, this market has been witnessing significant growth and is
expected to grow more aggressively.
Growing Global Surgery Numbers

Surgery or surgical procedures are essential for managing diverse health conditions such as injuries,
obstructed labor, malignancy, infections and diseases. Despite the technological advancements and
significant changes in healthcare, surgical procedures are still an indispensable component of a
functioning health system.
The need for surgeries has been growing across the globe irrespective of a country’s economy, health
conditions or healthcare spends. In 2016 the WHO performed an analysis to understand the surgery
levels at a global level. In this study, the WHO estimated 226.4 million operations for the year 2004. For
the year 2012, the WHO estimated the total global volume to be 312.9 million operations. An increase of
38.2% in the span of seven years is significantly high. In 2012, the estimated mean global surgical rate
was 4469 operations per 100,000 people per year.
Figure 1
Global Surgery Volumes, 2004 and 2012
(Millions)
350
300
250
200
Millions
150
100
50
0
2004 2012
Source: Bulletin of the World Health Organization 2016
Impact on Anesthesia and Respiratory Market

It is an established fact that administering a certain amount of anesthesia to the patient is mandatory
for most surgical procedures for pain management. In developing countries especially, even in 2016, it
was observed that surgeons and anesthesiologists preferred manual dosage and administration.
Because of recent healthcare advancements and the demand for ease and accuracy, automation of
anesthetic drug administration is preferred over manual administration. Anesthesia devices are
employed before or during surgeries for efficient administration and ensuring measured and safe
delivery of anesthetic gases. The growing global population and increasing surgery numbers will create
additional demand for anesthesia devices and increases the possibility for development of inventions or
novel products in this field. The demand for respiratory devices is dependent on surgeries; at least 80%
of critical surgeries require respiratory support or artificial respiration. Hence, the increase in the global
number of surgeries is a key factor for the positive trend of the anesthesia and respiratory devices
market.
Market Restraints
Regulatory Constraints
The medical device industry throughout the world has become very competitive. To handle the
competition efficiently and to gain a better market share, most manufacturers aim at new designs and
innovative devices to be introduced into the market with enhanced performance. Every product that is
planned to be launched in a specific region must face mandatory regulatory hurdles. To ensure patient
safety, various regulatory bodies introduce regulations to control the medical devices entry at a global
or country level.
Regulatory bodies are mainly responsible for prequalifying medical devices intended for human use.
Among the global regulatory firms, the U.S. Food and Drug Administration’s (USFDA) Center for Devices
and Radiological Health (CDRH) plays a key role in regulating firms who manufacture, repackage, relabel,
and/or import medical devices sold in the U.S. Being the world’s biggest market, the U.S. market is vital
for any device’s success and the devices that gain the USFDA approval have the best chances to cross
other countries’ regulatory pathways.
Medical devices are classified into Class I, II, and III. Regulatory control increases from class I to class III.
The device classification regulation defines the regulatory requirements for a general device type. Most
class I devices are exempt from Premarket Notification 510(k); most class II devices require Premarket
Notification 510(k); and most class III devices require Premarket Approval.
The anesthesia and respiratory devices are mostly classified under Class II as per regulatory classification
rules.
Governments in both in the U.S. and Europe have implemented strict regulations for the production,
standardization, and utilization of anesthesia and respiratory related devices. In Europe, the European
commission is the regulatory authority that regulates the Medical Device Directories (MDD), this agency
monitors the usage and approval of medical devices in the European Union (EU). In the U.S., it is
mandatory for the manufacturers and initial distributors of medical devices to register their
establishments with the USFDA and list their products and follow the standards set by the authority.
Communaute Europeenne (CE) marking certification is mandatory for all the medical devices sold in the
EU. This certification requires only proof of safety, whereas the USFDA requires evidence of both safety
and efficacy of a device.
Impact on Market
As discussed above, regulatory bodies control the entry of novel products which are scheduled to enter
the market to ensure patient safety. As a process of regulatory pathway, many manufacturers are still
fumbling at some point of time because of a lack of any individual requirement listed by the regulatory
agencies. Typically, a timeline required for the regulatory approval of medical device post clinical testing
is between three and five years. Despite the abundant care taken by the medical device manufacturers
to follow the regulatory pathway, some devices are rejected or are kept on hold.
Listed in Table 3 below are some of the respiratory devices which were recalled or rejected by the
USFDA in recent years:
Table 3
Respiratory Devices Recalled/Rejected by FDA
FDA Recall
Product Manufacturer
Posting Date
731 Series-Portable Critical Care
January 03, 2018 ZOLL Medical Corporation
Ventilator
STATCheck- Resuscitation Bag June 01, 2016 Ventlab LLC
Foot Switches -Philips
March 31, 2016 Philips Medical Systems, Inc.
MultiDiagnost
Mercury Medical Neo-Tee T-Piece
January 12, 2016 Mercury Medical
Resuscitator and T-Piece Circuit.
Alaris EtCO2 Module, Model 8300.
December 21, 2015 CareFusion 303, Inc.
A capnograph
Breas Vivo 50 Home Care
July 16, 2015 Breas Medical AB
Ventilator
Puritan Bennett 980 Ventilator
February 05, 2015 Covidien LP
System
Invacare Perfecto 2 V Oxygen
December 12, 2014 Invacare Corporation
Concentrator
Source-USFDA Medical Device Recalls Database
Macroeconomic Factors
The world economy suffered in the early months of 2016 and recovered as the year continued. Both
industrialized/developed countries and developing and emerging countries contributed to the upturn.
The total economic growth reported was 3.1%, a slight decrease compared to the previous year at 3.2%.
This growth was reinforced by stable commodity prices and recovering growth rates in China. The surge
in the key interest rate in the U.S at the end of 2015 had only a marginal effect on the global economy.
The Gulf States decided at the end of 2016 to reduce the production of oil, causing a slight price
increase. The year 2016 predominantly featured governmental elections in the U.S., Great Britain and
Italy, which drastically altered the political environment. The consequences for the global economy
cannot yet be determined.
Investment activity in the eurozone augmented cautiously because of the political uncertainty brought
about by the Brexit referendum. However, the British pound fell sharply against the euro. While the
Spanish economy is currently recovering from its sovereign debt crisis, France and Italy are both
suffering from a marked unwillingness to enact reforms to address structural investment activity in the
eurozone.
Impact on Market
The healthcare industry and especially the medical devices sector is a technology and capital investment
based industry which tends to experience high impact from macroeconomic factors. For the year 2016,
though the medical devices industry overall witnessed a growth curve, speculations in the European
market, changes incurred by the U.S. government’s health policies, a decline in private insurance, an
increase in the geriatric population, and poor revenues reported by the insurance companies across the
globe demonstrate the possibility of poor growth.
Currently, medical device manufacturers are experiencing certain pressures because of factors including
reduced health care budgets in many countries, stagnating insurance provider revenues, declining tax
revenues and increased import prices over the preceding two years.
Europe
Western European countries needed to save on healthcare because of a slight drop in economic growth
and obstinate economic pressure. This situation has caused health care spending to only marginally
grow in the EU region countries.
Greece, Italy, Ireland, Portugal and Spain had considerably low budgets that were affected by the
sovereign debt crisis.
Healthcare in Great Britain is facing a huge challenge as the demand for healthcare services has
increased while the budget for medical services has almost decreased.
The Russian healthcare industry was significantly impacted by Russia’s international dealings and the
subsequent economic challenges.
North America
Healthcare spending in North America increased in 2016.
Canadian healthcare was enforced by a progressing demographic shift.
The increase of insurance coverage because of health care reform (Affordable Care Act) in the U.S. led to
an increase in the North Americas’ healthcare spending. It is still uncertain if the trend will continue
following changes in healthcare reform by the new government administration is uncertain.
Japan
After the U.S., Japan is considered as a strategic center and offers significant opportunity for business by
healthcare companies. Japan is known for its growing economy, technological advancements,
encouraging healthcare policies and high pricing opportunity. This scenario, however, has shifted as the
Japanese healthcare system faces progressively more pressures.
The Japanese healthcare system was established in the 1960s and was based on stable demographic
developments; however, the current state is in total contrast as the funding agencies can no longer
sustain the increased spending that is the result of an aging population, increases in chronic diseases
and the emergence of expensive, innovative treatment options. This situation has been worrying the
government and the medical device manufacturers. Recently the Japanese government made plans to
restructure its healthcare system with better funding options to alleviate the funding situation.
Chapter 5
Market Breakdown by
Product Type
Chapter 5: Market Breakdown by Product
Type
Product Types in Anesthesia and Respiratory Devices

Anesthesia and respiratory devices are typically classified based on various parameters like mode of
usage, technology, etc. However, here we have tried to provide the classification by segregating the
devices as per the product type.
The global anesthesia and respiratory devices market is categorized into below segments by product
type:
• Airway and Anesthesia devices.
• Anesthesia Machines.
• Pain Management Devices.
• Regional Anesthesia Disposables.
• Respiratory Devices.
• Respiratory Disposables.
• Respiratory Measurement Devices.
• Sleep Apnea Diagnostic Systems.
For the year 2016 the global anesthesia and respiratory devices market was valued at just over $20.0
billion and by 2022 is expected to exceed $26.7 billion with a CAGR of 4.8%.
Table 4
Global Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
2016 2017 2022
2017–2022
Global 20,051.6 21,094.2 26,716.9 4.8
Figure 2
Global Market for Anesthesia and Respiratory Devices, 2016-2022
($ Millions)
30,000.0
25,000.0
20,000.0
$ Millions
15,000.0
10,000.0
5,000.0
0.0
2016 2017 2022
Segmental Market Shares of Anesthesia and Respiratory Device Market
Figure 3
Global Market Share for Anesthesia and Respiratory Devices, by Product Type,
2016
(%)
Regional Pain Management Devices Sleep Apnea

Anesthesia 1% Diagnostic Systems
Disposables 3%
6%
Anesthesia Machines
6%
Respiratory Devices
37%
Airway and
Anesthesia Devices
8%
Respiratory Respiratory
Disposables Measurement
12% Devices
27%
As depicted in the above figure, the respiratory devices, respiratory measurement devices and
respiratory disposables capture the highest share in the global market, with more than 75%; followed by
the airway and anesthesia devices (8%), anesthesia machines (6%), anesthesia disposables (6%), sleep
apnea diagnostic systems (3%) and pain management devices (1%).
Below is the market size by product type/segment.
Table 5
Global Market for Anesthesia and Respiratory Devices, by Product Type, 2016
($ Millions)
Segment Market Size for 2016

Respiratory Devices 7,456.3
Respiratory Measurement Devices 5,432.5
Respiratory Disposables 2,517.4
Airway and Anesthesia Devices 1,622.7
Anesthesia Machines 1,161.6
Regional Anesthesia Disposables 1,077.6
Pain Management Devices 319.4
Sleep Apnea Diagnostic Systems 464.1
Total 20,051.6
Although respiratory devices have the highest share of the market, it was found that over a period,
anesthesia machines have an abundant scope of growth because of technological advancements and
increasing healthcare automation. The sleep apnea diagnostic systems are also expected to grow at a
higher rate as public awareness increases and there are changes in physician attitudes towards the
disease. Below are the expected market shares of various segments for the forecasted years 2017 and
2022.
Table 6
2017 vs. 2022
(%)
Segment 2017 2022

Respiratory Devices 37.2 37.4
Respiratory Measurement Devices 27.0 26.3
Respiratory Disposables 12.3 11.4
Airway and Anesthesia Devices 8.1 8.3
Anesthesia Machines 5.9 6.3
Regional Anesthesia Disposables 5.4 5.7
Pain Management Devices 1.7 1.9
Sleep Apnea Diagnostic Systems 2.4 2.7
Total 100.0 100.0
Below is the market size by product type/segment for the forecasted years 2017 and 2022.
Table 7
Through 2022
($ Millions)
CAGR%
Segment 2017 2022
2017-2022
Respiratory Devices 7,852.4 9,996.4 4.9
Respiratory Measurement Devices 5,687.2 7,020.9 4.3
Respiratory Disposables 2,604.0 3,040.0 3.1
Airway and Anesthesia Devices 1,714.9 2,222.8 5.3
Anesthesia Machines 1,239.7 1,688.5 6.4
Regional Anesthesia Disposables 1,148.0 1,522.9 5.8
Pain Management Devices 347.5 513.5 8.1
Sleep Apnea Diagnostic Systems 500.5 711.9 7.3
Total 21,094.2 26,716.9 4.8
Figure 4
Global Market for Anesthesia and Respiratory Devices, by Product Type, 2016-
2022
($ Millions)
12,000.0
10,000.0
8,000.0
$ Millions
6,000.0
4,000.0
2,000.0
0.0
2016 2017 2022
Respiratory Devices Respiratory Measurement Devices

Respiratory Disposables Airway and Anesthesia Devices
Anesthesia Machines Regional Anesthesia Disposables
Pain Management Devices Sleep Apnoea Diagnostic Systems
The anesthesia and respiratory devices market is expected to witness growth at a CAGR of 4.8%; the
market will grow from $21.1 billion in 2017, to an expected $26.7 billion in 2022. The highest share
belongs to respiratory devices and respiratory measurement devices and disposables. In terms of
growth rate, the respiratory related segments are expected to freeze and grow leisurely, pain
management devices are expected to grow at higher rate (8.1%), followed sleep apnea devices and
anesthesia machines (7.3% and 6.4% respectively), regional anesthesia disposables (5.8%) and airway
and anesthesia devices (5.3%).
Figure 5
2017
(%)
Regional Pain Management Devices Sleep Apnea

Anesthesia 2% Diagnostic Systems
Disposables 2%
6%
Anesthesia
Machines
Respiratory
6%
Devices
37%
Airway and
Anesthesia
Devices
8%
Respiratory
Disposables
12%
Respiratory
Measurement
Devices
27%
Figure 6
2022
(%)

Regional Anesthesia
2%
Disposables Sleep Apnoea
6% Diagnostic Systems
3%
Anesthesia Machines
6%
Respiratory Devices
Airway and 38%
Anesthesia Devices
8%
Respiratory
Disposables
11%
Respiratory
Measurement
Devices
26%
Respiratory Devices
Below are the key types of devices of respiratory devices available globally:
• Humidifiers.
• Nebulizers.
• Oxygen concentrators.
• Oxygen conservers.
• Positive airway pressure devices.
• Reusable resuscitators.
• Ventilators.
Respiratory devices are the highest selling segment in the anesthesia and respiratory devices market.
This segment held a market share of 37.2% in 2016 and is expected to increase its share reaching 37.4%
by 2022. The key aspects of growth rate of these devices are increases in COPD incidence, air pollution
levels and insurance coverage. Although there are many factors that enable the growth of this segment,
its market share is expected decline because the market is established and saturated. Additionally, it is
expected that the average selling prices will decline sharply because of competitive pricing pressures.
For 2016 the respiratory devices market size at a regional level is shown below in Table 8.
Table 8
Global Market for Respiratory Devices, by Region, 2016
($ Millions)
Region Market Size

North America 3,487.0
Asia-Pacific 1,409.7
Europe 1,706.4
ROW 853.2
Total 7,456.3
Below is a snapshot of respiratory device market size for the year 2016 and for the forecasted years
2017 and 2022.
Figure 7
Global Market for Respiratory Devices, by Region, 2016-2022
($ Millions)
12,000.0
10,000.0
8,000.0
$ Millions
6,000.0
4,000.0
2,000.0
0.0
2016 2017 2022
Among the respiratory devices the positive airway pressure devices have the highest market share (62%)
followed by Ventilators (14%), Nebulizers (11%), Oxygen Concentrators (9%), Humidifiers (3%) and
Reusable Resuscitators (1%).
Figure 8
Global Market Share for Respiratory Devices, by Sub-Types, 2016
(%)
Oxygen Humidifiers Reusable

Concentrators 3% Recuscitators
9% 1%
Nebulizers
11%
Ventilators Positive Airway

14% Pressure Devices
62%
Table 9
Global Market for Respiratory Devices, by Sub-Types, 2016
($ Millions)
Sub Segment Market Size

Positive Airway Pressure
4,622.8
devices
Ventilators 1,043.9
Nebulizers 820.2
Oxygen Concentrators 671.1
Humidifiers 223.7
Reusable Resuscitators 74.6
Total 7,456.3
Key Companies
Globally, Philips Respironics, Inc., ResMed Inc. and Medtronic plc, are the leading companies in the
respiratory devices market with a combined share of 50.0%. All other international companies compete
for the market shares and in case of Asia-Pacific and South American countries, the local manufacturers
compete aggressively with the leading players.

Respiratory measurement devices, as the name signifies, are the devices which measure the respiratory
health of an individual. They play a crucial role in the diagnosis of various respiratory conditions by
calculating the respiratory levels and abilities of a patient. These devices are of various types:
• Capnographs.
• Spirometers.
• Pulse oximeter systems.
The respiratory measurement devices segment has second highest market share in the anesthesia and
respiratory devices market. It held a market share of 27% for 2016 and is expected to decline its share
reaching 26.3% by the year 2022. The key aspects of growth rate of these devices are increasing COPD
incidence, an increase in the number of hospitals and healthcare facilities in Asia-Pacific countries and
insurance coverage. Although there are many factors that enable the growth rate of this segment, its
market share is expected decline because the market is established and saturated; local manufacturers
will continue to grow and reduce the average selling prices because of competitive pricing pressures.
Table 10
Global Market for Respiratory Measurement Devices, By Region, 2016
($ Millions)
Region Market Size

Asia-Pacific 1,020.1
Europe 1,245.2
ROW 622.6
Total 5,432.5
Below is a snapshot of respiratory measurement device market size for the year 2016 and for the
forecasted years 2017 and 2022.
Figure 9
Global Market for Respiratory Measurement Devices, 2016-2022
($ Millions)
8,000.0
7,000.0
6,000.0
5,000.0
$ Millions
4,000.0
3,000.0
2,000.0
1,000.0
0.0
2016 2017 2022
Among the respiratory measurement devices, the Pulse Oximeter Systems was the largest contributor
with a significant market share (80%) followed by capnographs (11%) and spirometers (9%).
Figure 10
Global Market Share for Respiratory Measurement Devices, by Sub-types, 2016
(%)
Spirometers
9%
Capnographs
11%
Pulse Oximeter
Systems
80%
Table 11
Global Market for Respiratory Devices, by Sub-types, 2016
($ Millions)

Pulse Oximeter Systems 4,346.0
Capnographs 597.6
Spirometers 488.9
Total 5,432.5
Key Companies
Medtronic plc, Philips Respironics, Inc. and Masimo Corporation are the leading companies in the
Respiratory Measurement Devices market globally with approximate combined share of 50%. All other
international companies compete for the market shares and in the case of Asian countries, especially
India and China, local manufacturers compete aggressively with the leading players.
Respiratory disposables are the devices or aids which are used as a part of providing artificial respiratory
support to a patient. These may be employed to assist bigger devices, which are mostly one-time-use
devices for patient safety. There are various types of respiratory disposables used in healthcare; these
types have been considered as a part of this market for this study:
• Patient interfaces.
• Positive end expiratory pressure (PEEP) valves.
• Oxygen masks.
• Resuscitators.
• Aerosol masks.
• Nasal cannula.
• Cardio-pulmonary resuscitation (CPR) barriers.
Respiratory disposables contribute the third highest market share in the anesthesia and respiratory
devices market. This segment held a market share of 12.6% for 2016 and is expected to decline its share
reaching 11.4% by 2022. Although there are many positive aspects like increasing chronic disorders,
ease in availability and insurance coverage, this segment is expected to decline its market share. A few
factors that account to the decline of this segment are a saturated market, high competition from local
manufacturers, reductions in the average selling prices because of competitive pricing pressures, lack of
regulations for disposable products and no abundant patent protected products available.
Table 12
Global Market for Respiratory Disposables, by Region, 2016
($ Millions)
Region Market Size
Asia-Pacific 556.4
Europe 553.4
ROW 276.7
Total 2,517.4
Below is a snapshot of respiratory disposables market size for the year 2016 and for the forecasted years
2017 and 2022.
Figure 11
Global Market for Respiratory Disposables, 2016–2022
($ Millions)
3,500.0
3,000.0
2,500.0
$ Millions
2,000.0
1,500.0
1,000.0
500.0
0.0
2016 2017 2022
Among the respiratory disposables market, the patient interface constitutes of 75% share followed by
PEEP valves (5%), oxygen masks and resuscitators (together 10%), aerosol masks (5%), nasal cannula
(4%) and CPR barriers (1%).
Figure 12
Global Market Share for Respiratory Disposables, by Sub-types, 2016
(%)
Nasal Cannula CPR Barriers

4% 1%
Aerosol Masks
5%
Resuscitators
5%
Oxygen Masks
5%
PEEP Valves
5%
Patient Interface
75%
Source- BCC Research
Table 13
Global Market for Respiratory Disposables, by Sub-types, 2016
($ Millions)

Patient Interface 1,888.0
PEEP Valves 125.9
Oxygen Masks 125.9
Resuscitators 125.9
Aerosol Masks 125.9
Nasal Cannula 100.6
CPR Barriers 25.2
Total 2,517.4
Airway and anesthesia devices are generally used with the anesthesia machines and devices which are
mostly single-use or disposable in nature. They are used to ensure the safe administration of anesthetic
vapors. Below are the types of airway and anesthesia devices considered under this segment:
• Airway management.
• Anesthesia circuits.
• Anesthesia masks.
• Laryngoscope blades.
• Breathing filters.
• Laryngoscope handles.
Airway and anesthesia devices comprise the fourth highest share in the market. It held a market share of
8.1% in 2016 and is expected to grow slightly and reach 8.3% by 2022. This study’s findings showed that
the anesthesia market share as a total would grow, but this segment of devices are usually small sized
consumables for which the prices are already stabilized.
For 2016 the airway and anesthesia devices market size at a regional level is shown below in Table 14.
Table 14
Global Market for Airway and Anesthesia Devices, by Region, 2016
($ Millions)
Region Market Size
North America 754.6
Asia-Pacific 314.8
Europe 368.4
ROW 184.9
Total 1,622.7
Below is a snapshot of airway and anesthesia devices market size for 2016 and for the forecasted years
2017 and 2022.
Figure 13
Global Market for Airway and Anesthesia Devices, 2016-2022
($ Millions)
2,500.0
2,000.0
1,500.0
$ Millions
1,000.0
500.0
0.0
2016 2017 2022
Among the airway and anesthesia devices, the airway management segment constitutes of 68% share
followed by anesthesia circuits (16%), anesthesia masks (7%), laryngoscope blades (5%), breathing filters
(3%) and laryngoscope handles (1%).
Figure 14
Global Market Share for Airway and Anesthesia Devices, by Sub-types, 2016
(%)
Laryngoscope
Breathing Filters
Handles
3%
1%
Laryngoscope Blades
5%
Anesthesia Masks
7%
Anesthesia Circuits
16%
Airway Management
68%
Anesthesia Machines
Anesthesia machines are the advanced machines that are used to deliver the measured quantity of
anesthetic gases and vapors to the patient safely and effectively. These machines are generally used
along with respiratory devices during surgical procedures. Anesthesia machines are classified into three
types:
• Anesthesia workstations.
• Stand alone anesthesia delivery machines.
• Portable anesthesia delivery machines.
Anesthesia is a common requirement for most of the surgeries. Despite of ample scope for usage,
anesthesia machines currently have a minor market share of 6.3% out of the anesthesia and respiratory
devices market. This segment is expected to grow at rate of 6.4%. A few factors enabling the growth of
this segment are technical advancements in the hospital and healthcare systems of Asian-Pacific and
South American countries, a growing demand for automation and technical sophistications in hospitals,
and increasing skill sets of anesthesiologists.
For 2016 the anesthesia machines market size at a regional level is shown below in Table 15.
Table 15
Global Market for Anesthesia Machines, by Region, 2016
($ Millions)
Region Market Size

North America 580.8
Asia-Pacific 151.0
Europe 290.4
ROW 139.4
Total 1,161.6
Below is a snapshot of anesthesia machines market size for 2016 and for the forecasted years 2017 and
2022.
Figure 15
Global Market for Anesthesia Machines, 2016- 2022
($ Millions)
2,000.0
1,800.0
1,600.0
1,400.0
1,200.0
$ Millions
1,000.0
800.0
600.0
400.0
200.0
0.0
2016 2017 2022
The anesthesia machines market comprises of three types of products and is mainly dominated by
anesthesia work stations with 56% followed by standalone anesthesia delivery machines (36%) and
portable anesthesia delivery machines (8%).
Figure 16
Global Market Share for Anesthesia Machines, by Sub types, 2016
(%)
Portable
Anesthesia Delivery
Machines
8%
Stand Alone
Anesthesia Delivery Anesthesia Work
Machines Stations
36% 56%

Regional anesthesia disposables are single-use disposable products that are used as a part of delivering
anesthetic gases during a regional anesthesia procedure. These disposables are generally used in
conjunction with, or as a support to, the anesthesia machines. They include:
• Spinal anesthesia disposables.

• Peripheral anesthesia disposables.
• Epidural anesthesia disposables.
Regional anesthesia disposables contribute about 5.8% in the anesthesia and respiratory devices market
for 2016. With the increasing awareness and technological advancements, and an expected increase of
anesthesia machines usage, this segment is expected to grow at a growth rate of 5.8%. For 2016 the
regional anesthesia disposables machines market size at a regional level is shown below in Table 16.
Table 16
Global Market for Anesthesia Disposables, by Region, 2016
($ Millions)
Region Market Size

North America 538.8
Asia-Pacific 140.1
Europe 269.4
ROW 129.3
Total 1,077.6
Below is a snapshot of regional anesthesia disposables market size for 2016 and for the forecasted years
2017 and 2022.
Figure 17
Global Market for Anesthesia Disposables, 2016-2022
($ Millions)
1,800.0
1,600.0
1,400.0
1,200.0
$ Millions
1,000.0
800.0
600.0
400.0
200.0
0.0
2016 2017 2022
The regional anesthesia disposables market is mainly dominated by the spinal anesthesia disposable
with a market share of 54% followed by peripheral anesthesia (30%) and epidural anesthesia disposables
(16%).
Figure 18
Global Market Share for Anesthesia Disposables, by Sub-types, 2016
(%)
Epidural Anesthesia
Disposables
16%
Spinal Anesthesia
Disposables
54%
Peripheral
Anesthesia
Disposables
30%

Sleep apnea diagnostic systems are used to detect or diagnose sleep apnea in patients. These diagnostic
systems are operated to perform polysomnography, also known as a sleep study, by sleep specialists.
Sleep apnea diagnostic systems are of two types:
• Fixed polysomnography systems

• Portable polysomnography systems
Sleep apnea diagnostic systems contributed about 2.3% in the anesthesia and respiratory devices
market for 2016. With the increasing incidence of OSA, public awareness about the severity of OSA,
healthcare advancements, and expected increase of anesthesia machines usage, this segment is
expected to grow at a rate of 7.3%. For 2016 the sleep apnea diagnostic systems market size at a
regional level is shown below in Table17.
Table 17
Global Market for Sleep Apnea Diagnostic Systems, by Region, 2016
($ Millions)
Region Market Size

North America 235.6
Asia-Pacific 55.6
Europe 115.3
ROW 57.6
Total 464.1
Below is a snapshot of sleep apnea diagnostic systems market size for 2016 and for the forecasted years
2017 and 2022.
Figure 19
Global Market for Sleep Apnea Diagnostic Systems, 2016-2022
($ Millions)
1000
900
800
700
600
$ Millions
500
400
300
200
100
0
2016 2017 2022
Sleep apnea diagnostic systems market shares for 2016 are as follows: Fixed polysomnography systems
(68%) and portable polysomnography systems (32%).
Figure 20
Global Market Share for Sleep Apnea Diagnostic Systems, by Sub-types, 2016
(%)
Portable
Polysomnography
Systems
32%
Fixed
Polysomnography
Systems
68%

Pain management devices are external pain pumps that administer anesthetic drugs to patients. There
are generally of two types: reusable and disposable pumps. Pain management devices contribute about
1.6% in the anesthesia and respiratory devices market for 2016. With the increasing demand for pain
management, this segment is expected to grow at a rate of 8.1%.
Table 18
Global Market for Pain Management Devices, by Region, 2016
($ Millions)
Region Market Size

North America 141.4
Asia-Pacific 74.2
Europe 69.2
ROW 34.6
Total 319.4

Below is a snapshot of pain management devices market size for 2016 and for the forecasted years 2017
and 2022.
Figure 21
Global Market for Pain Management Devices, 2016-2022
($ Millions)
500
450
400
350
300
$ Millions
250
200
150
100
50
0
2016 2017 2022
Chapter 6
Market Breakdown by
Region
Chapter 6: Market Breakdown by Region
Global Medical Device Industry Scenario

The global medical device market experienced growth in 2016. Despite numerous hurdles, the market
still showed a growth rate of approximately 4%. The majority of the world’s nations are confronting the
challenge of dealing with the hiking costs of healthcare. As a result, healthcare providers, clients,
governments and other interested parties are striving toward efficient, effective and reasonably-priced
healthcare. Therefore, the industry is currently shifting to business, hospital and operating models. In
some countries, the privatization of healthcare is resulting in a merging of hospitals into networks that
work with self-governing physicians. However, the medical device market has been characterized by
strong competitive and price pressure. While sales volumes and the range of new treatment methods
are on the rise, profit margins in the market are declining.
The wave of consolidation among suppliers of pharmaceutical products and medical technology during
the previous two years continued in 2016, albeit to a lesser extent. Larger manufacturers continue to
focus on selected therapy fields. In doing so, they hope to stabilize their profit margins despite the
competitive and price pressures.
Global Anesthesia and Respiratory Devices Market

In 2016 the global anesthesia and respiratory devices market was valued at $20.0 billion. It is expected
to reach $26.7 billion by 2022 with a CAGR of 4.8%.
Table 19
Global Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
2016 2017 2022
2017–2022
Total 20,051.6 21,094.2 26,716.9 4.8
This market grew in line with the growth rate of the global medical devices market. Despite of few
unanticipated economic fluctuations in the eurozone, this market witnessed a growth due to the strong
and stable growth observed in the Asian-Pacific and South American regions.
Figure 22
Global Market for Anesthesia and Respiratory Devices, 2016-2022
($ Millions)
30,000.0
25,000.0
20,000.0
$ Millions
15,000.0
10,000.0
5,000.0
0.0
2016 2017 2022
In terms of regional market shares, North America leads the market with a share of 47% in 2016,
followed by Europe at 23%, Asia-Pacific at 18.5% and the Rest of the World (ROW) at 11.5%.
Table 20
Global Market for Anesthesia and Respiratory Devices, by Region, Through 2022
($ Millions)
CAGR %
Region 2016 2017 2022
2017-2022
North America 9,424.3 9,896.7 12,423.4 4.7
Asia-Pacific 3,709.5 3,955.2 5,343.4 6.2
Europe 4,611.9 4,798.9 5,744.1 3.7
ROW 2,305.9 2,443.4 3,206.0 5.6
Global 20,051.6 21,094.2 26,716.9 4.8
Key companies that account for the anesthesia and respiratory market are Philips Respironics, Inc,
Medtronic plc, ResMed Inc, GE Healthcare, Smiths Medical, Teleflex Incorporated, Draegerwerk AG &
Co. KGaA, Ambu A/S, Fisher & Paykel Healthcare Corporation Limited, B. Braun Melsungen AG and
Becton, Dickinson and Company.
Figure 23
Global Market for Anesthesia and Respiratory Devices, by Region, 2016-2022
($ Millions)
14,000.0
12,000.0
10,000.0
$ Millions
8,000.0
6,000.0
4,000.0
2,000.0
0.0
2016 2017 2022
North America Asia Pacific Europe ROW
North America
The North America region dominates the global anesthesia and respiratory devices market with a
leading market share of $9.4 billion in 2016, which is forecasted to reach $12.4 billion in 2022, growing
at a CAGR of 4.7%.
Table 21
North America Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
2016 2017 2022
2017–2022
North America 9,424.3 9,896.7 12,423.4 4.7
Table 22
North America Market for Anesthesia and Respiratory Devices, by Country,
Through 2022
($ Millions)
CAGR%
Country 2016 2017 2022
2017-2022
U.S. 8,010.7 8,395.7 10,435.7 4.4
Canada 753.9 800.0 1,056.0 5.7
Mexico 659.7 701.0 931.7 5.9
Total 9,424.3 9,896.7 12,423.4 4.7
Figure 24
North America Market Share for Anesthesia and Respiratory Devices, by Country,
2016
(%)
Mexico
7%
Canada
8%
U.S
85%
Of the North America region’s 2016 anesthesia and respiratory devices market, the U.S. stands out with
a biggest market share of $8 billion or approximately 85% of the regional share followed by Canada with
$753.9 million and Mexico with $659.7 million. The regional market is expected to reach $12.4 billion by
2022 with a CAGR of 4.7%.
Table 23
North America Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
Segment/Product Type 2016 2017 2022
2017-2022
Respiratory Disposables 1,130.9 1,168.6 1,347.9 2.9
Airway and Anesthesia Devices 753.9 794.2 1,012.5 5.0
Anesthesia Machines 584.3 616.9 795.1 5.2
Regional Anesthesia Disposables 546.6 577.3 745.4 5.2
Total 9,424.3 9,896.7 12,423.4 4.7
United States
The U.S. is considered the biggest hub for healthcare market. Likewise, the U.S. held the highest market
share for the anesthesia and respiratory market in 2016; in the global market the U.S. held 40% and in
the regional market the U.S. held 85%.
In 2016 the anesthesia and respiratory market of the U.S was valued at $8 billion and is expected to
grow at a CAGR of 4.4% to reach more than $10.4 billion by 2022.
Table 24
U.S. Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
U.S. 8,010.7 8,395.7 10,435.7 4.4
Keys for Growth
Growth in the anesthesia and respiratory devises market in the U.S. is the result of several distinct
drivers.
In 2016, healthcare companies found relief from a special tax on medical devices (Medical Device Excise
Tax). The U.S. Congress suspended the tax for two years in 2015.
A slight dip in the country’s GDP was backed up with a strong U.S. dollar performance and high volatility
in the financial markets.
There was an increase in healthcare spending because of the expansion of insurance coverage arising
from health care reform with the Affordable Care Act.
Enhanced financial performance of U.S. based manufacturers.
Growing prevalence of OSA and COPD promises better business for the companies.
Table 25
U.S. Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Respiratory Disposables 961.2 991.4 1,132.2 2.7
Airway and Anesthesia Devices 640.8 673.8 850.5 5.0
Total 8,010.7 8,395.7 10,435.7 4.4
Figure 25
U.S. Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016
(%)
Pain Management
Sleep Apnea
Devices
Diagnostic Systems
1%
3%
Regional Anesthesia
Disposables
6%
Respiratory Devices
37%
Anesthesia Machines
6%
Airway and
Anesthesia Devices
8%
Respiratory
Respiratory Measurement
Disposables Devices
12% 27%
In terms of product type or segment contributions within the U.S. market in 2016 the respiratory devices
hold the highest share with 37% followed respiratory measurement devices (27%) and respiratory
disposables (12%), airway and anesthesia devices (8%), anesthesia machines (6%), anesthesia
disposables (6%), sleep apnea diagnostic systems (3%) and pain management devices (1%).
Canada
Canada holds the second highest market share of the regional market with a share of 8% for 2016. The
anesthesia and respiratory market in Canada for 2016 was valued at $753.9 million and is expected to
grow at a CAGR of 5.7% to exceed $1.1 billion by 2022.
Table 26
Canada Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Canada 753.9 800.0 1,056.0 5.7
Market Scenario
Canada managed to deliver constant growth rates despite the country’s GDP being minorly affected by
the dipping U.S. economy.
The country experienced certain demographic stress as it recovered from damage caused by isolated
incidents, such as the wildfire in Alberta.
As a part of country’s strategy towards firm growth, in October 2016 Canada and the EU concluded the
CETA (Comprehensive Economic and Trade Agreement), which promises new export opportunities for
both sides.
With increasing incidence of OSA and chronic respiratory conditions and sufficient insurance coverage,
the medical device manufacturers can explore better opportunities in the future.
Table 27
Canada Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Respiratory Devices 279.0 296.5 394.8 5.9
Respiratory Measurement Devices 203.6 215.5 280.9 5.4
Respiratory Disposables 90.5 94.5 114.6 3.9
Total 753.9 800.0 1,056.0 5.7
Figure 26
Canada Market Share for Anesthesia and Respiratory Devices, by Product type,
2016
(%)
Pain Management
Sleep Apnoea
Devices
Diagnostic Systems
2%
3%
Regional Anesthesia
Disposables
4%
Respiratory Devices
36%
Anesthesia Machines
9%
Airway and
Anesthesia Devices
12%
Respiratory
Measurement
Respiratory Devices
Disposables 21%
13%
In terms of product type or segment contributions within Canada’s market, the respiratory devices hold
the highest share with 36% followed respiratory measurement devices (21%) and respiratory
Mexico
Mexico holds the third place in the regional market share with 7% for 2016. The anesthesia and
respiratory market of Mexico for 2016 was valued at $659.7 million and is expected to grow at a CAGR
of 5.9% to reach $931.7 million by 2022.
Table 28
Mexico Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Mexico 659.7 701.0 931.7 5.9
Table 29
Mexico Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 659.7 701.0 931.7 5.9
Figure 27
Mexico Market Share for Anesthesia and Respiratory Devices, by Product type,
2016
(%)
Pain Management
Devices Sleep Apnoea
2% Diagnostic Systems
2%
Regional Anesthesia
Disposables
6%
Respiratory Devices
37%
Anesthesia Machines
6%
Airway and
Anesthesia Devices
8%
Respiratory
Respiratory Measurement
Disposables Devices
12% 27%
In terms of product type or segmental contributions within Mexico market in 2016, the respiratory
devices hold the highest share with 37% followed respiratory measurement devices (27%) and
respiratory disposables (12%), airway and anesthesia devices (8%), anesthesia machines (6%),
anesthesia disposables (6%), sleep apnea diagnostic systems (2%) and pain management devices (2%).
Asia-Pacific
The Asia-Pacific region’s anesthesia and respiratory devices market was valued at $3.7 billion in 2016
and is forecasted to reach $5.3 billion in 2022, growing at a CAGR of 6.2%. Asia-Pacific accounts for a
market share of 18.5% of the global anesthesia and respiratory devices market.
Table 30
Asia-Pacific Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Region 2016 2017 2022
2017-2022
Asia-Pacific 3,709.5 3,955.2 5,343.4 6.2
Table 31
Asia-Pacific Market for Anesthesia and Respiratory Devices, by Country, Through
2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
China 1,242.6 1,328.6 1,819.5 6.5
India 630.6 675.7 935.1 6.7
Japan 779.0 832.6 1,138.1 6.5
South Korea 222.6 283.3 328.6 6.6
Australia 463.7 491.1 641.2 5.5
Rest of Asia-Pacific 371.0 388.9 480.9 4.3
Total 3,709.5 3,955.2 5,343.4 6.2
Among the Asia-Pacific region’s anesthesia and respiratory devices market, China holds the biggest
market share of $1.2 billion (33.5%) followed by Japan with $779 million (21%), India with $630.6 million
(17%), Australia with $463.7 million (12.5%), South Korea with $222.6 million (6%) and Rest of Asia-
Pacific (includes countries the Philippines, New Zealand, Sri Lanka, Singapore, Thailand and Malaysia)
with $371 million (10%).
Keys for Growth
Healthcare spending in Asia-Pacific experienced a visible increase in 2016 because of an expansion of
state healthcare programs and the growing affluence of the population by the key member countries.
India saw an increase in spending because of the government’s resolution to improve healthcare
facilities and upgrade technology.
Healthcare in China continued to grow swiftly. In addition to government initiatives, this growth was
primarily to the result of the increasing affluence of the population and rapidly progressing economy.
Most importantly, the Chinese market has high growth opportunity because of the country’s changing
mindset towards traditional medicine. Both the government and the people of China are shifting their
preference towards modern healthcare.
Japanese healthcare is currently experiencing certain pressures that include an ageing population,
increased prevalence of chronic disorders resulting in a huge flow of claims to the private insurers and
financial pressure reported by the funding agencies in recent past. However, this increased spending is
expected to be dealt with by the government soon; the Japanese government is working towards
revamping healthcare policies for better healthcare support.
Figure 28
Asia-Pacific Market Share for Anesthesia and Respiratory Devices, by Country,
2016
(%)
Rest of Asia-Pacific
10%
China
Australia 33%
13%
South Korea
6%
Japan
21% India
17%
Table 32
Asia-Pacific Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 3,709.5 3,955.2 5,343.4 6.2
Figure 29
Asia-Pacific Market Share for Anesthesia and Respiratory Devices, by Product
type, 2016
(%)
Regional Pain Management

Sleep Apnea
Anesthesia Devices
Diagnostic Systems
Disposables 2%
1%
3%
Anesthesia
Respiratory Devices
Machines
38%
4%
Airway and
Anesthesia Devices
9%
15% Devices
28%
In terms of product type or segmental contributions within Asia-Pacific market, the respiratory devices
China
China, the most populated country in the world, stands as a country with the highest market share in
2016 of $1.2 billion (34%) among the Asia-Pacific’s anesthesia and respiratory devices market. This
market is expected to grow at a CAGR of 6.5% to reach a size of $1.8 billion by 2022.
Table 33
China Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
China 1,242.6 1,328.6 1,819.5 6.5
Keys for Growth

The Chinese government is in the process of making significant changes to the country’s healthcare
system with which the healthcare spending is expected to grow abundantly. It was estimated that
China’s healthcare spending would reach $1000 billion by 2020.
China’s GDP has been drastically growing in recent years; with the same growth rate it is anticipated
that the China’s GDP will reach 19% of the global GDP.
With increasing population and air pollution levels, there is an abundant scope for the usage of
respiratory devices.
This country can be a strategic focus for this market because of epidemiological factors like increasing
incidence of OSA and COPD.
There is a paradigm shift from traditional medicine to modern medicine.
Table 34
China Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 1242.6 1,328.6 1,819.5 6.5
Figure 30
China Market Share for Anesthesia and Respiratory Devices, by Product type,
2016
(%)
Pain Management
Sleep Apnoea
Regional Anesthesia Devices
Diagnostic Systems
Disposables 2%
1%
3%
Anesthesia Respiratory Devices

Machines 39%
4%
Airway and
Anesthesia Devices
8% Respiratory
Measurement
Respiratory Devices
Disposables 28%
15%
In terms of product type or segmental contributions within China’s market, respiratory devices hold the
highest share with 39% followed respiratory measurement devices (28%) and respiratory disposables
(15%), airway and anesthesia devices (8%), anesthesia machines (4%), anesthesia disposables (3%), sleep
apnea diagnostic systems (2%) and pain management devices (1%).
India
India is considered strategically important by the majority of medical device manufactures because of its
financial performance and progression towards innovations. As the second highest populated country in
the world, India has the third highest market share in 2016 with $630.6 million (17.0%) among Asia-
Pacific’s anesthesia and respiratory devices market. This market is expected to grow at a CAGR of 6.7%
to reach a size of $935.1 million by 2022.
Table 35
India Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
Country 2016 2017 2022 CAGR % (2017-2022)
India 630.6 675.7 935.1 6.7
Keys for Growth

Increased healthcare spends and growing economy. Despite demonetization, the Goods and Services
Tax Bill and few more typical measures taken by the government, the country still tends to strongly
move towards growth.
Increased insurance coverage, both public and private, is a positive sign and many of the healthcare
companies and providers are benefited directly or indirectly through this step.
Increase in the prevalence of chronic respiratory conditions and public awareness regarding OSA would
enhance the opportunities for this market.
Table 36
India Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Respiratory Measurement Devices 173.6 183 233.8 5.0
Airway and Anesthesia Devices 53.6 58 84.2 7.7
Total 630.6 675.7 935.1 6.7
Figure 31
India Market Share for Anesthesia and Respiratory Devices, by Product type, 2016
(%)
Pain Management
Regional Anesthesia Devices Sleep Apnea
Disposables 2% Diagnostic Systems
4% 2%
Anesthesia Machines
4% Respiratory Devices
38%
Airway and
Anesthesia Devices
8%
15% Devices
27%
In terms of product type or segmental contributions within India’s market, the respiratory devices hold
the highest share with 38% followed by respiratory measurement devices (27%) and respiratory
Japan
After the U.S., Japan is the strategic center for many of this market’s manufacturers because the country
is known for its desire for sophisticated healthcare facilities and technological advancements. In 2016
Japan held the second highest market share of $779.0 million (21%) among the Asia-Pacific’s anesthesia
and respiratory devices market. This market is expected to grow at a CAGR of 6.5% to reach a size of
$1.1 billion by 2022.
Table 37
Japan Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
Country 2016 2017 2022 CAGR % (2017-2022)
Japan 779.0 832.2 1,138.1 6.5
Table 38
Japan Market for Anesthesia and Respiratory Devices, by Product Type, Through
2022
($ Millions)
CAGR %
2017-2022
Regional Anesthesia Disposables 27.3 31.238.5 51.2 10.4
Total 779.0 832.6 1,138.1 6.5
Figure 32
Japan Market Share for Anesthesia and Respiratory Devices, by Product Type,
2016
(%)
Sleep Apnea
Pain Management Diagnostic Systems
Devices 3%
2%
Regional Anesthesia
Disposables
4% Respiratory Devices
35%
Anesthesia Machines
5%
Airway and
Anesthesia Devices
12%
Respiratory
Measurement
Devices
Respiratory
25%
Disposables
14%
In terms of product type or segmental contributions within Japan’s market, the respiratory devices hold
South Korea
South Korea held a market share of $222.3 million (6%) among the Asia-Pacific’s anesthesia and
respiratory devices market in 2016. This market is expected to grow at a CAGR of 6.6% to reach a size of
$328.6 million by 2022.
Table 39
South Korea Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
South Korea 222.6 238.3 328.6 6.6
Table 40
South Korea Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Pain Management Devices 4.5 5 8.2 10.4
Total 222.6 238.3 328.6 6.6
Figure 33
South Korea Market Share for Anesthesia and Respiratory Devices, by Product
Type, 2016
(%)
Pain Management
Sleep Apnoea
Devices
Regional Anesthesia Diagnostic Systems
2%
Disposables 1%
4%
Anesthesia Machines Respiratory Devices

4% 38%
Airway and
Anesthesia Devices
8%
15% Devices
28%
In terms of product type or segment contributions within South Korea’s market, the respiratory devices
Australia
Australia’s healthcare market is mature and consists of a well-organized regulatory system. This country
is considered as one of the key countries among the Asia-Pacific region. Australia holds a market share
of $463.7 million (12.5%) among the APAC’s anesthesia and respiratory devices market for 2016. This
market is expected to grow at a CAGR of 5.5% to reach a size of $641.2 million by 2022.
Table 41
Australia Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Australia 463.7 491.1 641.2 5.5
Keys for Growth

Australia's healthcare industry is sophisticated and highly receptive to novel products.
With an ageing population, there is a consistent demand for a full range of medical devices which are
intended to treat chronic diseases.
The Australian government’s policies encourage the aggressive import of medical devices from
manufacturers who offer novel and cost-effective medical devices.
The regulatory pathway has been made simple as the CE mark devices have a relaxed clearance.
Table 42
Australia Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Respiratory Disposables 69.5 72 86.6 3.8
Pain Management Devices 9.3 10.2 16 9.4
Sleep Apnea Diagnostic Systems 7 7.8 12.8 10.4
Total 463.7 491.1 641.2 5.5
Figure 34
Australia Market Share for Anesthesia and Respiratory Devices, by Product Type,
2016
(%)
Pain Management
Sleep Apnoea
Devices
Regional Anesthesia Diagnostic Systems
2%
Disposables 2%
3%
Anesthesia Machines Respiratory Devices

4% 38%
Airway and
Anesthesia
Devices
9%
Respiratory
Disposables 27%
15%
In terms of product type or segmental contributions within Australia’s market, respiratory devices hold
Europe
Europe holds the second highest share among the global anesthesia and respiratory devices market with
a market share of $4.6 billion in 2016, which is forecasted to reach $5.7 billion in 2022, growing at a
CAGR of 3.7% over the forecasted years.
Table 43
Europe Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
2016 2017 2022
2017-2022
Europe 4,611.8 4,798.9 5,744.2 3.7
Market Scenario
• The healthcare market suffered a certain level of pressure in the Eurozone due to the economic
fluctuations that happened in the member states.
• A few constraining events including the decline of the British pound against the euro that
showed an impact on the U. K.’s market.
• A few member states of the EU faced certain pressures including Spain’s sovereign debt crisis
and both France and Italy faced market unwillingness (rejection of the referendum in Italy).
• The majority of the EU member states reduced or froze the healthcare costs for the cost
optimization. However, all the countries are recovering from the unexpected economic shifts
and are focused to move towards providing better healthcare.
• Despite the discouraging factors, the overall medical device industry managed to grow by 3-4%
which is a positive sign to investors and manufacturers.
Table 44
Europe Market for Anesthesia and Respiratory Devices, by Country, Through
2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Germany 1,937.0 2,017.9 2,435.5 3.8
France 737.9 769.8 933.4 3.9
U.K. 645.7 669.9 789.8 3.3
Italy 501.0 527.9 631.9 3.7
Russia 513.6 529.5 637.6 3.8
Rest of Europe 276.7 283.9 315.9 2.2
Total 4,611.8 4,798.9 5,744.2 3.7
Figure 35
Europe Market Share for Anesthesia and Respiratory Devices, by Country, 2016
(%)
Rest of Europe
6%
Russia
11%
Germany
Italy 42%
11%
U.K.
14%
France
16%
Among the Europe’s 2016 anesthesia and respiratory devices market, Germany holds the biggest market
share of $1.9 billion (42%) followed by France with $737.9 million (16%), the U.K. with $645.7 million
(14%), Italy with $501.0 million (10.9%), Russia with $513.6 million (11.1%) and Rest of Europe (includes
other countries of the European Union) with $276.7 million (6%).
Table 45
Europe Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 4,611.9 4,798.9 5,744.1 3.7
Figure 36
Europe Market Share for Anesthesia and Respiratory Devices, by Product type,
2016
(%)
Pain Management
Regional 1.5% Diagnostic Systems
Anesthesia 2.5%
Disposables
5.8% Respiratory Devices
37.0%
Anesthesia
Machines
6.2%
Airway and
Anesthesia Devices
8.0%
12.0% Devices
27.0%
In terms of product type or segmental contributions within Europe’s market, the respiratory devices
Germany
Germany is one of the world’s largest manufacturers or suppliers of medical devices across the globe.
German manufacturers are renowned for their sophisticated medical devices and health technologies. In
2016 the country held the highest market share of $1.9 billion (42%) among the Europe’s anesthesia and
respiratory devices market. This market is expected to grow at a CAGR of 3.8% to reach a size of $2.4
billion by 2022.
Table 46
Germany Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Germany 1,937.0 2,017.9 2,435.5 3.8
Table 47
Germany Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 1,937.0 2,017.9 2,435.5 3.8
Figure 37
Germany Market Share for Anesthesia and Respiratory Devices, by Product Type,
2016
(%)
Pain Management
Devices Sleep Apnea
1.5% Diagnostic Systems
Regional 2.5%
Anesthesia
Disposables
Respiratory Devices
5.8%
37.0%
Anesthesia
Machines
6.2%
Airway and
Anesthesia Devices
8.0%
12.0% Devices
27.0%
In terms of product type or segmental contributions within Germany’s market, the respiratory devices
France
In 2016 France held the second highest market share of $737.9 million (16%) among the Europe’s
anesthesia and respiratory devices market. This market is expected to grow at a CAGR of 3.9% to reach a
size of $933.4 million by 2022.
Table 48
France Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
France 737.9 769.8 933.4 3.9
Table 49
France Market for Anesthesia and Respiratory Devices, by Product Type
($ Millions)
CAGR %
2017-2022
Airway and Anesthesia Devices 59 61.8 76.1 4.3
Anesthesia Machines 45.7 48 59.7 4.5
Total 737.9 769.8 933.4 3.9
Figure 38
France Market Share for Anesthesia and Respiratory Devices, by Product Type,
2016
(%)
Pain Management
Regional 2.5%
Anesthesia
Disposables
Respiratory Devices
5.8%
37.0%
Anesthesia
Machines
6.2%
Airway and
Anesthesia Devices
8.0%
12.0% Devices
27.0%
In terms of product type or segmental contributions within France’s market, the respiratory devices hold
United Kingdom
The U.K. is one of the key markets across the globe. After the U.S., this country is actively involved in
operating the healthcare regulations through its activities (European Medicine Agency). However, in
recent times, post Brexit the country has experienced certain level of socioeconomic disturbances that
led to the slow growth rates of the medical devices market.
In 2016 the U.K. held a market share of $645.7 million (14%) among the Europe’s anesthesia and
respiratory devices market. This market is expected to grow at a CAGR of 3.3% to reach a size of $789.8
million by 2022.
Table 50
U.K. Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
U.K. 645.7 669.9 789.8 3.3
Table 51
U.K. Market for Anesthesia and Respiratory Devices, by Product Type, Through
2022
($ Millions)
CAGR %
2017-2022
Anesthesia Machines 40 41.7 50.5 3.9
Total 645.7 669.9 789.8 3.3
Figure 39
U.K Market Share for Anesthesia and Respiratory Devices, by Product Type, 2016
(%)
Pain Management
Sleep Apnea
Devices
Diagnostic Systems
1.5%
Regional 2.5%
Anesthesia
Disposables Respiratory Devices
5.8% 37.0%
Anesthesia
Machines
6.2%
Airway and
Anesthesia Devices
8.0%
12.0% Devices
27.0%
Segmental contributions within the U.K. market are as follows, the respiratory devices hold the highest
share with 37% followed respiratory measurement devices (27%) and respiratory disposables (12%),
airway and anesthesia devices (8%), anesthesia machines (6%), anesthesia disposables (6%), sleep apnea
diagnostic systems (2%) and pain management devices (2%).
Italy
Italy held a market share of $501 million (11%) among the Europe’s anesthesia and respiratory devices
market for the year 2016. This market is expected to grow at a CAGR of 3.7% to reach a size of $631.9
million by 2022.
Table 52
Italy Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Italy 501.0 527.9 631.9 3.7
Table 53
Italy Market for Anesthesia and Respiratory Devices, by Product Type, Through
2022
($ Millions)
CAGR %
2017-2022
Airway and Anesthesia Devices 40.0 42.4 51.5 4
Total 501.0 527.9 631.9 3.7
Figure 40
Italy Market Share for Anesthesia and Respiratory Devices, by Product type, 2016
(%)
Pain Management
Sleep Apnea
Devices
Diagnostic Systems
1.5%
Regional 2.5%
Anesthesia
Disposables Respiratory Devices
5.9%
Anesthesia 37.0%
Machines
6.2%
Airway and
Anesthesia Devices
8.0%
11.8% Devices
27.1%
Segmental contributions within Italy market are as follows, the respiratory devices hold the highest
Russia
Russia holds a market share of $513.6 million (11%) among the Europe’s anesthesia and respiratory
devices market for the year 2016. This market is expected to grow at a CAGR of 3.8% to reach a size of
$637.6 million by 2022.
Table 54
Russia Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Country 2016 2017 2022
2017-2022
Russia 513.6 529.5 637.6 3.8
Table 55
Russia Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Total 513.6 529.5 637.6 3.8
Figure 41
Russia Market Share for Anesthesia and Respiratory Devices, by Product type,
2016
(%)
Pain Management
Regional 2.5%
Anesthesia
Disposables
Respiratory Devices
5.7%
36.9%
Anesthesia
Machines
6.3%
Airway and
Anesthesia Devices
8.1%
Respiratory
Respiratory
Disposables
Measurement
12.1%
Devices
26.9%
Segmental contributions within Russia market are as follows, the respiratory devices hold the highest
Rest of the World (ROW)
The regions covered under ROW here are South America and the Middle East and Africa. With the
altering global socio-economic conditions, these regions have turned out to be the second fastest
growing market.
Market Scenario
South America
The healthcare markets in Latin America grew in 2016 in spite of budget cuts in many countries.
Governments are working to improve their public healthcare systems. In 2016 numerous hospitals were
under construction in Peru and Chile. Brazil kept decreasing its healthcare spending because of difficult
failing consumer trust, economic conditions, and a restrictive monetary policy inculcated by the
government. Despite discouraging economies, Latin America has witnessed highest growth after Asia-
Pacific in the anesthesia and respiratory market.
Low establishment costs, ease in doing business, growing population, increasing industrialization
activities, high prevalence of chronic respiratory infections are few factors that attract the medical
device manufacturers to explore the business in this region.
Middle East and Africa (MEA)

Health care spending increased in Africa and the Middle East. This was resulted due various reasons like
elections in several countries (including Ghana, Niger, Uganda, Zambia and Somalia), healthcare
expansion and population growth. The need for medical technology and medical devices also increased
drastically in these countries because of low domestic production, the region is reliant on imported
medical products.
The import quota in many countries is 80 to 90 percent. Following the settlement of the nuclear dispute
between the U.S., the EU and Iran at the start of 2016, there are a handful of new export opportunities
to the Middle East for medical device manufacturers.
Table 56
ROW Market for Anesthesia and Respiratory Devices, Through 2022
($ Millions)
CAGR %
Region 2016 2017 2022
2017-2022
ROW 2,305.9 2,443.4 3,206.0 5.6
Table 57
ROW Market for Anesthesia and Respiratory Devices, by Region, Through 2022
($ Millions)
CAGR %
Country/Region 2016 2017 2022
2017-2022
South America 1,844.7 1,962.9 2,628.9 6.0
MEA 461.2 480.5 577.1 3.7
Total 2305.9 2443.4 3,206.0 5.6
Figure 42
ROW Market Share for Anesthesia and Respiratory Devices, by Country, 2016
(%)
MEA
20%
South America
80%
Among the ROW’s anesthesia and respiratory devices market, South America holds the biggest market
share of $1.8 billion (80%) followed by MEA with $461.2 million (20%).
Table 58
ROW Market for Anesthesia and Respiratory Devices, by Product Type,
Through 2022
($ Millions)
CAGR %
2017-2022
Respiratory Devices 853.2 905.6 1,198.0 5.8
Total 2,305.9 2,443.4 3,206.0 5.6
Chapter 7
Patent Review/New
Developments
Chapter 7: Patent Review/New
Developments
Significance of Patents
A patent can be defined as "a set of exclusive rights granted by a government office to an inventor or his
assignee for a fixed period of time in exchange for a disclosure of an invention." Applications for patents
are usually handled by a government agency. In the U.S., the U.S. Patent and Trademark Office (USPTO)
issues patent applications, and patents and in Europe, the European Patent Office (EPO) provides the
same service. In the same way, every country which is involved in certain research and development
activities hold a country level patent office.
Table 59
International Patent Offices
International Patent Offices

Australian Patent Office Japanese Patent Office
Austrian Patent Office Korean Patent Office
Brazilian Patent Office Mexican Patent Office
Belgian Patent Office Netherlands Patent Office
Benelux Patent Office New Zealand Patent Office
Canadian Patent Office Norwegian Patent Office
Czech Patent Office Polish Patent Office
Chinese Patent Office Portuguese Patent Office
Croatian Patent Office Russian Patent Office
Danish Patent Office Singaporean Patent Office
European Patent Office Spanish Patent Office
Finland National Board of Patents Swedish Patent and Registration Office
French Patent Office Swiss Institute of Intellectual Property
German Patent Office Thai Patent Office
Greek Industrial Property Organization United Kingdom Patent Office
Hong Kong Intellectual Property Department United States Patent and Trade-mark Office
Hungarian Patent Office World Intellectual Property Office (WIPO-PCT)
Italian Patent Office World Trade Organization (WTO)
Source: Patent Office Australia-Website
By granting the right to produce a new product without the threat of competition, patents provide
incentive for companies or individuals to continue developing innovative new products or services. As
pharmaceutical companies spend large sums on research and development, patents are essential for the
pharmaceutical companies to earn a profit.
Patents enable them to recoup development costs and give them time to earn a fair return on their
investment. Effective patent protection provides incentives to research and development and is a key
requirement for raising venture capital. It fosters the technical innovation so crucial to competitiveness
and overall economic growth. Patent rights create an incentive for companies to develop workarounds
to patented inventions, thereby creating improved or alternative technologies that might not otherwise
be developed.
Patent Analysis
This report presents the number of patents issued to some of the key players in this market in 2016 and
2017. This demonstrates the strategies of a company towards gaining more market share by relying on
innovation and product development to compete with new products scheduled to come to market.
Patent Review by Company

Draegerwerk
In 2016 Draegerwerk’s basic research experts analyzed over 180 new technologies in 27 technological
fields. Innovation efforts had been continued by the company, and number of patents filed was
drastically increased.
• In 2016 patent and trademark offices around the world issued 234 new patents to Draegerwerk.
• In 2016 the company applied for another 86 patents at international patent offices.
• In 2015 patent and trademark offices around the world issued 147 new patents to Draegerwerk.
• In 2015 the company applied for another 93 patents at international patent offices.
Figure 43
Draegerwerk Patent Share, by Region, 2016
(%)
U.S.
37%
Outside the U.S.

63%
Source: Company Annual Report
ResMed
ResMed has been involved in numerous R&D activities to grow its novelty base and enhancing market
share opportunities with its new products. Below is the snapshot of its patent portfolio
Figure 44
ResmMed Number of Patents Issued, 2016
(%)
USPTO
35%
Foreign
65%
Source-Company Annual SEC File

Further research efforts of the company are depicted below-
Figure 45
ResMed Patent Activities, 2017
1,200.0
1,000.0
Number of Patents
800.0
600.0
400.0
200.0
0.0
Pending US Patent Pending Foreign Patent Number of Registered Number of pending
applications Applications designs designs
As of 2017 pending U.S. Patent applications: 468 (including approximately 44 design patent
applications).
Pending Foreign Patent applications: 952 pending foreign patent applications.
The company currently holds approximately 983 registered foreign designs and 50 pending foreign
designs. Most of the patents, patent applications and designs relate to aspects and features of ResMed
products.
Loss of Exclusivity
The loss of exclusivity of the patents is very crucial as the competitors would have abundant opportunity
to explore the markets vigorously. ResMed consists of multiple patents to be expired in the coming
years. Of the company’s patents, 222 United States patents and 483 foreign patents are due to expire in
the next five years. Below is a year-wise projection of loss of exclusivity of the company’s patent
portfolio:
Table 60
ResMed Patent Loss of Exclusivity Scenario
Year US/Foreign Number of Patents due for LOE

2018 US 99
Foreign 54
US 46
2019
Foreign 17
US 134
2020
Foreign 72
US 75
2021
Foreign 33
US 129
2022 Foreign 46
Fisher & Paykel

Fisher and Paykel is a specialty company that is focused on design, development and sales of anesthesia
and respiratory devices and technologies. In 2016 the company was issued 36 patents in the USPTO. For
the year 2017, this number grew to 45.
Table 61
Patents issued to Fisher and Paykel, 2016
Patent
S.no Title
File
1 9526807 Breathing assistance apparatus
3 9509184 Appliance, rotor and magnet element
4 D772,388 Humidifier heater base
6 D771,239 Crown strap of a headgear assembly for a breathing interface
7 D770,522 Display screen or portion thereof with graphical user interface
8 D770,036 Breathing interface assembly
9 D770,035 Seal
10 9474512 Relating to systems for laparoscopic surgery
11 9468733 Components for medical circuits
13 D766,711 Clip
14 D766,324 Breathing apparatus display screen with graphical user interface
Patent
S.no Title
File
15 9440042 Humidified gases delivery apparatus and methods for controlling same
16 D762,844 Headgear assembly for a patient interface
17 9393379 Water out alarm
18 9387298 Fan unit with improved surge characteristics
21 9339621 Mask
22 9339619 Pressure adjustment method for CPAP machine
24 RE45,985 Face mask
Rotor for a motor, and a motor and an appliance comprising the rotor, and a method
25 9325210
for making a rotor
27 D753,812 Breathing apparatus
28 9295801 Breathing tube
30 9290882 Speed dependent clutch
32 9265902 Apparatus for measuring properties of gases supplied to a patient
33 D747,792 Nasal cannula body
34 RE45,836 Face mask
35 D747,473 Dual-connector wye piece
36 D747,471 Connector
Source: USPO Patent Search
Table 62
Patents issued to Fisher and Paykel, 2017
Patent
S.no Title
number
3 9827393 Conduit with heated wick
4 9816221 Washing machines
5 9814856 Apparatus for measuring properties of gases supplied to a patient
6 9808612 Conduit connector for a patient breathing device
Rotor for a motor, and a motor and an appliance comprising the rotor, and a method for
7 9806581
making a rotor
Patent
S.no Title
number
8 9802023 Humidifier
9 9802021 Mouthpiece
10 9802020 Expiratory limb for a breathing circuit
11 D800,895 Face mask cushion
12 D798,439 Frame assembly cover for a patient interface
16 9750908 System, apparatus and methods for supplying gases
18 D796,027 Patient interface connector for a patient interface assembly of a respiratory system
19 9737675 Breathing assistance apparatus with serviceability features
20 9726390 Humidifier arrangements and control systems
21 9719201 Laundry machine
22 9717874 Conduit and method of forming
24 D790,054 Swivel connector
25 9685840 Motor
26 9677212 Suspension unit and laundry washing machine
27 9656039 Breathing assistance apparatus with a manifold to add auxiliary gases to ambient gases
28 9649468 Respiratory gas humidifier
29 9634529 Electrical machine
30 D784,516 Face mask frame
31 D784,515 Headgear
32 9605666 Linear compressor
33 D782,031 Face mask cushion and frame assembly
34 D782,030 Face mask
35 9579480 Method and apparatus for increasing therapy compliance
36 9572951 Apparatus for supplying gases to a patient
37 9561339 Nasal interface
41 9546025 Lid construction for breathing apparatus
44 9539401 Tracheal couplings and associated systems and methods
Patent
S.no Title
number
45 9533117 Limb for breathing circuit
Smiths Medical
Smiths Medical is one of the key players in the anesthesia and respiratory devices and technologies. In
2016 the company was issued 11 patents in the USPTO. For the year 2017 this number grew to 45.
Table 63
Patents issued to Smiths Medical, 2016
S. No Patent File Title

1 95,04,629 Medication dispensers
2 94,83,615 Communication of original and updated pump parameters for a medical infusion pump
3 94,27,521 Syringe pump rapid occlusion detection system
4 93,99,116 Method of making catheter assembly with seal member
5 93,78,333 Display for pump
6 93,64,651 Adapter with special fitting
8 93,27,106 Portal and septum therefore
Systems and methods for illuminated medical tubing detection and management
9 93,08,323
indicating a characteristic of at least one infusion pump
10 93,08,051 Illuminated tubing set
11 92,27,013 Device for insertion of a cannula of an infusion device and method
Table 64
Patents issued to Smiths Medical, 2017
S. No Patent File Title

1 D806,018 Battery pack
2 98,01,535 Medico-surgical apparatus
3 97,89,251 Flow stop insert apparatus and methods
4 97,50,396 Variable length portal access device
5 97,40,829 Interface for medical infusion pump
6 97,24,030 Fluid handling device having a spring mechanism
7 96,62,437 Infusion pump pressure plate
8 D785,792 Guidewire introducer
9 96,29,955 Drug or fluid delivery devices
Needle protection device with gauge specific color coding and method for
10 95,72,941
manufacturing thereof
11 95,55,221 Constant force hold tip protector for a safety catheter
12 95,55,220 Tip protector for a safety catheter
13 95,45,495 Catheter assembly with seal member
Medtronic plc
Medtronic is the global leader in anesthesia and respiratory devices. Although the company’s primary
focus in not the anesthesia and respiratory devices market, with its extensive product line and global
presence and huge distributor network, the company manages to lead the market. For the year 2016,
the USPTO issued 588 patents to Medtronic and in 2017, 577 patents were issued. It is estimated that
15% of these patents belong to anesthesia and respiratory devices. The top patents of the company as
per USPTO are listed below.
Table 65
Top 50 Medical Device Patents issued to Medtronic, 2016
S. No. Patent Number Title

1 D775,360 Patient diagnostic medical device
2 9529972 Patient event indication
3 9526910 Therapy delivery method and system for implantable medical devices
4 9526908 Method and apparatus for discriminating tachycardia events in a medical device
Implantable medical device having power supply for generating a regulated power
5 9526905
supply
6 9526891 Intracardiac medical device
7 9526834 Safeguarding measures for a closed-loop insulin infusion system
Sodium and buffer source cartridges for use in a modular controlled compliant flow
8 9526822
path
9 9526610 Method and device for percutaneous valve annuloplasty
10 9526522 Interventional medical systems, tools, and assemblies
11 9526509 Dynamic locking device
12 9526483 Apical closure system
Method and determination of cardiac activation from electrograms with multiple
13 9526435
deflections
14 9522281 Varying lead configuration implantable medical device
15 9522279 System, apparatus and method for interacting with a targeted tissue of a patient
16 9522277 Lead integrity testing triggered by sensed signal saturation
17 9522276 Accelerometer integrity alert
18 9522225 Adhesive patch systems and methods
19 9522223 Systems for fluid reservoir retention
Transcatheter prosthetic heart valve delivery system with recapturing feature and
20 9522063
method
21 9522062 Mitral prosthesis and methods for implantation
22 9522030 Purge phase for cryoablation systems
23 9521979 Control of spectral agressors in a physiological signal monitoring device
24 9518813 Sensing systems and methods
25 9517352 Accessory apparatus for improved recharging of implantable medical device
26 9517341 Lead electrode for use in an MRI-safe implantable medical device
Electrode assemblies and associated fixation members for implantable medical
27 9517336
devices
Anchors including rigid bodies defining full length slots for use with implantable
28 9517332
medical leads
Coordination of control commands and controller disable messages in a medical
29 9517304
device system
30 9517303 Reservoir plunger position monitoring and medical device incorporating same
31 9517299 Smart connection interface
32 9517074 Surgical cutting instrument with near-perimeter interlocking coupling arrangement
33 9517032 Sensor over-mold shape
34 9513104 Systems and methods for alignment and detection of a consumable component
Criteria for optimal electrical resynchronization derived from multipolar leads or
35 9511234
multiple electrodes during biventricular pacing
36 9511233 Systems and methods for leadless cardiac resynchronization therapy
37 9511217 Arcuate introducer
38 9511178 Reducing centrifugal pump bearing wear through dynamic magnetic coupling
39 9510943 Stented heart valve devices and methods for atrioventricular valve replacement
40 9510888 Cryogenic balloon device with electroporation treatment region
41 9510777 Monitoring of neuromodulation using biomarkers
42 9510773 Multi-electrode apposition judgment using pressure elements
43 9510763 Assessing intra-cardiac activation patterns and electrical dyssynchrony
Methods of dimensionally stabilizing a lumen of a multi-lumen device during
44 9505159
manufacture
45 9504837 Automated phrenic nerve stimulation and pacing capture threshold test
46 9504820 System and method for implantation of an implantable medical device
47 9504572 Apparatus and methods for creating a venous valve from autologous tissue
48 9504569 Transapical delivery device and method of use
49 9504568 Replacement prosthetic heart valves and methods of implantation
50 9504564 Heart valve prosthesis and methods of manufacture and use
Table 66
Top 50 Medical Device Patents issued to Medtronic, 2017

1 9849295 User interface with 3D environment for configuring stimulation therapy
2 9849293 Brain stimulation programming
3 9849279 Lead delivery device and method
4 9849240 Data modification for predictive operations and devices incorporating same
Generation and application of an insulin limit for a closed-loop operating mode of an
5 9849239
insulin infusion system
6 9849010 Method of forming a nitinol stent
7 9849009 Method of forming a nitinol stent
8 9848950 Methods and devices for localized disease treatment by ablation
9 9848869 Prosthesis systems and methods
10 9848805 Biostable glucose permeable polymer
11 9848779 Separable monitoring device and method
12 9848778 Method and device to monitor patients with kidney disease
13 9848604 Antimicrobial wash
Systems, apparatus and methods facilitating communication between an implantable
14 9844676
device and an external device
Enabling and disabling anti-tachyarrhythmia pacing in a concomitant medical device
15 9844675
system
16 9844667 System for conditioning surfaces in vivo
17 9844664 Interventional medical systems, catheters, and subassemblies
18 9844659 Implantable medical device fixation
19 9844643 Catheters with enhanced flexibility and associated devices, systems, and methods
20 9843067 Methods for electrode assemblies including at least one insulative portion
21 9841014 Insulin pump data acquisition device and system
22 9839784 Identifying lead insulation breaches and externalization of lead conductors
Magnetic field detectors, implantable medical devices, and related methods that utilize
23 9839783
a suspended proof mass and magnetically sensitive material
24 9839766 Centering coiled guide
25 9839753 Systems for managing reservoir chamber pressure
Flanged sealing element and needle guide pin assembly for a fluid infusion device
26 9839741
having a needled fluid reservoir
27 9839542 Mobile external coupling for branch vessel connection
Optical systems and methods for ratiometric measurement of blood glucose
28 9839378
concentration
29 9835580 Methods and systems for detecting the hydration of sensors
Facilitating integrity of telemetry connectivity between an implantable device and a
30 9833628
remote device
31 9833625 Implantable medical device delivery with inner and outer sheaths
32 9833616 System and method for cardiac lead
33 9833564 Fluid conduit assembly with air venting features
34 9833563 Systems for managing reservoir chamber pressure
35 9832867 Embedded metallic structures in glass
36 9827367 Surgical instrument, system, and method for frontal sinus irrigation
37 9827361 pH buffer measurement system for hemodialysis systems
38 9827097 Sinus-engaging valve fixation member
39 9827090 Prosthetic heart valve devices and methods of valve replacement
40 9827063 Hybrid sealed tray for long catheter delivery systems
41 9827042 Renal neuromodulation methods and devices for treatment of polycystic kidney disease
42 9827041 Balloon catheter apparatuses for renal denervation
43 9827040 Methods and apparatus for intravascularly-induced neuromodulation
44 9826963 Minimally invasive implantable neurostimulation system
45 9821166 Indication of coupling between medical devices
46 9821162 Deep brain stimulation for sleep disorders
Inductively rechargeable external energy source, charger, system and method for a
47 9821112
transcutaneous inductive charger for an implantable medical device
48 9820803 Subxiphoid connective lesion ablation system and method
Apparatus and method for mechanically providing power to a generator on a
49 9820708
continuous rotatable rotor of an X-ray scanner
Implantable medical devices including elongated conductor bodies that facilitate device
50 9819135
and lead configuration variants
Chapter 8
Pipeline Analysis
Chapter 8: Pipeline Analysis
Definition of Pipeline
A pipeline product is a series of products, either in a state of development, preparation, or production,
developed and sold by a company, and ideally in different stages of the product’s life cycle.
Need for Novelty/Pipeline Products

Most companies’ have a strategic goal to have some products in the growth stage, which is the key stage
for establishing a product's position in a market, increasing sales, and improving profit margins; and in
the maturity stage, which is key to maintaining market share. In the healthcare industry, most
importantly in the medical devices sector, the products can spend a decade or more in the pipeline.
A concept of having a product as a part of the pipeline usually begins with brainstorming by the
companies to come up with new ideas for possible products that a firm can add to its product portfolio
that meets unmet demand in a market and gain or withstand the market share.
Pipeline Analysis
In the patent analysis section, this report attempts to depict the key player’s research interests and
pipeline product listing. This following report identifies products in the pipelines of various companies
leading this market.
Table 67
Pipeline products of Key Players
Stage Product Name Company

Clinical Pulse Oximeter with Universal Sensor Medtronic Plc
On Hold INVOS System-Cerebral Autoregulation Medtronic Plc
Capnostream 35 Portable Respiratory
Approved Medtronic Plc
Monitor
ARROW JACC Nurse Insertion CVC
Late Stage Clinical and Inactive Teleflex Inc
System
Inactive CorAide Left Ventricular Assist Systems Teleflex Inc
Clinical Double-Sided Mesh Teleflex Inc
Under Approval Process Mobi ResMed Inc
Fisher and Paykel Healthcare
Under Approval Process SleepStyle CPAP Device
Corporation
Fisher and Paykel Healthcare
Clinical, Under Approval Process F&P 950 Heated Humidification System
Corporation
Clinical Ventilator-Neonates GE Healthcare
In a highly competitive business like the medical devices sector, the need for innovative products in any
market segment is required. It was observed that the pipeline products are low in number at this period
but with the strong patent portfolio of the companies, it is expected that the companies are being
futuristic and will gain a robust pipeline to maintain or increase their market share.
It is anticipated that all the products currently in the early stages of development by the key players will
progress drastically towards clinical development and regulatory pathways when compared to previous
generations. This is because standardized healthcare systems are emerging in markets and there are
reduced local approval challenges.
Chapter 9
Company Share Analysis
Chapter 9: Company Share Analysis
Industry Scenario
The anesthesia and respiratory devices industry is a competition of a variety of U.S. and non-U.S.
companies and services providers. Customers/healthcare providers require products and services that
allow them to provide better access to healthcare, improve the affordability of care, and improve the
quality of patient outcomes.
Technology upgrades and innovative solutions are employed by the manufacturers to provide products
that meet these customer requirements while maintaining cost effectiveness. Every product that is
being sold or that is scheduled to enter the market is subject to regulation by numerous government
agencies, including the USFDA, as well as various laws and regulations that apply to claims submitted
under Medicare, Medicaid or other government funded healthcare programs.
Controlling Factors
The medical device industry grew at a growth rate of 4%. It was observed that manufacturers especially
in the Anesthesia and Respiratory devices business segment experienced decreases in revenues or
minimal growth. A few factors that controlled this market are mentioned below:
• The effects of inflation and the impact of a stronger U.S. dollar compared to foreign currencies.
• Lower prices because of competitor pricing pressure.
• Decreased research and development budgets reported by many companies because of a hike
in the cost of production.
• Increased labor costs and need for automation of industrial technology upgrades which incurred
increased operational costs.
• Stagnant national healthcare budgets in most of the EU and in developing countries in recent
years have created pressure on prices in most of the products.
• Market conditions are experiencing dynamic shifts and becoming a harder environment for the
manufacturers, and the competition for market share is intense.
• An emphasis by regulatory agencies on stricter standards is being imposed on suppliers.
• Regulatory constraints have been continuously affecting the market and especially the local
registration of novel products remains a challenge, often taking years.
• Few companies, especially the leading companies, are still suffering with complex sales and
contracting models. This is based on aged sales strategies and an inability to reach the dynamic
mindsets of start-up or fast progressing companies.
• Increased import and export costs and taxes by many governments across the globe.
Market Opportunities
The anesthesia and respiratory devices industry observed a sluggish growth from 2016 to 2017.
Numerous controlling factors listed above have accounted to the decline of the growth rate. However,
the positive side is that the sector is a well-established market and multiple probing drivers offer
multiple opportunities.
Scope for Product Innovations

The anesthesia and respiratory devices industry is refined and receptive to novel products. There is a
consistent demand for a full range of medical devices, particularly those intended to treat and manage
age-related diseases and chronic respiratory conditions.
The majority of the key players including Philips Respironics, ResMed, Medtronic, Ambu A/S and Fisher
and Paykel Healthcare have adopted strategies to invest significant resources on the development of
new product ranges that are highly efficient and cost-saving. This can be proven by the increase in the
research and development budgets of most of the companies; additionally the companies are
aggressively working towards reducing costs of production through employing the latest cost-effective
techniques. The rise in the number of patents filed or consistent patent filing or issuance patterns of the
manufacturers clearly demonstrate the vision towards product innovations. Several countries have
implemented encouraging strategies as a process of uplifting the local companies or research institutes
to dominate or aid market growth through their innovations.
Emerging Markets: A New Ray of Hope for Struggling Manufacturers

With changing global demographics, slashing or stagnating economies and the potential risks anticipated
in the developed or key markets like North America and Europe, the medical device manufacturers are
shifting their focus towards progressing markets. Asia-Pacific is the highest potential growth zone with
an abundant scope for dynamic business. Most importantly, holding the world’s two highest populated
countries on the globe, China and India, has turned Asia-Pacific into a magnet for investments and is
attracting manufacturers to enter the business. A few factors that prove Asia-Pacific as a better outlook
for the market are:
• Reduced cost of production when compared to other zones in terms of establishment costs and
availability of skilled labor.
• Cost effective sales and marketing capabilities because of the low-cost of workforce and
operations compared to western counterparts.
• Encouraging government policies, like the “Make in India” Initiative of the government of India
to welcome manufacturers and provide cost-effective production units with numerous
subsidized benefits.
• A change in the stern regulatory pathways to move products to market especially China and
India.
• Increase in the country level GDPs and healthcare spends.
• Increase in reimbursement and insurance coverage.
• Promising socioeconomic development and political scenario.
• Increasing demand for single-use devices in all regions. This is because of low production costs
incurred, increased demand, less opportunities of contamination and increased patient safety;
most of the companies are exploring options to design, deliver and market cost-efficient single-
use devices.
Competitor Market Share

The competitor market share data is intended to represent the companies that gain the most revenues
from the given market and the percentage share of the market that they hold. If a company derives
most of its revenues from the market, its revenues are given in full. If a large part of the company's
revenues come from other markets, only the division of the company which operates in this market is
included. Where accurate information is not available on the revenues a company generates from the
market its market share is not included, however a profile of the company may still be included if it is a
significant competitor in the market.
Figure 46
Global Market Share for Anesthesia and Respiratory Devices, by Company, 2016
(%)
Others and Local

Armstrong Medical Medtronic
Players
0.1% 12.5% Smiths Medical
15.0%
1.5%
Medline Industries
Inc
5.0% Philips Respironics
9.5%
Masimo Corp
1.7% Teleflex
GE Healthcare LLC 2.8%
11.4% Ambu A/S
1.4%
Fisher and Paykel ResMed Inc
Healthcare 10.3%
Corporation Ltd Draegerwerk AG &
3.0% Co. KGaA
BD Diagnostic 8.0%
Systems
B. Braun Medical Inc
6.0% Halyard Health Inc Invacare 8.7%
1.6% Corporation
1.5%
Source: Company Annual Reports & BCC Research
Key companies that account for the anesthesia and respiratory market, and the percent of their market
share for 2016, are:
• Medtronic plc -13%

• GE Healthcare -11%
• ResMed -10%
• Philips Respironics, Inc-9%
• B. Braun Melsungen AG-9%
• Draegerwerk AG & Co. KGaA-8%
• Becton and Dickson Diagnostic Company-6%
• Medline Industries -5%
• Teleflex Incorporated -3%
• Fisher & Paykel Healthcare Corporation Limited -3%
• Smiths Medical, Ambu A/S, Masimo, Halyard Healthcare & Invacare (together account about 5-
6%)
With increasing competition, an increase in the number of emerging companies and strengthening local
or country level players, the market share for other companies and local manufacturers was estimated
as 15%.
Table 68
Global Market for Anesthesia and Respiratory Devices , by Company, 2016
($ Millions)
Company Estimated Revenue
Medtronic 2,520.0
Smiths Medical 300.0
Philips Respironics 1,900.0
Teleflex 560.4
Ambu A/S 276.7
ResMed Inc 2,066.7
Draegerwerk AG & Co 1,596.5
B. Braun Medical Inc 1,740.0
Invacare Corporation 300
Halyard Health Inc 318.4
BD Diagnostic Systems 1,209.0
Fisher and Paykel 603.2
GE Healthcare LLC 2,286.3
Masimo Corp 347.3
Medline Industries Inc 1,012.0
Armstrong Medical 15.0
Others and Local Players 3,000.0
Total Anesthesia and Respiratory Devices Market 20,051.5
Source: Company Annual Reports & BCC Research
Chapter 10
Company Profiles
Chapter 10: Company Profiles
AMBU A/S
Baltorpbakken 13
DK-2750 Ballerup
Denmark
Tel: 45-7225-2000, Fax: 45-7225-2050
Website: https://www.ambu.com/
Company Location
Ambu is headquartered in Ballerup, Denmark. It has production and research and development facilities
in China, Malaysia, the U.K., Denmark and the U.S. Ambu sells its products through its direct sales force
in and a network of distributors worldwide
Company Background
Ambu A/S (Ambu) is a medical device company with focus on anesthesia, patient monitoring and
diagnostics, and emergency care. It manufactures and markets life supporting devices, catering to
hospitals, clinics, sleep laboratories and rescue services. The company focuses on production of single
use anesthesia and respiratory products. The company currently consists of over 25,000 employees.
In 1937, Testa Laboratory was founded by an engineer named Holger Hesse. Later in 1986, the company
was renamed as Ambu. The Sicca Haemometer was the first product developed by the company that
enabled private practitioners to measure the amount of hemoglobin in the blood without having to send
a blood sample to an external laboratory. In 1956, Testa developed the world’s first self-inflating
resuscitator bag in collaboration with anaesthetist Henning Ruben. This turned out to be a revolution
and the bag and few more products of the company were used extensively by hospitals and clinics.
In 2001, Ambu acquired Medicotest, the largest European manufacturer of electrodes. With the
acquisition the company had large portfolio of quality electrodes called BlueSensor. With this
acquisition, Ambu expanded its production base from Denmark to Malaysia and China.
In 2009, Ambu launched the world’s first single-use flexible videoscope Ambu aScope. In 2013, Ambu
acquired US based King Systems Corp, a manufacturer and distributor of airway management,
anesthesia and respiratory devices.
Financials
In 2017, Ambu A/S reported an annual revenue of US$ 386.1 million (DKK 2355 millions) for the FY 2016.
There was a significant growth of 14% when compared to FY 2015. Below is a representation of the
company’s financial performance for last five years:
Figure 47
Ambu A/S Company Financial Performance, 2012-2016
($ Millions)
450
400
350
300
$ Millions
250
200
150
100
50
0
2012 2013 2014 2015 2016
Below is the segmental share of company’s 2016 revenue.
Figure 48
Ambu A/S Revenue Share, by Business Unit, 2016
(%)
Patient Monitoring
and Diagnostics
36%
Anesthesia
64%
Product Portfolio
Ambu A/S (Ambu) is a medical device company with focus on anesthesia, patient monitoring and
diagnostics, and emergency care. The products of the company are segregated by category of usage as
below:
• Anesthesia.
• Face Masks.
• Resuscitators.
• Breathing bags.
Airway management:
• Video Laryngoscopes.
• Double Lumen tube with Integrated Camera.
• Endobronchial Blocker.
• Laryngeal Masks.
• Flexible endoscopes
• Bronchoscope
• Cardiology
• ECG Electrodes
Neurology:
• EEG electrodes.
• EMG electrodes.
• EMG guided injections.
• IOM.
• Sleep.
Emergency Care and Training

• Training Manikins.
• CPR Breathing Barriers.
• Head Immobilizers.
• Extrication Collars.
• Suction Pumps.
• Resuscitators.
• Video Laryngoscopes.
B. BRAUN MELSUNGEN AG
Carl-Braun-Strasse
34212 Melsungen
Germany
Tel: 49-0-56 61-71-0, Fax: 49-0-56-61-71-45-67
Website: www.bbraun.com/
Company Location
B. Braun is headquartered in Melsungen, Germany. It operates in Europe, the Americas, Asia-Pacific,
Africa and the Middle East. B Braun currently operates in 64 countries across the globe.
Company Background
B. Braun Melsungen AG (B. Braun) is a global healthcare company which was founded in 1839. It
markets and sells products and services catering to basic healthcare, intensive care units, anesthesia and
emergency care sectors. The company also provides solutions for extracorporeal blood treatment and
core surgical procedures. The company currently consists of 58,000 employees globally.
The company operates in four business divisions:

• Hospital Care division, which supplies the hospitals with infusion, injection solutions and
disposable medical products.
• Aesculap division, which supplies products and services for all the core processes in surgery.
• Out Patient Market (OPM) division suppling medical products outside the hospital for
chronically ill and long-term care patients.
• B. Braun Avitum division compiles the product and services concerning extra-corporeal blood
treatment.
Financials
In 2017, B. Braun reported an annual revenue of US$ 7968.6 million (EUR 6471 million) for FY 2016. The
company observed a growth of 5.6% when compared to FY 2015. Below is a representation of the
company’s financial performance for last two years.
Figure 49
B. Braun Company Revenues, 2015 & 2016
($ Millions)
8,100.0
8,000.0
7,900.0
7,800.0
$ Millions
7,700.0
7,600.0
7,500.0
7,400.0
7,300.0
2015 2016
Germany, being the company’s base B. Braun holds a major share in the whole healthcare market of the
country. Hence, the company depicts Germany as a separate region in terms of revenue generation.
Below is the regional revenue split for the year 2016:
Figure 50
B. Braun Revenue Share, by Region, 2016
(%)
Africa and Middle East

3%
Germany
17%
Latin America
6%
Asia Pacific
18%
Europe
32%
North America
24%
B. Braun operates in four divisions namely Hospital Care, Aesculap division, Out Patient Market and B.
Braun Avitum. Below is the financial performance at a divisional level for 2016:
Figure 51
B. Braun Revenue Share, by Business Unit, 2016
(%)
Avitum
15%
OPM
12%
Hospital Care
46%
Aesculap
27%
Product portfolio
Based on therapy area, the products offered by the company are categorized as:
• Cardio-Thoracic Surgery.
• Continence Care & Urology.
• Degenerative Spinal Disorders.
• Diabetes Care.
• Extracorporeal Blood Treatment.
• General Open Surgery.
• Infection Prevention.
• Infusion Therapy.
• Interventional Vascular Diagnostics and Therapy.
• Laparoscopic Surgery.
• Neurosurgery.
• Nutrition Therapy.
• Orthopaedic Joint Replacement.
• Pain Therapy.
• Ostomy Care.
• Wound Management Services.
For each of the above therapy areas, the company offers a robust range of injectables, devices,
consumables and disposables.
Anesthesia Portfolio
B. Braun consists of multiple products that assists regional anesthesia. Below are few products marketed
by the company:
• Epidural anesthesia catheters including Perifix FX Springwound, Perifix ONE, Perifix SoftTip and
Perifix.
• Perifix epidural needles and Epican short length needles.
• Spinal Needles- Pencil-Point (Pencan) and Quincke (Spinocan) range of needles for spinal
anesthesia.
• Spinal Trays (Kits)-Consists of collection of drugs, needles and basic spinal anesthesia aids.
• Spinal anesthesia accessories- Includes glass syringe and introducer needles.
• Combined spinal epidural (CSE) needles- Espocan, a range of precision needles used for CSE.
• CSE Kits- Consists of Espocan Tuohy needle, Spinocan needle, spinal syringe and basic CSE aids.
• Peripheral Nerve Block needles-A range of Stimuplex and Ultraplex needles which are
stimulating, non-stimulating and echogenic single shot needles to suit all clinical preferences.
• Continuous Nerve Block Sets and Trays (Kits)- Contiplex, a range of stimulating, non-stimulating
and echogenic nerve block catheters.
• Nerve Block Support Trays (Kits).
• Monitoring Accessories- B-Smart Injection Pressure Monitor, Stimuplex HNS12 Nerve Stimulator
and other peripheral nerve block accessories.
• Xperius Ultrasound System- A mobile system from B. Braun and Philips, specifically designed for
ultra-sound guided regional anesthesia.
BECTON, DICKINSON AND CO.

1BectonDr.
Franklin Lakes, NJ 07417-1880
Tel:201/847-6800
Website: www.bd.com/
Company Location
Becton and Dickinson (B&D) is headquartered in New Jersey, U.S. and currently operates in more than
50 countries.
Company Background
Becton and Dickinson and Company is engaged in the development and manufacture of medical devices,
instrument systems, and reagents. The area of focus for the company is on drug delivery, diagnosing
infectious diseases, cancer, and the development of drugs and vaccines. It employs more than 40,000
people and improves the efficiency, healthcare outcomes, healthcare safety, and access to health.
The company’s operations consist of two business segments: BD Medical and BD Life Sciences. BD
Medical’s segments engage in the development and manufacture of broad array of medical devices
catering to the needs of the hospitals, government and non-profitable organizations, and
pharmaceutical companies. The BD Medical segment is itself divided into the following divisions each
catering to its respective target audiences: Diabetes Care, Medication and Procedural Solutions,
Medication Management Solutions, and Pharmaceutical Systems. The BD Life Sciences segment engages
in development and manufacture of products for collection of diagnostic specimens, diagnostic systems
for infectious disease and cancer testing. Further the unit also manufactures all the life science units
catering to the needs of advanced biological research and development activities. The BD Life Sciences
segment offers these products through its smaller units namely Preanalytical Systems, Diagnostic
Systems, and Biosciences.
Financials
Table 69
B&D Company Revenue, 2014-2016
($ Millions)
Particulars 2016 2015 2014

Revenue ($ Millions) 12,483 10,282 8,446
Operating income 1,430 1,074 1,606
Source- Company Annual Report
Figure 52
B&D Revenue Share, by Business Segment, 2014-2016
($ Millions)
10,000.0
9,000.0
8,000.0
7,000.0
6,000.0
$ Millions
5,000.0
4,000.0
3,000.0
2,000.0
1,000.0
0.0
2014 2015 2016
Medical Life Sciences
Figure 53
B&D Revenue, by Region, 2014-2016
($ Millions)
8,000.0
7,000.0
6,000.0
5,000.0
$ Millions
4,000.0
3,000.0
2,000.0
1,000.0
0.0
2014 2015 2016
U.S Europe Asia Others
Product portfolio
BD offers anesthesia products through its BD Medical business segment. It offers regional anesthesia
products for epidural and combined spinal-epidural (CSE) procedures. The products include needles,
syringes and trays.
Table 70
B&D Product Portfolio
Product Description
The set consists of the traditional BD CSE products and key
BD Durasafe Plus epidural lock CSE needle set
design elements.
It consists of a double-ribbed stopper designed for prevent
BD Epilor plastic LOR syringe
leakage during aspiration.
It features a smooth moving plunger designed to locate
BD glass LOR syringe
epidural space.
It features a calibrated needle depth marking for placing the
BD Perisafe modified Tuohy point epidural
needle tactile. The needles are tougher than standard needles
needles
for penetrating tough tissue.
BD Perisafe tactile Tuohy epidural needles The needle features a secondary bevel point geometry.
CSE tray is a single deck tray consisting of a removable basin
Regional anesthesia trays CSE tray
catheter connector, sharps stick pads and a caution belt.
Contains a wide array of precision components and
Continuous epidural and single-shot trays
accessories.
These trays are designed for keeping procedural syringes,
Nerve block trays
needles and extension sets.
Standard components of regional anesthesia They contain prep section, povidone-iodine (PVP-I) topical
trays solution and a fenestrated drape.
Source-Company Website
DRAEGERWERK AG & CO. KGAA

Moislinger Allee 53-55
23558 Lubeck
Germany
Tel: 49 451-882-0, Fax: 49 451-882-2080
Website: https://www.draeger.com/en_corp/Home
Company Location
Draegerwerk is headquartered in Lubeck, Germany. The company has development and production
facilities in Germany, the U.K., Sweden, Czech Republic, South Africa, the U.S., Brazil and China. It
operates in more than 190 countries and has sales and service subsidiaries in more than 50 countries.
Company Background
Draegerwerk AG & Co. KGaA (Draegerwerk) is a medical devices and safety technology provider. It
develops, produces and markets system solutions, equipment and services for the acute point of care
(APOC) process chain including emergency care, perioperative care, critical care, perinatal care and
home care. It also develops safety equipment, system solutions and services for individual personal
protection, stationary and mobile gas detection technology, and integrated hazard management.
Drager was found in 1889 by Johann Heinrich Drager, later turned into a family business which is
currently managed by the fifth generation by the current CEO Stefan Drager. The company’s journey
started with filing the first patent for Lubeca valve which regulates the gas pressure. Since 1902, the
company has been involved in anesthesia solutions.
Financials
In 2017, the company reported its revenue for the financial year 2016 as US$ 3120.4 million (EUR 2538.7
million), which was a minimal increment of 0.3% when compared to 2015.
Figure 54
Draegerwerk Annual Revenue, 2015 and 2016
($ Millions)
3,122.0
3,120.0
3,118.0
$ Millions
3,116.0
3,114.0
3,112.0
3,110.0
3,108.0
2015 2016
Source: Company Annual report
Being Europe based, the company’s revenue generation was more centric to the Europe. Below is the
regional revenue split for 2016:
Figure 55
Draegerwerk Revenue Share, by Region, 2016
(%)
Africa, Asia and

Australia
25%
Europe
55%
Americas
20%
Europe consisted of 55% of the company’s sales followed by Asia, Africa and Australia (25%) and the
Americas (20%).
Product portfolio
• Ventilation equipment- Draegerwerk offers a range of products for adult and pediatric ICU
ventilation, neonatal ICU ventilation, sub-acute care ventilation.
• Respiratory Care Solutions.
• Apollo Anesthesia workstation- This is an integrated workstation developed and sold by the
company across the globe. It is a simplified anesthesia workstation with reduced complexity and
enables hassle free experience to the anesthetists.
• Fabius GS premium- This is a ventilator support system which provides the customizing options
for ventilation as per doctor’s choice.
• Fabius MRI- This works similar to other Fabius ventilator support systems, this system is
designed to work under MRI atmosphere.
• Fabius Tiro- A ventilator support system which is compact in size and integrates with any gas
delivery system.
• Fabius Tiro M- A mobile ventilator system which is extensively used by military anesthetists in
held operations. This is a very light and mobile in nature.
• D-Vapor/Vapor 2000- This is a gas delivery platform which has an integrated nebulizer and
humidifier.
• Scio- This is a gas analyzer system which offers flexible gas analysis options.
Key Product Developments-

In 2016, the company launched 7 new and extended devices, and 5 new accessory products into the
market. In 2017, are few launches made by the company included:
Draegerwerk launched Babyleo TN500 IncuWarmer which provides optimal conditions for neonatal care.
Launch of ClassicStar- New noninvasive ventilation mask with silicone sealing lip designed for better
patient experience.
Oxylog VE300- A dynamic and small sized ventilator that is useful for emergency conditions.
FISHER & PAYKEL HEALTHCARE

15 Maurice Paykel Pl.
East Tamaki, Auckland 2013
P.o. Box 14 348
Panmure, Auckland 1 741
New Zealand
Tel: 64-9-574-0100, Fax: 64-9-574-0158
Website: www.fphcare.com/
Company Location
Fisher & Paykel is headquartered in Auckland, New Zealand. The company has a large network of sales
offices and distributors for a presence in more than 120 countries.
Company Background
Fisher & Paykel Healthcare Corporation Limited (F&P) is a medical devices company. It undertakes the
design, manufacture and marketing of heated humidification products and systems for use in respiratory
care and the treatment of obstructive sleep apnea. The company also offers a broad range of neonatal
care products.
The company was started in 1934, as an importer of refrigerators and washing machines. In 1938, F&P
started manufacturing white-ware to several major international appliance companies and in 1960, the
company started manufacturing products using in-house technology. In 1968, the company started
producing respiratory aids and later the company’s only focus of business turned out to be respiratory
devices and sleep devices. As of 2017, the company employed 4112 people who are based in 36
countries.
Financials
In 2018, the company reported annual revenue of US$ 651.3 million (NZ$ 894.4 million) for the FY 2017,
an increase of 9.6% when compared to FY 2016. Below is a graphical representation of company’s
financial performance.
Figure 56
Fisher & Paykel Annual Revenue, 2014-2017
($ Millions)
700
600
500
$ Millions
400
300
200
100
0
2014 2015 2016 2017
Figure 57
Fisher and Paykel Revenue Share, by Region, 2017
(%)
Other
4%
Asia Pacific
17%
North America
49%
Europe
30%
Product portfolio
The company offers more than 2900 products in its product offering. In terms of mode of usage the
company’s products are segregated as homecare and hospital products. More than 50% of the
company’s revenue is from the hospital care products.
This includes accessories, spares, consumables and devices.
• Masks-Fisher & Paykel offers a variety of masks that would suffice the respiratory support
functions for various conditions. Most of the masks are developed by the company’s FlexiFit
technology. Some of the key product among this range are-
• AcIaim2 Nasal Mask- An overhead mask specially designed with Glider strap mechanism offers
better hold and stability.
• Eson Nasal Masks- This is a product line includes the FlexiFit 406 Petite Nasal Mask, FlexiFit
• 405 Nasal Mask, FlexiFit 407 Nasal Mask and FlexiFit 432 Full Face Mask.
• Infant nasal mask-As the name signifies, the company offers a huge range of nasal masks that
specially suits the respiratory needs of infants and neonatal care.
• Breathing circuits- Breathing circuits play a significant role in providing artificial respiration or
respiratory support to the patients. Fisher and Paykel offers a various product under this
category, few of the key products are:
• Bubble CPAP system. The system comes with Bubble CPAP generator, heated breathing
• circuits, humidification chamber and pressure manifold.
• CPAP Breathing Circuit Kits with PEEP Valve.
• Evaqua Breathing Circuits- It allows water vagar diffusion through the tubing wall.
• Infant breathing circuit adaptors.
• Inspiratorv/expiratorv breathing circuit filters.
• Nasal cannulas- Nasal cannulas are the consumables which are frequently used as a process of
providing respiratory support. The company offers various types of nasal cannulas those differ in
size, make and quality. Key products in this range are:
• Infant Nasal CannuIa—Equipped with a shorter oxygen delivery tube.
• Optiflow Junior Nasal CannuIa—Designed for neonatal and pediatric patents.
• Optiflow Nasal CannuIa—A special range of nasal cannulas offered by Fisher & Paykel
Healthcare systems those provide optimally humidified respiratory gas at a wide range of flows.
GE HEALTHCARE
945 N Edgewood Ave # A1,
Wood Dale, IL 60191
Tel: +1 630-595-6642, Fax: 910/392-8159
Website: http://www3.gehealthcare.com/en/global_gateway
Company Location
General Electronics (GE) Healthcare is headquartered in Chicago, IL, USA. In 2016, as a part of company’s
strategic decision the company’s headquarters were moved from Little Chalfont, United Kingdom to
Chicago, US. GE's products and services reach more than 100 countries.
Company Background & Overview
GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient
monitoring systems, drug discovery, biopharmaceutical manufacturing technologies and performance
improvement and performance solutions services.
The company’s history started in 1903 as a company named Victor Electric from Chicago, US. Initially this
company was solely focused in developing X-ray tube and basic diagnostic imaging components. For the
next 20 years the company had grown regressively by various acquisitions that included Western Electric
Coil Co, MacAlaster & Wiggin, Radio Electric Co and Scheidel Western X-Ray Coil Co. Since 1920, General
Electronics was actively partnered with Victor Electric for various business deals and in 1926, the
company became a wholly owned subsidiary of GE. Initially the company was named as General Electric
X-Ray Corporation, later company observed abundant misuse of x-ray technology for World War II and
then renamed the company as GE Medical Systems. Since then the company progressed aggressively in
the medical technology business and transformed into a leading player in global medical devices
industry.
The company also partners with other healthcare companies to innovate.
Table 71
GE Healthcare List of Subsidiaries
Asymptote Ltd. Caradigm USA LLC Dynamic Imaging, LLC

Amersham Biosafe SA Kretztechnik AG
Biacore GE Medical Systems, LLC Living Independently Group, Inc
API Healthcare ONI Medical Systems Parallel Design, Inc
Medi-Physics, Inc. Asymptote Ltd. GE Healthcare Danmark A/S
Wipro GE Healthcare Pvt. Ltd. GE Imatron General Electric Portuguesa S.A.
GE Healthcare Bio Sciences AB GE Healthcare Holdings Inc.
Puridify Limited
GE Medical Systems Lunar Wave Biotech, LLC SerphyDose SARL
GE Medical Systems Oxford Magnets Coincidence Technologies S.A.

Ambassador Medical, LLC
Limited
General Electric Medical Systems GE Healthcare Funding Ireland
MEDIMEX GmbH & Co. KG
Israel Ltd.
Nihon Medi-Physics Co.,Ltd. GE OEC Medical Systems GmbH SeqWright, Inc.
Agility Healthcare Solutions, LLC GE Medical Systems Polska Sp. z VersaMed Medical Systems, LLC
Source: Company website
Financials
For the FY2016, GE’s total revenue (including Industrial sectors revenue only) was US $113.1 billion.
Below is a graphical representation of financial performance of GE for years 2012-2016.
Figure 58
GE Annual Revenue, 2012-2016
($ Millions)
1,14,000.0
1,12,000.0
1,10,000.0
1,08,000.0
$ Millions
1,06,000.0
1,04,000.0
1,02,000.0
1,00,000.0
98,000.0
96,000.0
2012 2013 2014 2015 2016
Figure 59
GE Revenue Share, by Business Unit, 2016
(%)
Energy Connections
& Lighting
14% Power
Transportation 24%
4%
Healthcare
16% Renewable Energy
8%
Oil & Gas

Aviation 11%
23%
GE Healthcare Financials
In 2016, the Healthcare division reported a revenue of US$ 18.3 Billion. The U.S. is a key market for the
company with a share of 46% followed by Asia with 24% and Europe 20%. Below is a snapshot of the GE
Healthcare’s geographic revenue breakdown.
Figure 60
GE Healthcare Market Share, by Region, 2016
(%)
MEA
Americas 5%
5%
Europe
20%
USA
46%
Asia
24%
Source: Company Annual SEC File
The GE Healthcare operates in three segments namely Healthcare Systems, Life Sciences and Healthcare
Digital. Revenue from medical device sale was US$ 10.4 Billion. Below is a sub-segmental share of GE
Healthcare’s revenue:
Figure 61
GE Healthcare Revenue Share, by Product Division, 2016
(%)
Healthcare Digital
7%
Life Sciences
23%
Healthcare Systems
70%
Product Portfolio
GE Healthcare provides essential healthcare technologies to developed and emerging markets and has
expertise in medical imaging, digital solutions, patient monitoring and diagnostics, drug discovery,
biopharmaceutical manufacturing technologies and performance improvement solutions. Products and
services are sold worldwide primarily to hospitals, medical facilities, pharmaceutical and biotechnology
companies, and to the life science research market.
• Healthcare Systems – provides a wide range of technologies and services that include diagnostic
imaging and clinical systems.
• Diagnostic imaging systems such as X-ray, digital mammography, computed tomography (CT),
magnetic resonance (MR), surgical and interventional imaging and molecular imaging
technologies allow clinicians to see inside the human body more clearly.
• Clinical systems such as ultrasound, electrocardiography (ECG), bone densitometry, patient
monitoring, incubators and infant warmers, respiratory care, and anesthesia management that
enable clinicians to provide better care for patients every day – from wellness screening to
advanced diagnostics to life-saving treatment.
• Healthcare systems also offers product services that include remote diagnostic and repair
services for medical equipment manufactured by GE and by others.
• Life Sciences – Company designs and produces products, services and manufacturing solutions
for drug discovery, the biopharmaceutical industry and cellular technologies, so scientists and
specialists discover new ways to predict, diagnose and treat disease. It also researches,
manufactures and markets innovative imaging agents used during medical scanning procedures
to highlight organs, tissue and functions inside the human body, to aid physicians in the early
detection, diagnosis and management of disease through advanced in-vivo diagnostics.
• Healthcare Digital – Provides medical technologies, software, analytics, cloud solutions,
implementation and services to drive increased access, enhanced quality and more affordable
healthcare around the world. Healthcare Digital delivers integrated digital solutions that
improve outcomes in industrial, hospital and other healthcare facilities.
Anesthesia and Respiratory Portfolio
• Aespire 7900- This product works with the company’s 7900 SmartVent system ensuring as
effective anesthesia delivery for ambulatory surgery centers. The system also offers cable
management solutions and a large work surface. Other optional integrated features include
auxiliary 02, suction control, and multiple monitoring integration kits.
• Aespire View- Aespire View consists of a 12-inch color ventilator display and equipped with GE's
Advanced Breathing System (ABS). This is especially suited for low flow anesthesia. The Optional
Total Flow Sensing module enables electronic measuring and display of individual gas flow and
total fresh gas flow.
• Aestiva 7900- This system offers an advanced ventilation with a cost-effective approach to
anesthesia therapy. The Aestiva with the 7900 SmartVent enables support varying patent needs.
It is compatible with existing monitors and data management systems.
• Aestiva MRI- This is an advanced MRI-compatible anesthesia system equipped with an

integrated ventilator.
• Aisvs Care- This is a digital controlled machine which measures the ventilation, vaporization and
gas delivery. Enables changes as per requisite functionality.
• Aladin2 Cassettes- These cassettes deliver isoflurane, desflurane and other anesthetic agents.
• Avance Care - Provides anesthesia delivery, anesthesia patent monitoring, and system
information management.
• Avance CSZ - This is a user-friendly interface with a 15-inch touch screen display. Helps in
workflow management. This is an extension of the original Avance Care station.
• Navigator Applications Suite- This product is a digital clinical decision support tool that brings
together information of the patient and health condition. The system consists of Navigator
Therapy, Navigator Protocol and Navigator Device.
• Tec 6 Plus Vaporizer- This electronic vaporizer is used to deliver desflurane. It has an LED display
vaporizer status such as no output, low agent, warm-up, operational and alarm battery low.
• Tec 7 Plus Vaporizer - Used to deliver isoflurane, sevoflurane, enflurane and halothane. Tec 7
does not require factory service.
• Engström Care station- This critical care respirator care station measures functional residual
capacity (FRC), Tracheal pressures among others
• Engström Pro- This is an advanced ventilator providing both Invasive and noninvasive mode of
operations.
HALYARD HEALTH INC.

5405 Windward Parkway
Alpharetta, GA 30004
Tel: 844/425-9273
Website: www.hatyardhealth.com
Company Location
Halyard Health is a medical technology company headquartered in Georgia, U.S.
Company Background
Halyard is focused on advancing health and healthcare by preventing infection, eliminating pain and
speeding recovery. Formerly it was a part of Kimberly-Clark. Halyard Health markets in more than 100
countries and operates 11 global manufacturing facilities. Halyard Health focuses on seven categories of
products. The company delivers products and solutions in infection prevention, surgical solutions,
respiratory health, digestive health and pain management and IV therapy that enable it to provide more
complete, innovative solutions that improve both medical outcomes and business performance.
Financials
Figure 62
Halyard Annual Revenue, 2014-2016
($ Millions)
580
560
540
$ Millions
520
500
480
460
2014 2015 2016
Product Portfolio
Table 72
Halyard Health Product Portfolio
Product Type Description

Equipment that is used in operating rooms.
Surgical Solution products
Products are designed for enteral feeding, diagnostics and
Digestive Health
endoscopy procedures.
Products designed for airway management and pain management
products include tools to manage chronic and surgical pain such as
Respiratory Health products needles, trays, radiofrequency generators, cooled RF treatment
systems, incisional pumps, ambulatory pumps and peripheral block
pumps.
Include equipment designed to protect against contamination and
Infection Prevention products
infections.
Include pumps designed for in-home delivery of IV drugs.
IV Therapy products
Include dressings designed to improve healing and maintain
Wound Care products
moisture.
Source-Company website
INVACARE CORP
1 Invacare Way
Elyria, Ohio
Phone: (800) 333-6900
Website: http://www.invacare.com
Company Location
Invacare Corp is headquartered in Ohio, U.S. The company currently has a presence across 100
countries.
Company Background
Invacare Corp is a leading manufacturer of medical equipment for non-acute care settings. The products
cater to the treatment of medical solutions for congenital, acquired and degenerative ailments. It sells
its products to home medical equipment providers holding ownership of retail and e-commerce
distribution channels, government health services groups in North America, Europe and Asia. The
company employs more than 4500 people.
The company operates in five business segments: Mobility and Seating, Lifestyle Products, Continuing
Care, Respiratory Therapy Products and Others. The Mobility and Seating segment manufactures
mobility support products for patients. The Lifestyle Products business segment offers pressure relieving
overlays, beds, personal care products, and manual wheelchairs. The Respiratory Therapy Products
segment engages in the business of developing and manufacturing of oxygen concentrators for home
and portable use.
Financials
Table 73
Invacare Corp Company Revenue, 2014-2016
($ Millions)

Revenue ($ Millions) 1,047 1,142 1,270
Gross profit ($ Millions) 283 312 347
Operating Loss ($ Millions) (15.2) (7.7) (58.8)
Source-Company Annual Report
Figure 63
Invacare Corp Revenue Share, by Business Unit, 2014-2016
($ Millions)
700.0
600.0
500.0
$ Millions
400.0
300.0
200.0
100.0
0.0
2014 2015 2016
Lifestyle Products Mobility and Seating Continuing care
Figure 64
Invacare Corp Revenue Share, by Region, 2014-2016,
($ Millions)
1,400.0
1,200.0
1,000.0
$ Millions
800.0
600.0
400.0
200.0
0.0
2014 2015 2016
North America Europe Asia-Pacific
Product portfolio
Table 74
Invacare Corp Product Portfolio
Product Description
It is an ambulatory oxygen allowing patients to fill their own cylinders. They
Invacare HomeFill Oxygen System
reduce the costs by eliminating the cylinder deliveries.
Invacare SOLO2 Transportable
Portable and used by customers with an active lifestyle.
Oxygen Concentrator
Aerosol Products and Oxygen Consists of nebulizers, compressed oxygen, cylinders, pulse oximeters, and
Accessories stationary products.
Source: Company website
MEDTRONIC
710 Medtronic Parkway
Minneapolis, Minnesota
55432-5604
USA
Website: http://www.medtronic.com
Company Location
Medtronic Plc is headquartered in Minnesota, U.S. The company currently operates in approximately
160 countries worldwide.

Medtronic, the world’s largest medical device company, is headquartered in Minneapolis, Minnesota. It
offers its solutions and services to alleviate pain and health restoration services. On January 26, 2015,
the company acquired Covidien plc in Ireland to form Medtronic plc with headquarters in Dublin,
Ireland. Post this acquisition the company has restructured its business segments.
The business segments of Medtronic are: Cardiac and Vascular Group, Minimally Invasive Therapies
Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group engages in
development, manufacturing and marketing of products for diagnosis, treatment and management of
heart rhythm disorders and heart failure. The business unit offers implantable devices, leads and
delivery systems, products for the treatment of atrial fibrillation (AF), products designed to reduce
surgical site infections, information systems for the management of patients with Cardiac Rhythm and
Heart Failure devices, and integrated health solutions.
The Minimally Invasive Therapies Group offers advanced surgical technologies and patient monitoring
and recovery products and solutions. The surgical solutions include stapling, vessel sealing, fixation
(hernia mechanical devices), mesh, hardware and surgical instruments, as well as wound closure, and
electrosurgical products. The patient monitoring and recovery solutions offers sensors, monitors,
temperature management, airway, ventilator and inhalation therapy, incontinence, wound care, enteral
feeding, urology, and suction operating room supply products, electrodes, and sharp safety products,
like needles, syringes, and sharps disposal.
The Restorative Therapies Group offers solutions catering to the treatment of spine and musculoskeletal
system, pain management, common movement disorders, spasticity, and urologic and gastrointestinal
disorders. The Diabetes Group offers solutions catering to the treatment and management of diabetes.
It offers insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management
software.
Financials
Table 75
Medtronic Company Revenue, 2014-2016
($ Millions)

Revenue 28,833 20,261 17,005
Operating income 5,291 3,766 3,813
Figure 65
Medtronic Revenue, by Business Unit, 2014-2016
($ Millions)
12,000.0
10,000.0
8,000.0
$ Millions
6,000.0
4,000.0
2,000.0
0.0
2014 2015 2016
Cardiac and Vascular Group Minimally Invasive Therapies Group

Restorative Therapies Group Diabetes Group
Figure 66
Medtronic Revenue, by Region, 2014-2016
($ Millions)
18,000.0
16,000.0
14,000.0
12,000.0
$ Millions
10,000.0
8,000.0
6,000.0
4,000.0
2,000.0
0.0
2014 2015 2016
U.S Non-U.S. Developed Markets Emerging Markets
Product portfolio
Table 76
Medtronic Anesthesia and Respiratory Devices-Product Portfolio
Product Description
Manages patient’s work of breathing and supports natural breathing
Puritan Bennett 840 ventilator
when compared to existing mechanical ventilation.
Puritan Bennett 980 Ventilator Designed for patients to breathe more naturally.
Designed for long term and hospital care facilities. It offers a full
Newport e360 Ventilator spectrum of features for flexibility for active management of cycling off
timing for every breath.
Puritan Bennett Neonatal Expiratory It is a disposable neonatal filter unit designed for Puritan Bennett980
Filtration System ventilator.
Shiley Evac Endotracheal Tube with It is designed for reducing ventilator-associated pneumonia by about
TaperGuard Cuff 50%.
Shiley Esophageal Endotracheal It allows blind placement without laryngoscope and used for emergency
Airway, Double Lumen airway management.
It is a video laryngoscope combining the benefits of both direct
McGRATH MAC Video Laryngoscope
laryngoscope and video laryngoscope.
It is a portable ventilator designed for use in home care, transport,
Newport HT70 Plus Ventilator hospital, long-term care and emergency preparedness, as well as for
invasive or noninvasive ventilation settings.
PHILIPS RESPIRONICS
Philips Healthcare
1010 Murry Ridge Ln.
Murrysville, PA 15668
Tel: (724) 733-0200
Website: wvvw.respironics.com
Company Location
Koninklijke Philips N.V. (or Royal Philips) is based out of the Netherlands. Philips Respironics is
headquartered in Pennsylvania, U.S. Royal Philips operates in 120 countries.

Royal Philips, as a group, is involved in numerous industries such as healthcare, consumer lifestyle and
lighting. The company has approximately 118,000 employees in 100 countries. The healthcare business
is divided into four business groups: Imaging Systems, Patient Care and Clinical Informatics, Home
Healthcare Solutions and Customer Services.
In 2008, Royal Philips acquired a U.S. based respiratory care company named Respironics. The Philips
Respironics is a part of Philips Healthcare arm which employed approximately 37,400 people worldwide
as of 2017.
Below is the list of Subsidiaries or entities under Philips Group.
Table 77
Royal Philips-List of Subsidiaries
Company Name Principal Country of Business

Metaaldraadlampenfabriek “Volt” B.V. Netherlands
Philips (China) Investment Company, Ltd. China
Philips Consumer Lifestyle B.V. Netherlands
Philips Domestic Appliances and Personal Care Company of Zhuhai SEZ, Ltd. China
Philips Electronics Hong Kong Limited Hong Kong
Philips Electronics Nederland B.V. Netherlands
Philips Electronics UK Limited United Kingdom
Philips GmbH Germany
Philips Japan, Ltd. Japan
Philips Medical Systems Nederland B.V. Netherlands
Philips Medizin Systeme Hofheim-Wallau GmbH Germany
Philips North America LLC United States
Philips Oral Healthcare, LLC United States
Philips Ultrasound, Inc. United States
Respironics, Inc. United States
RI Finance, Inc. United States
RIC Investments, LLC United States
Financials
In 2017 Philips Group reported sales revenue of US $21.9 billion (EUR 17.8 billion) and a growth of 2%
compared to the previous year. Below is the three-year revenue performance of the company:
Figure 67
Philips Sales Revenue, 2015-2017
($ Millions)
17,800.0
17,600.0
17,400.0
17,200.0
$ Millions
17,000.0
16,800.0
16,600.0
16,400.0
16,200.0
2015 2016 2017
Philips Group operates in three main segments namely Personal Health, Diagnosis & Treatment,
Connected Care & Health Informatics, HealthTech.
Figure 68
Philips Sales Revenue Shares, by Business Unit, 2016
(%)
HealthTech
Connected Care Other
& Health 2.3%
Informatics
17.5%
Personal Health
41.0%
Diagnosis &
Treatment
39.2%
Figure 69
Philips Sales Revenue Shares, by Business Unit, 2017
(%)
Connected Care
& Health HealthTech
Informatics Other
18.0% 2.4%
Personal Health
41.2%
Diagnosis &
Treatment
38.4%
Table 78
Philips Health-Business Segments
Personal Health Diagnosis & Treatment Connected Care & Health

HealthTech & Other
businesses businesses Informatics businesses
Patient Care &
Health & Wellness Diagnostic Imaging Innovation
Monitoring Solutions
Personal Care Image-Guided Therapy Healthcare Informatics Emerging Businesses
Population Health
Domestic Appliances Ultrasound IP Royalties
Management
Sleep & Respiratory Care Central costs
Other
Source: Company Website
Philips Respironics Revenue
Sleep and Respiratory care division under the company’s Personal Health is considered as Philips
Respironics. As per 2017 financial results, Philips Respironics’ revenue accounted 22% of the Philip’s
Personal Health business segment. Philips Respironics’ annual revenue was estimated to be US$ 1.9
billion.
Figure 70
Philips Health Revenue Share, by Division, 2017
(%)
Respironics (Sleep &

Respiratory Care) Health & Wellness
22% 21%
Personal Care
24%
Domestic Appliances
33%
Recent Developments
In 2017, the Philips Respironics’ product portfolio was further extended with the launch of the
connected Trilogy ventilator in North America, this device works with the company’s unique patient
management solution Care Orchestrator.
In 2017, a new product named DreamWear Pillow mask was introduced which enhanced the sales of the
DreamWear masks business.
In 2017, Philips acquired Respiratory Technologies, a U.S.-based provider of an innovative airway

clearance solution for patients with chronic respiratory conditions.
In China, Philips partnered with Oranger, a service provider specialized in chronic respiratory disease
management, and Health 100, the largest health examination organization in China, to provide
integrated solutions for chronic respiratory diseases that cover screening, referral, treatment and
recovery. As part of the agreement, Philips acquired a minority interest in Oranger.
Building on its strategy to deliver relevant solutions and business models, Philips acquired Australian
Pharmacy Sleep Services (APSS), a pioneer in pharmacy sleep testing. APSS will complement Philips’
sleep and respiratory care portfolio and will help to accelerate the business’s home sleep testing
offering through the pharmacy channel in Australia.
Product Portfolio
Philips Respironics is one of the major players in the global respiratory and anesthesia devices market.
The company offers a rich portfolio of devices, disposables and consumables ensuring end-to-end
respiratory and anesthesia requirements.
Below is a list of key devices offered by the company in various segments based on nature of the device-
• Anesthesia machines
• IntelliSave AX700-This is a full-length anesthesia platform designed by the company to
meet the patient needs.
• Siesta i TS- This is a touch screen interface, which was created to enhance the user
experience and ease for the users.
• MRI 508-This is a device specially designed to perform even in strong magnetic fields.
• Siesta i Whispa-This is a latest platform created by the company ensuring advanced
features and better flexibility.
• Patient Monitoring
The company offers a number of monitoring products from freestanding ambulatory surgical
centers to hospital-based anesthesia departments. The company's series of IntelliVue products
can share a common user interface. Products used in this solution include:
• IntelliVue MP80 and MP90-This system is useful for the high care environments.
• IntelliVue MP60 and MP70-A system that can be used for adult, pediatric and neonatal
intensive care; anesthesia and perioperative care; and cardiac care.
• IntelliVue MP40 and MP50-Enables care environments at the patient's side.
• IntelliVue MP20 and MP30-Used especially for the clinical environments.
• InteliVue MX450-This is a portable monitoring device offering sophisticated features in
small space.
• Respironics ventilators
Ventilators accelerate the patient’s path to natural breathing. They are used mainly in the
critical care facilities. Various products include:
• Respironics NM3- Provides monitoring of physiologic gas exchange, dead space, and
alveolar tidal volume.
• Respironics V60- This device was created using auto-adaptive technology which suffices
both patent synchrony and therapy acceptance. Improved signal processing technology
is finely tuned for both adult and pediatric patents.
• Respironics Trilogy 202-This device is employed as a part of providing invasive and
noninvasive ventilation and consists of both volume and pressure-control.
• Respironics Respi-Link-lt is a device that serves a s a coordinating system which enables
authorized Philips support specialists to securely access certain devices via the internet
monitoring.
• System integration
To enable mechanical and electrical systems to work together with human operators, an open
system allowing all patient monitors to be hooked up with the anesthesia machine, other
external devices, and information management systems, among others. Various products that
are used include:
• DeviceLink Il
• VueLink
• Clinical measurements
Respironics provides an integrated line of products which are very specific to measurement of
anesthesia. Products include:
• IntelliVue Anesthetic Gas Modules-Gl and G5: Measures the most commonly used
anesthetic gases, nitrous oxide (N20) and carbon dioxide (C02).
• MAC values-Provides a model of anesthetic potency with features including multi-
measurement module, and multi-measurement server.
• Microstream C02-This an advanced device for sidestream capnography.
• Bi-spectral Index-It is a sedation monitoring device which is used in the operation
theaters, intensive care units and other clinical settings.
• VueLink-This serves a s a connection between doctor and a patient by providing real-
time information from bedside monitors.
• Clinical decision support

These products are used to provide advanced support to the doctors and anesthesia care teams:
• CompuRecord-This information management system which aids the doctors and helps
in decision support with the realtime data represented in a simpler manner.
• Event Surveillance- Provides clinical correlation up to four parameters from IntelliVue
patient monitors.
• Home respiratory solutions
Nebulizers and compressors play a vital role in treating respiratory conditions. They provide
targeted respiratory drug delivery. The various products that are available are:
• Aeroneb GO-A basic nebulizer which is fast and simple to use.

• InnoSpire Mini-It is a small and light-weight device that allows patients to nebulize their
medications whenever they want.
• InnoSpire Elegance-Home based nebulizer with a powerful compressor and a compact
design.
• InnoSpire Deluxe-Advanced delivery system that ensures aerosol medication treatment
plans.
• InnoSpire Essence-Utilizes the company’s Sidestream technology that provides fast and
efficient aerosol drug delivery in a compressor nebulizer system.
• Sami the Seal-Sami the Seal pediatric compressor is shaped like a seal to appeal to
children, their parents and pediatricians, and to support aerosol therapy compliance.
• I-neb AAD system-The I-neb is a small, battery powered, lightweight and virtually silent
drug delivery device.
• Sidestream Plus-Philips Sidestream Plus is a breath-enhanced, reusable nebulizer
designed with improve drug delivery.
• Sidestream Nebulizer Reusable/Disposable-These Sidestream Nebulizers work similar to
the company’s Sidestream devices but are designed for shorter treatment times.
• Sidestream Masks-Specially designed patient masks for adult and pediatric patients.
• Pediatric Sidestream Masks-Sami the Seal and Tucker the Turtle child-friendly pediatric
character masks combine a soft, flexible material that contours to the face for comfort
and fit with a vent design that blows medication away from the eyes.
• Airway clearance-Threshold PEP is used for airway clearance, bronchial hygiene, or as an
alternative to chest physical therapy. The resistive load creates positive pressure during
exhalation that helps open the airways and allows mucus to be expelled.
• Digital imaging
There are two products as part of this solution which include ultrasound guided nerve block
solutions and live 3-0 echo.
RESMED INC
9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
Website: www.resmed.com
Company Location
ResMed Inc is a Delaware corporation formed in March 1994 as a holding company for the ResMed
Group in San Diego, CA, USA. Through its subsidiaries, the group designs, manufactures and markets
equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory
disorders, including OSA, COPD. ResMed manufacturing operations are in Australia, Singapore,
Malaysia, France, China and the U.S. Major distribution and sales sites are in the U.S., Germany, France,
the U.K., Switzerland, Australia, Japan, China, Norway and Sweden.
Company Background
ResMed Holdings Limited, was originally formed in 1989, through acquisition by Dr. Peter Farrell from
Baxter Center for Medical Research Pty Limited, or Baxter. This purchase included rights related to
certain technology relating to CPAP treatment as well as Baxter’s existing CPAP device business. Baxter
acquired the rights to the technology in 1987, and sold CPAP devices in Australia from 1988 until
ResMed’s acquisition of the business. In 1989, ResMed introduced its first CPAP device into the market.
In June 1995 the company completed an initial public offering of common stock and their common
stocks began trading on the NASDAQ National Market. In September 1999, the company transferred its
principal listing to the New York Stock Exchange, or NYSE, trading under the ticker symbol “RMD”. In
November 1999, ResMed established a secondary listing of their common stock via Chess Depositary
Instruments, or CDIs, on the Australian Stock Exchange (now known as the Australian Securities
Exchange), or ASX, also under the symbol “RMD”. Ten CDIs on the ASX represent one share of their
common stock on the NYSE.
As of 2017, the company consists of 6,080 employees and the products are sold approximately in 120
countries through a combination of wholly owned subsidiaries and independent distributors.
Financials
ResMed has been witnessing a consistent growth in terms of net sales and revenues in past few years. In
2017, the company has reported a net revenue of $ 2066.7 million (US$ 2.00 Billion).
63% of the company’s revenue was accounted by the devices sale in North America and Latin America.
26% of the company’s revenue was accounted by the devices sale in Europe and 11% from the Asia-
Pacific region.
Below are the annual revenues reported by the company.
Table 79
ResMed Net Revenue, 2014-2017
($ Millions)
Year Net Revenue

2014 1,544.9
2015 1,678.9
2016 1,838.7
2017 2,066.7
Figure 71
ResMed Inc, Annual Net Revenues, 2014-2017
($ Millions)
2,500.0
2,000.0
1,500.0
$ Millions
1,000.0
500.0
0.0
2014 2015 2016 2017
Recent Developments
During fiscal year 2017, ResMed launched AirMini, the smallest portable CPAP on the market which is
being developed with the similar concept of the company’s AirSense 10 product with waterless
humidification enabling portable convenience.
In the last five years the company launched below products into the market:
Table 80
ResMed’s Product Launches in Last Five Years
Product Name Device Type Launch Year and Month

AirSense 10 Elite CPAP Aug-14
AirSense 10 CPAP CPAP Aug-14
S9 VPAP ST-A VPAP Mar-13
S9 VPAP COPD VPAP Apr-13
AirCurve 10 S VPAP Dec-14
AirCurve 10 V Auto VPAP Dec-14
AirCurve 10 ST VPAP Dec-14
AirCurve 10 ASV VPAP Dec-14
AirCurve 10 CS VPAP Dec-14
AirSense 10 Auto APAP Aug-14
AirMini APAP May-17
Astral 100 and 150 Ventilator May-14
Activox Ventilator Jul-14
Lumis 100 and 150 Ventilator Apr-15
Lumis ST-A Ventilator Oct-15
Quattro Air Masks Jun-13
Swift FX Nano Masks Jun-13
AirFit P10 Masks Jan-14
AirFit F10 Masks Apr-14
AirFit N10 Masks Apr-14
AcuCare HFNC Masks Aug-15
AirFit F20 Masks Nov-16
AirFit N20 Masks Nov-16
AirTouch F20 Masks May-17
Apnealink Air Diagnostics Dec-13
EasyCare Data/Patient Management Apr-12
U-Sleep Data/Patient Management Aug-12
AirView Data/Patient Management Aug-14
myAir Data/Patient Management Oct-14
S+ Data/Patient Management Oct-14
Brightree Solutions Data/Patient Management Apr-16
Connectivity Module Data/Patient Management May-16
Product Portfolio
ResMed is a leading manufacturer of Respiratory and Anesthesia devices and consists of numerous
products related to this segment. Below is a brief overview of each product that has been launched in
last five years by the company:
CPAP Devices
• AirSense 10 Elite- This is an advanced fixed-pressure therapy device with an integrated
humidifier. It is designed to be intuitive and easy-to-use. The device also consists built-
in wireless connectivity.
• AirSense 10 CPAP- The AirSense 10 CPAP is a fixed-pressure therapy device. It provides

compliance, AHI and leak data reporting. This device also features built-in wireless connectivity.
VPAP Devices
• S9 VPAP ST-A- This device serves as a bilevel pressure support therapy device with pressures up
to 30 cmH2O. The device also has an optional integrated humidifier (H5i), ClimateLine heated
tube and the small, lightweight SlimLine tube.
• S9 VPAP COPD- This device serves as a bilevel pressure support therapy device with pressures
up to 30 cmH2O. This device has been specifically designed for COPD patients.
• AirCurve 10 S- This is a bilevel pressure support device for patients who need extra pressure
support or find it difficult to adjust to therapy on a fixed pressure continuous positive airway
pressure device. Features built-in wireless connectivity and works in compatible with ResMed’s
AirView patient monitoring software.
• AirCurve 10 V Auto- An auto-adjusting bilevel device for patients who need greater pressure
support to treat their obstructive sleep apnea. Features built-in wireless connectivity and works
compatible with ResMed’s AirView patient monitoring software.
• AirCurve 10 ST- This is a bilevel device with backup rate that provides exceptional patient-
ventilator synchrony, reducing the work of breathing so patients remain comfortable and well
ventilated. Features built-in wireless connectivity and works seamlessly with ResMed’s AirView
patient monitoring software.
• AirCurve 10 ASV- This is an adaptive servo-ventilator specifically designed to treat patients

exhibiting central sleep apnea (CSA), mixed sleep apnea and periodic breathing, with or without
obstructive sleep apnea. The device also features built-in wireless connectivity.
APAP Products
• AirSense 10 Auto- This is a premium auto-adjusting therapy device featuring AutoRamp with
sleep onset detection, expiratory pressure relief (EPR) and Easy-Breathe technology.
• AirMini- This product is the world’s smallest portable PAP device which provides a premium
auto-adjusting therapy featuring the same therapy modes used in the company’s AirSense 10
Auto. AirMini also consists of advanced features like built-in Bluetooth connectivity and
effective waterless humidification enabled by HumidX technology.
Ventilator Products
• Astral 100 and 150- This is a pressure support and volume ventilator for invasive and non-
invasive purposes. This product is suitable for hospital and home usage as well.
• Activox- This is a portable oxygen concentrator system which is compatible with the company’s
ventilator systems.
• Lumis 100 and 150- These are the pressure support non-invasive ventilators that support a
variety of therapy modes, which facilitates built-in wireless connectivity and integrated
humidification.
• Lumis ST-This product is a pressure support non-invasive ventilator that supports a variety of
therapy modes, built-in wireless connectivity, integrated humidification and a range of fixed and
adjustable alarms.
Masks and Nasal pillows
• Quattro Air, Swift FX Nano- Both products are the lightweight full-face masks which offer
improved comfort, fit and ease of use.
• AirFit P10- This is a lightweight nasal pillows system that has two parts, including a soft pillow
and stable QuickFit headgear.
• AirFit F10- A compact, lightweight full-face mask designed for improved comfort and stability.
• AirFit N10- This is a compact nasal mask offering better comfort and visual freedom for the user.
• AcuCare HFNC- The AcuCare high-flow nasal cannula (HFNC) is specially used for high flow
oxygen therapy.
• AirFit F20-and AirFit N20- This are full-face masks that feature an InfinitySeal silicone cushion
that adapts to the unique facial contours of each patient offering increased comfort and
reduced leakage.
Diagnostics
Apnealink Air-This is a portable diagnostic device which measures oximetry, respiratory effort, pulse,
nasal flow and snoring. It works with the EasyCare Online interface to provide comprehensive diagnostic
solution to clinicians.
Data/Patient Management Systems

• EasyCare- This product is ResMed’s compliance management solution that offers both wireless
and card-to-cloud functionality. This system provides access to patient data anywhere with an
internet connection. Simple user interface, reports and automated compliance notifications are
some salient features of the system.
• U-Sleep- This is a compliance solution created by the company that monitors CPAP device usage
and helps the specialists to manage their patients during their initial acclimatization and ongoing
therapy.
• AirView- This is a cloud-based system enabling remote monitoring and changing of patients’
device settings.
• myAir- This is ResMed’s personalized therapy management application specially designed for
patients with sleep-disordered breathing. It provides support, education and troubleshooting
tools ensuring patient engagement and improved compliance.
• S+- A personalized sleep solution developed by the company that uses patented bio-motion
sensors, designed to measure an individual’s sleep stages and environment, and deliver
personalized feedback that helps sleep improvement.
SMITHS MEDICAL
6000 Nathan Lane North
Minneapolis, MN 55442
Tel: 614/210-7300
Website: www.smiths-medical.com
Company Location
Smiths Medical is headquartered in MN, US. The company operates in more than 30 countries with
manufacturing concentrated in the U.S., the U.K., Mexico, Italy, Germany, Czech Republic and China. The
company is currently operating sales in approximately 120 countries through direct and distributor
networks.
Smiths Medical is a division of Smiths Group plc, a global technology company. This company started in
1940 as Portland Plastics in London which was producing plastic consumables for medical and dental
surgeries. Since 1979, the company managed to rapidly progress with numerous acquisitions and
investments. A few of the company’s key acquisitions include Concorde Laboratories in 1979, Downs
Surgical in 1984, Avon Medicals in 1988, H.G. Wallace and Intertech in 1992, Graseby Medical in 1997,
Bivona (respiratory product range) in 2001, DHD Healthcare (respiratory specialty) in 2004 and Medex
Inc (critical care, diagnostic and therapeutic specialty).
Smiths Medical is one of the leading suppliers of medical devices and consumables for patient care.
The company currently employs more than 7,800 people.
The company functions in various countries effectively through its key subsidiaries which are:
• Smiths Medical International Limited (U.K.).

• Smith Medical France SA (France).
• Smiths Medical Deutschland GmbH (Germany).
• Smiths Medical ASD, Inc (U.S.).
• Smiths Medical Japan Limited (Japan).
The company focuses on three specialties:
Infusion Systems - Consists of fluid and medication delivery devices which are used for the treatment of
acute and chronic diseases and pain management.
Vital Care and Specialty products - Vital care devices are designed for use during surgeries for managing
patients’ airways and body temperature. Specialty products include products for the specialty care areas
including in vitro diagnostics, fertilization, veterinary health, transport ventilation, patient monitoring
and medical device manufacturing.
Vascular Access - Devices that allow healthcare professionals to access patients’ vasculature for delivery
and withdrawal of fluid and medication.
Financials
Smiths Medical’s 2017 annual revenue was US $1.33 Billion (£951million) which was 29% of Smiths
group. Around 82% of Smiths medical's revenue was from single-use devices used in daily hospital
procedures. The remaining 18% was from capital equipment, such as infusion pumps.
Figure 72
Smith Medical Revenue Share, by Sector, 2017
(%)
Vital care and Infusion systems

speciality products 32%
35%
Vascular Access
33%
Source: Company Annual SEC File
Product Portfolio
Airway & Anesthesia
The company’s anesthesia breathing circuit accessories under the brand name Portex includes a number
of products to meet different anesthesia needs. These products are mostly single use and include
standard and gas sampling connectors, breathing bags, masks and scavenging tubes.
Anesthesia Breathing Circuits

These include:
• Disposable anesthesia breathing circuits.

• Adult disposable anesthesia breathing circuits.
• Pediatric disposable anesthesia breathing circuits
• Disposable single limb anesthesia breathing circuits.
• Single-use non-rebreathing anesthesia breathing circuits.
• Non-rebreathing single-use anesthesia breathing circuits
• Ventilator breathing circuits.
• Ventilator breathing circuit accessories and water traps.
Bivona tracheostomy tubes
This range has 21 different products, broadly categorized as follows:
• Bivona Customized Tracheostomv Tube Service.
• Bivona Tracheostonw Tube Accessories.
• Bivona Tracheostonw Neonatal and Pediatric.
• Bivona Tracheostonw Tubes Adult.
• Smiths Medical Tracheostomy Neonatal and Pediatric.
Endobronchial tubes
The company’s Portex product line includes a large range of endobronchial tubes in six sizes: 28, 32, 35,
37, 39 and 41 French sizes, in both left and right orientations.
Endotracheal tubes
The company’s Portex has a new range of endobronchial tubes that meets the needs of pediatric
patents.
Portex tracheostomy tubes

The company offers numerous products in this range, few key products include:
• The Smiths Medical tracheostomy head.

• Tracheostomy tubes accessories.
• Tracheostomy tubes adult.
• Blue Line Cuffed, Blue Line Ultra, Blue Line Ultra Change Kits, Blue Line Ultra-Tube.
• Kits, Blue Line Uncuffed (Non USA), DIC DIC Flex, UniPerc.
• Portex Cole's Neonatal Tube.
• Tracheostomy tubes inner cannula.
Ventilation
Pneupac ventilators, such as the VRI or the paraPAC, can function in various demanding scenarios such
as the high magnetic field of an MRI scanner to life threatening toxic environments. The compPAC
ventilator is designed for military use.
TELEFLEX
550 E. Swedesford Rd
suite 400
wayne, PA 19087-1603
Tel: 610/225-6800
Website: www.teleflex.com
Company Location
Teleflex is headquartered in Pennsylvania, U.S. The company manufactures its products at
approximately 30 manufacturing sites, with major manufacturing operations located in the Czech
Republic, Germany, Malaysia, Mexico and the U.S.

The company began in 1943, with one product, a multi-strand helical cable and a gear that could convert
push-pull motions into rotary motions. Initially Teleflex was operating as a company focused on
engineering to become a diversified industrial company and later transitioned to a pure medical device
company. Teleflex is now a global provider of medical technology products for clinical use. Teleflex’s
primary focus is to design, develop, manufacture and supply single-use medical devices used by
hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care
and surgical applications. The company markets and sells their products to hospitals and healthcare
providers worldwide through a combination of a direct sales force and distributors.
Teleflex employed approximately 12,600 as of 2016. Of these employees, approximately 2,900 were
employed in the U.S. and 9,700 in other countries.
The company mainly operates as four segments:
• Anesthesia.
• Vascular.
• Surgical.
• Speciality Care.
Mergers and Acquisitions

Teleflex has been actively involving in partnerships, active mergers and acquisitions to progress towards
growth and stronger business base. A list of key acquisitions by Teleflex in last few years includes:
2017
• Acquired Tianjin Medis Medical Co. LTD, which earlier served as a contract manufacturer of the
company's laryngeal masks. The aggregate consideration for the assets was US$ 21.3 million.
• Acquired Pyng Medical Corp ("Pyng"), a medical device company that develops and markets
sternal intraosseous infusion products, which complement the company's anesthesia product
portfolio. The aggregate consideration for the assets was US$ 17.9 million.
2016
• Acquired certain assets of CarTika Medical, Inc., ("CarTika"), an original equipment manufacturer
(OEM) of catheters and other medical devices that complement the company's OEM product
portfolio.
• Acquired remaining 24% of stake in Teleflex Medical Private Limited, India (74% already owned)
with an ownership interest from the non-controlling shareholders. Teleflex Medical Private
Limited is part of the company's Asia reportable operating segment.
• Acquired Truphatek Holdings Limited ("Truphatek"), a manufacturer of a broad range of
disposable and reusable laryngoscope devices that complement the company's anesthesia
product portfolio. Previously, the company held a non-controlling 6% interest in Truphatek.
2015
• Acquired Human Medics, a distributor of Teleflex products in Korea.
• Acquired Truphatek, a manufacturer of disposable and reusable laryngoscope devices.
• Acquired Trintris Medical, an OEM supplier of balloon catheters.
• Acquired exclusive North American distribution rights to AutoFuser® range of disposable pain
pump products from Ace Medical.
• Acquired N. Stenning & Company, a distributor of Teleflex surgical products in Australia.
• Acquired Atsina Surgical, a developer of surgical clips.
• Acquired Nostix LLC, Catheter Tip Placement Solutions.
2014
• Acquired assets of MiniLap Technologies, Inc.
• Acquired Mayo Healthcare, a distributor of Teleflex products in Australia.
2013
• Acquired Eon Surgical, Ltd, micro-laparoscopy surgical technology.
• Acquired Ultimate Medical and its affiliates, technology for laryngeal masks and other airway
management devices.
• Acquired Vidacare Corporation, leading technology platform for intraosseous access devices.
2012
• Acquired assets of Axiom Technology Partners, LLC, which makes the EFx family of laparoscopic
fascial closure.
• Acquired EZ-Blocker disposable catheter product line.
• Acquired Hotspur Technologies, Inc.
• Acquired assets of LMA International N.V.
• Acquired Semprus BioSciences.
Financials
Teleflex’s 2016 annual revenue was $ 1.86 billion. Below was the financial performance of the company
in last three years:
Figure 73
Teleflex Annual Revenue, 2014-2016
($ Millions)
1,880.0
1,870.0
1,860.0
1,850.0
1,840.0
$ Millions
1,830.0
1,820.0
1,810.0
1,800.0
1,790.0
1,780.0
1,770.0
2014 2015 2016
North America has been the company’s major business base and it has been consistently playing a key
role in the company’s revenue generation. In 2016, North America’s share was 48% percent of the
company’s consolidated revenue.
Figure 74
Teleflex Revenue Shares, by Region, 2016
(%)
Others
12%
APAC
13%
North America
48%
EMEA
27%
Source: Company Annual Report, 2016
North America anesthesia division revenues for the years 2014-2016 were reported as below-
Table 81
Teleflex, North America Anesthesia Segment Revenues, 2014-2016
($ Millions)
Revenue
Year
($ Millions)
2014 183.9
2015 189.2
2016 198.8
Source: Company Annual SEC File, 2016
Product Portfolio
Teleflex is a leading manufacturer of medical devices for vascular access, respiratory care, cardiac care,
urology, surgery, orthopedic devices and specialty medicine. Below is a brief overview of company’s
product areas:
Vascular access
Devices include central venous catheters, peripherally inserted central catheters, catheter navigation
and location technology, micro-introducers and arterial access products.
Interventional access
Devices include Hemodialysis catheters, declottng devices, angioplasty balloon catheters, paracentesis
and thoracentesis devices.
Anesthesia
Devices include laryngeal masks, endotracheal tubes, epidural catheters, stimulators and neuromuscular
blocking agent monitors, spinal anesthesia and pain management PCA pumps.
Respiratory
Devices used for aerosol delivery, oxygen therapy, humidification, bacterial/viral filtration, asthma
management and spirometers.
Urology
Devices include foley balloon catheters, intermittent catheters, suprapubic urine drainage, urethral
dilation, ureteral catheters, nephrostomy, devices for stones and guide wires.
Surgical
Devices and instruments used for ligation, cardio-thoracic surgery and drainage. Surgical instruments,
trocars/ports, fiberoptic lighting systems and laparoscopic closure devices are few more devices sold by
the company.
Cardiac care
Devices include AutoCAT 2 WAVE IABP, FiberOptix IAB catheter, Conventional IAB catheters,
thermodilution catheters, wedge pressure catheters, Berman Angiographic, angioplasty balloon
catheters and TransRadial access kits.
Teleflex is one of the key players in the anesthesia and respiratory devices market. Under this market
segment the company is mainly dealing with below product segments:
• Airway management products

• Atomization
• Pain management
• Caregiver safety
Airway Management Products
Teleflex’s airway management products and related devices consist principally of the following:
LMA Airways: There are multiple devices which are produced under this product line namely LMA
laryngeal masks- Used by anesthesiologists and emergency responders to establish an airway to channel
anesthesia gas or oxygen to a patient's lungs during surgery or trauma.
The LMA Protector Airway- The company’s latest airway management device, is the single-use laryngeal
mask with a dual gastric drainage channel and pharyngeal chamber designed specifically to channel high
volume, high pressure gastric contents away from the airway. It also integrates company’s Second Seal
technology to isolate the respiratory tract from the digestive tract, reducing the risk of aspiration of
gastric contents. The LMA Protector Airway also includes Teleflex’s Cuff Pilot technology, which enables
clinicians to confirm that the inserted cuff is properly inflated and to monitor pressure levels.
RUSCH Endotracheal Tubes and Laryngoscopes: Teleflex offers a broad portfolio of products to facilitate
and support endotracheal intubation to administer oxygen, and anesthetic gases in multiple settings
(surgery, critical care and emergency settings).
Laryngoscopes- The company offers a wide range of products for laryngoscopy, a procedure that is
primarily used to obtain a view of the airway to facilitate tracheal intubation during general anesthesia
or CPR. One of the ey products under this category is the Rusch DispoLED Laryngoscope Handle and
Green Rusch Lite Blade, a single-use system designed to help facilities comply with standards designed
to reduce the potential for patient cross-contamination associated with reusable devices during
intubation.
Atomization Products
LMA Atomization
The LMA atomization portfolio includes products designed to facilitate atomized delivery of certain
medications. The key product among the portfolio is LMA MAD Nasal, an intranasal mucosal atomization
device that is designed to provide a safe and painless way to deliver medications approved for intranasal
delivery to a patient's blood stream without an intravenous line or needle.
Pain Management Products

The company offers pain management products, which are designed for use in a broad range of surgical
and obstetric procedures, consist principally of the following:
Arrow Epidural Catheters, Needles and Kits: Teleflex offers a broad range of Arrow epidural products,
including the Arrow FlexTip Plus epidural catheter, to facilitate epidural analgesia. Epidural analgesia
may be used separately for pain management, as an adjunct to general anesthesia, as a sole technique
for surgical anesthesia and for post-operative pain management.
Arrow Peripheral Nerve Block ("PNB") Catheters, Pumps, Needles and Kits: Arrow PNB products include
the Arrow Stimucath and FlexBlock catheters, are designed to be used by anesthesiologists to provide
localized pain relief by injecting anesthetics to deliberately interrupt the signals travelling along a nerve.
Nerve blocks are used in a variety of different procedures, including orthopedics.
AutoFuser Disposable Pain Pumps: AutoFuser Disposable Pain Pumps are designed for general infusion
use, which includes regional anesthesia and pain management. Routes of administration include
percutaneous, subcutaneous and epidural, and into the intra-operative (soft tissue/body cavity) sites.
The AutoFuser offers multiple reservoir sizes and configurations to meet a variety of clinical demands.
Arrow EZ-IO System: The EZ-IO system is one of the key products in the pain management product
portfolio administered in pre-hospital emergency settings.
Caregiver Safety
This product line is mainly related to patient safety and safe delivery systems. One of the key products in
this category is ISO-Gard mask, this mask was designed with the company’s ClearAir technology and
ensures safety of patient via monitored air supply.
Recent Developments
• Acquired Tianjin Medis Medical Co. LTD, which earlier serving as a contract manufacturer of the
Company's laryngeal masks.
• Acquired Pyng Medical Corp, a medical device company that develops and markets sternal
intraosseous infusion products, which complements the company's anesthesia product
portfolio.
About BCC Research
About BCC Research
With our unparalleled 45-year history, BCC Research provides comprehensive analyses of global market
sizing, forecasting and industry intelligence, covering markets where advances in science and technology
are improving the quality, standard and sustainability of businesses, economies and lives.
BCC Membership
From market sizing and forecasts, to opportunity assessments and competitive analyses, our ever-
expanding library gives you the data, insights and intelligence required to ensure your project is a
success. Members benefit from ongoing, unlimited access to the category or collections of their choice,
and most membership packages pay for themselves within two to three reports being accessed.
Did you buy this report? You may qualify to apply your purchase price towards a full membership. Call
866-285-7215 or email info@bccresearch.com to request a demo.
BCC Custom Research

Our experts provide custom research projects to those working to identify new markets, introduce new
products, validate existing market share, analyze competition and assess the potential for products to
impact existing markets. With impressive academic credentials and broad and deep knowledge of global
industrial markets, our independent analysts and consultants develop the facts, figures, analysis and
assessments to inform the decisions that will move your company ahead. Confidential inquiries to:
custom@bccresearch.com or 781-205-2429.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of
publication and is of a professional nature. This information does not constitute managerial, legal or
accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an
endorsement of any product, as much of the information is speculative in nature. BCC Research and the
author assume no responsibility for any loss or damage that might result from reliance on the reported
information or from its use.
ISBN: 978-1-62296-746-9
June 2018

Anesthesia and Respiratory Devices - BCC 2018

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Anesthesia and Respiratory Devices - BCC 2018

Uploaded by

Copyright:

Available Formats

Anesthesia and

BCC Research Staff

Report Code: HLC167C

Chapter 2: Summary and Highlights ..................................................................... 11

Chapter 4: Market Dynamics ............................................................................... 27

Chapter 5: Market Breakdown by Product Type .................................................. 40

Chapter 7: Patent Review/New Developments .................................................. 110

Chapter 8: Pipeline Analysis ............................................................................... 124

Chapter 9: Company Share Analysis ................................................................... 127

Chapter 10: Company Profiles ........................................................................... 133

• Anesthesia machines that contain and dispense the anesthetic vapor.

Study Goals and Objectives

Reasons for Doing This Study

Airway and Anesthesia devices:

Pain Management Devices.

Regional Anesthesia Disposables:

Respiratory Measurement Devices:

Sleep Apnea Diagnostic Systems:

• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers

Rest of World (ROW)

Airway and Anesthesia Devices

Pain Management Devices

Regional Anesthesia Disposables

Anesthesia and Respiratory Devices,

Respiratory Measurement Devices

Sleep Apnea Diagnostic Systems

Related BCC Research Reports

Source: BCC Research

Respiratory Devices Respiratory Measurement Devices

Source: BCC Research

Source: BCC Research

North America Asia Pacific Europe ROW

Source: BCC Research

Types of Anesthesia and Respiratory Devices

Airway Management Devices

Disposable Anesthesia Masks

Reusable Anesthesia Masks

Disposable Laryngoscope Blades

Reusable Laryngoscope Blades

Disposable Laryngoscope Handles

Reusable Disposables Laryngoscope Handles

Portable Anesthesia Delivery Machines

Stand Alone Anesthesia Delivery Machines

Pain Management Devices

Regional Anesthesia Disposables

Epidural Anesthesia Disposables

Peripheral Anesthesia Disposables

Spinal Anesthesia Disposables

Portable Compressor Nebulizers

Portable Ultrasonic Nebulizers

Standalone Compressor Nebulizer

Standalone Ultrasonic Nebulizers

Fixed Oxygen Concentrators

Portable Oxygen Concentrators

Positive Airway Pressure Devices

Automatic Self Adjusting Positive Airway Pressure (APAP) Devices

Bi-level Positive Airway Pressure (BPAP) Devices

Critical Care Ventilators

Cardio-Pulmonary Resuscitation (CPR) barriers

Pulse Oximeter Systems

Finger Pulse Oximeters

Handheld Pulse Oximeters

Tabletop Pulse Oximeters

Wrist Pulse Oximeters